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Summary 
Saponins are widely distributed among flowering plants and some marine invertebrates and serve in 
defense for these organisms. Their amphiphilic molecules are composed of a lipophilic aglycone and one 
or more hydrophilic sugar moieties, giving them a high degree of structural diversity. Their biological 
and pharmacological activities range from antimicrobial, antifungal, anticancer, to immunomodulatory, 
etc. The most prominent feature of saponins is linked to their effects on cell membranes; they strongly 
affect cell membrane structure and integrity by different mechanisms depending on their chemical 
structure. The ability of saponins to increase membrane permeability can be used to facilitate the 
passage of drug molecules or other natural products through the cell membrane. The ability of saponins 
to affect cell membrane structure and integrity makes them interesting natural products in 
pharmacological and medical research and therapy, in particular as agents for enhancing drug efficacy. 
Saponins are known to interact with cholesterol in cell membranes by forming complexes. Until 
recently, there has been limited information on their potential as cytotoxicity-enhancing agents and on 
their molecular mechanisms of action on the membrane.  
This study explores the mechanisms of action of saponins on membranes and their effects in enhancing 
the cytotoxicity of certain anticancer drugs/toxins as applied to various cancer cell lines. Two different 
kinds of saponins were chosen (digitonin, a steroid saponin, and quillaja extract, a triterpenoid saponin 
mixture). These were investigated in combination with the anticancer drugs berberine, cisplatin, 
doxorubicin, dexamethasone, and mitomycin C, as well as with the polar toxin ricin (extracted from 
castor beans), on HeLa, COS-7, MIA PaCa-2, and PANC-1 cancer cell lines. The associated molecular 
mechanisms of action on membranes were investigated by employing a series of bioanalytical/ 
biophysical techniques: 1) MTT assay (a formazan test) which measures cell viability;  
2) hemolysis (microscopic screening of erythrocytes) to measure the degree of membrane destruction; 
3) dynamic light scattering (DLS) on large unilamellar vesicles (LUVs) to observe and quantify 
membrane leakage; 4) fluorescene/confocal microscopy of giant unilamellar vesicles (GUVs) to visualize 
membrane permeability; 5) quartz crystal microbalance with dissipation (QCM-D), dual polarization 
interferometry (DPI), and high-energy specular X-ray (XRR) showing structural changes in supported 
lipid bilayers (SLB), and 6) differential scanning calorimetry (DSC) which reveals thermotropic features 
of membranes resulting from saponin action. 
Digitonin and quillaja extract both enhance the cytotoxicity of the selected anticancer drugs in several 
cancer cell lines, the effect being either synergistic or additive. Quillaja saponin exerts a stronger 
cytotoxicity-enhancing effect than digitonin. The highly toxic monodesmosidic digitonin causes 
complete disruption of membranes at very low concentrations. The membrane activity of saponins 
strongly depends on the presence and amount of cholesterol in the membrane. Digitonin destroys 
GUVs, while quillaja saponin rather leads to pore formation. The relatively stable pores formed by the 
quillaja saponin-cholesterol complexes have a diameter of about 1 nm, only allowing passage of small-
size molecules. Digitonin removes cholesterol from the inner membrane layer with formation of an 
additional layer on the outside, which eventually leads to membrane disruption. The quillaja saponins 
penetrate into the inner membrane layer forming complexes with cholesterol. The stabilized complexes 
form pores, which allow passage of water and other small molecules. Both sugar chains of the 
bidesmosidic quillaja saponins play an important role in stabilizing the pore formation in the membrane. 
Here, and for the first time, we report the occurrence of monodesmosides in the employed 
commercial quillaja saponin extract. The presence of both bidesmosides and monodesmosides in the 
quillaja saponin extract may be responsible for its bioactivity and pharmacological effects. 
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Zusammenfassung 
Saponine sind weit verbreitete sekundäre Stoffwechselprodukte, die in Blütenpflanzen, aber auch in 
einigen wirbellosen Tieren vorkommen und vor allem der Verteidigung dienen. Saponine bestehen 
aus einem lipophilen Aglykon und einer oder mehreren hydrophilen Zuckerketten; letztere sind sehr 
vielgestaltig und bilden eine große Anzahl unterschiedlicher Strukturen. Das Wirkungsspektrum der 
Saponine erstreckt sich von antibakteriell, antimykotisch und krebshemmend bis immunstimulierend 
– was vor allem auf deren Interaktion mit Zellmembranen beruht. Der Effekt auf die Zellmembran 
variiert je nach Art der Molekülstruktur der Saponine. Saponine bilden in der Zellmembran komplexe 
Verbindungen mit Cholesterin. Die exakten Wirkmechanismen der Saponine auf die Zellmembran 
sind allerdings noch unzureichend erforscht. 
Saponine erhöhen die Membranpermeabilität. Dies wird bereits genutzt, um die Wirksamkeit von 
intrazellulär agierenden Medikamenten zu verstärken. Die Möglichkeit der Zytotoxizitätsverstärkung 
von krebshemmenden Medikamenten bietet ein interessantes und weites Feld für die Zellforschung 
und für klinische Studien. 
Die vorliegende Arbeit konzentriert sich auf die spezifischen Effekte von Saponinen auf verschiedene 
Membranmodelle und die Zytotoxizitätsverstärkung verschiedener Zytostatika/Toxine durch 
Saponine an verschiedenen Krebszelllinien. Dazu wurden zwei unterschiedliche Saponine  
(Digitonin, ein Steroidsaponin, und Quillaja-Extrakt, ein Triterpenoidsaponin-Gemisch) mit Berberin, 
Cisplatin, Doxorubicin, Dexamethason, Mitomycin C, sowie Rizin kombiniert und an vier Krebs-
zelllinien untersucht (HeLa, COS-7, MIA PaCa-2, und PANC-1). Der molekulare Wirkungsmechanismus 
auf die Membran wurde mit verschiedenen bioanalytischen/biophysikalischen Messmethoden 
analysiert:  
1) MTT-Test (ein Formazan-Test) zur Messung der Zellvitalität;  
2) Hämolyse (Mikroskopie von Erythrozyten), ermittelt den Grad der Zerstörung von Zellmembranen;  
3) DLS (Dynamische Lichtstreuung) an LUVs (große lamellare Vesikel), misst die Membrandurchlässigkeit;  
4) Fluorescein/Konfokalmikroskopie an GUVs (riesige lamellare Vesikel) zur Visualisierung der 
    Membrandurchlässigkeit;  
5) QCM-D (Quarzkristall-Mikrowaage), DPI (Doppelpendelinterferometrie), und XRR (Röntgenreflektometrie), 
     zeigen Veränderungen der Struktur von SLBs (unterstützte Lipiddoppelschichten);  
6) DSC (Differentialkalorimetrie), gibt Hinweise auf thermotrope Eigen-schaften von Membranen. 
Sowohl Digitonin als auch Quillajaextrakt erhöhen die Zytotoxizität der hier eingesetzten Zytostatika 
gegenüber mehreren Krebszelllinien, synergistisch oder additiv, je nach Zytostatikum/Toxin und 
Zellart. Quillajaextrakt (bestehend aus Bisdesmosiden) erhöht die Zytotoxizität der verwendeten 
Zytostatika in einem höheren Maße als Digitonin. Das stark giftige Digitonin (ein Monodesmosid) 
führt bereits bei niedriger Konzentration zur Zerstörung der Membran. Die Untersuchungen belegen, 
dass der Membran-Effekt hauptsächlich auf der Interaktion der Saponine mit Cholesterin beruht. 
Digitonin zerstört GUV-Vesikel, während Quillajaextrakt dort lediglich zu Porenbildung führt, was 
die unterschiedliche Wirkung der beiden Saponine bezüglich der durch sie bedingten Erhöhung der 
Zytotoxizität der verwendeten Zytostatika erklärt. Die Porengröße der Quillajaextrakt-Cholesterin-
Komplexe beträgt ca. 1 nm, wodurch nur entsprechend kleine Wirkstoffe in die Zelle gelangen 
können. Digitonin führt zu Cholesterinverlust der inneren Membranschicht und zusätzlicher 
Cholesterinauflage der Außenmembran, und schließlich zur Zerstörung der Membran. 
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Quillajaextrakt dringt in die innere Membranschicht ein und bildet dort mit Cholesterin stabile 
Komplexe und eindeutig definierbare Poren in der Membran. Wasser und andere kleine Moleküle 
können somit die Membran ungehindert passieren. Das Vorhandensein von zwei Zuckerketten in der 
Struktur der bisdesmosidischen Quillaja-Saponine spielt dabei eine wesentliche Rolle. Hier berichten 
wir zum ersten Mal von Monodesmosiden in einem handelsüblichen Quillaja-Saponin.  
Das Vorhandensein von sowohl Bisdesmosiden als auch Monodesmosiden in Quillaja-Extrakten 
scheint für die Gesamt-Bioaktivität und die pharmakologische Wirkung entscheidend zu sein.  
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1 Introduction 
1.1 Saponins – structure and classification 
Saponins are natural glycosides, which are widely distributed in the plant kingdom and some 
marine animals like sea cucumbers (Holothuriidae) and sea stars (Asteroidea) (Caulier et al. 
2011; Andersson et al. 1989). Their amphiphilic molecular structure is due to a lipophilic 
aglycone and one or more hydrophilic sugar side chains. A main characteristic of saponins is 
their foaming, soap-like behavior in aqueous solution, leading to their name (Latin sapo = 
soap). Many plant extracts containing saponins, especially obtained from Saponaria officinalis 
(soap wort) and Quillaja saponaria (soapbark), traditionally have been used as soaps (Vincken 
et al. 2007; Augustin et al. 2011; Hostettmann and Marston 2005). 
 The aglycone moiety of saponins is generally referred to as the sapogenin, to which one or 
more sugar molecules are attached. Two classes of saponins are distinguished based on their 
type of aglycone; triterpene (or triterpenoid) saponins and steroid (or steroidal) saponins. 
Steroidal glycoalkaloids have been considered as a third type of saponins because their 
structural characteristics suggest a similar biosynthetic origin and their biological activities 
resemble those of steroidal saponins but their aglycones contain a nitrogen atom which 
classifies them as a separate group (Hostettmann and Marston 2005; Vincken et al. 2007). 
From a structural point of view, Vincken et al. suggested to omit steroidal glycoalkaloids from 
the class of saponins due to the occurrence of the characteristic nitrogen atom in the 
aglycone. Based on the carbon skeleton of the saponin aglycone, the latter authors proposed a 
detailed classification of saponins into 11 main classes: dammaranes, tirucallanes, lupanes, 
hopanes, oleananes, taraxasteranes, ursanes, cycloartanes, lanostanes, cucurbitanes, and 
steroids. The dammaranes, lupanes, hopanes, oleananes, ursanes, and steroids are further 
divided into 16 subclasses, because their carbon skeletons are subject to fragmentation, 
homologation, and degradation reactions. The oleanane skeleton is the most common 
representative in most of the orders of flowering plants (Fig. 1.1). 
 Both types of saponin aglycones have been synthesized from 2,3-oxidosqualene, a main 
metabolite in sterol biosynthesis. Saponin biosynthesis follows the isoprenoid pathway where 
three molecules of isopentenyl pyrophosphate (IPP), each consisting of five carbon atoms 
linked together in a head-to-tail manner, form a 15-carbon molecule, farnesyl pyrophosphate 
(FPP). Two molecules of FPP linked together resulting a 30-carbon molecule called squalene 
(Holstein and Hohl 2004; Vincken et al. 2007). The enzyme squalene monooxygenase converts 
squalene into 2,3-oxidosqualene, which becomes the precursor for the saponin aglycone.  
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Fig. 1.1. Main classes of carbon skeletons of saponins 
 
Cyclization of oxidosqualene leads up to all main classes of saponin aglycones. The cyclization 
process begins with oxidosqualene being converted into cyclic derivatives via protonation and 
opening of the epoxide ring leading to several types of cyclization reactions. After cyclization, 
subsequent rearrangements can proceed in different ways by a series of hydride shifts and/or 
methyl migrations, which lead to the formation of new carbocations. At the end of the 
process, the carbocations are neutralized by proton elimination to give double bonds or 
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cyclopropanyl rings or by reaction with water to give a hydroxyl group (Vincken et al. 2007; 
Haralampidis et al. 2002). The cyclization and rearrangement process results in triterpenoid 
aglycones (Abe et al. 1993; Haralampidis et al. 2002; Augustin et al. 2011) and cholesterol 
which can lead to steroid aglycones via oxidation at C-16, C-22, and C-26/27 and subsequent 
cyclization of the oxygenated cholesterol leading to the formation of the spiroketal ring (Sahu 
et al. 2008). 
 Saponins are also classified based on the number of sugars attached to the aglycone 
backbone. In monodesmosidic saponins the sugar chain is bound only to one particular 
position of the aglycone, mostly to the C-3 hydroxyl group. The glycosidic chain can be built of 
up to 11 sugar units and may also be branched. Saponins having two sugar chains attached to 
the aglycone are called bidesmosidic; here, one sugar chain is linked to the C-3 hydroxyl group 
and the other by an ester linkage to the C-28 carboxyl group. A third group, the tridesmosidic 
saponins, where three sugar chains are attached at different positions of the aglycone, is 
rather rare though. Aside from sugars, there may be other substances attached to the 
aglycone, such as small aliphatic and aromatic acids, monoterpene derivatives, or acyl groups 
(Vincken et al. 2007; Hostettmann and Marston 2005; Augustin et al. 2011).  
 
1.1.1 Digitonin – a steroid saponin 
Digitonin is a widely employed steroid glycoside from the plant of the foxglove, Digitalis 
purpurea (family Plantaginaceae) (Fig. 1.2). The plant is a common native to temperate Europe 
and naturalized in parts of North America and other regions of the temperate zone. The 
potency of Digitalis purpurea was first reported by William Withering in 1775, who referred to 
it as a remedy for treating dropsy. Since then chemists and pharmacologists have explored the 
potency of foxglove. Several active substances have been isolated, such as digitoxin, which is 
considered the most valuable constituent due to its cardiac activity and value as a therapeutic 
agent. Digitonin, in contrast, has no cardiac effect (Dixon 1912; Brown et al. 1962).  
 Later, digitonin was found to interact with cholesterol and affect cell membrane integrity 
and structure (Miller 1984; Nishikawa et al. 1984). Digitonin causes cell lysis, forming a rigid 
and immobilizing complex with cholesterol in model membranes. The complexes strongly 
perturb the lipid bilayer and induce hemolysis. However, the mechanism of digitonin-
cholesterol interaction and the nature of the resulting complex are not yet clearly understood 
(Takagi et al. 1982).  
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Fig 1.2. Digitonin (left) from Digitalis purpurea (right) 
 
 The chemical structure of digitonin was elucidated by mass spectrometry and 13C NMR – its 
molecular mass is 1228. The digitonin aglycone, referred to as digitogenin, is bound to an 
unbranched chain consisting of five sugar units (Posthumus et al. 1978; Muhr et al. 1996). 
Digitonin specifically interacts with cholesterol. The structure of the digitonin-cholesterol 
complex has been determined by 13C NMR. The steroid ring system with its 3β-hydroxyl group 
is essential for digitonin to form a complex with cholesterol with an equimolar stoichiometry 
(Takagi et al. 1982). The effect of the digitonin-cholesterol on cell membranes has been 
observed in different model membranes, such as liposomes and lipid monolayers. In fact, in 
the absence of cholesterol, digitonin neither penetrates nor affects the membranes. In 
membranes containing cholesterol, digitonin increases the surface pressure in penetrated lipid 
monolayers at the air-water interface and induces pore formation (Gögelein and Hüby 1984; 
Nishikawa et al. 1984). The morphology of digitonin-cholesterol complexes in the bilayer 
membrane is hemitubular and the structure is not correlated with the asymmetric structure of 
cholesterol across the membrane (Miller 1984). 
 Digitonin has been widely used to induce and modify membrane permeability of lipid 
membranes from various sources. Digitonin permeabilizes the plasma membrane allowing 
ions, ATP, and proteins to gain more access to intracellular spaces (Wilson and Kirshner 1983; 
Peppers and Holz 1986). Digitonin has also been shown to modify the permeability of 
mitochondrial membranes making the outer membrane lose its integrity and leading to a 
massive premature release of cytochrome c from mitochondria, which eventually induces cell  
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death (Duan et al. 2003; Adachi et al. 1997). Digitonin affects the cell membranes of the 
parasite Trypanosoma cruzi (Vercesi et al. 1991). Digitonin increases cell passage of a wide 
range of drugs, peptides and other secondary metabolites. Nontoxic concentrations of 
digitonin can considerably enhance drug efficacy. Thus, the potency of digitonin in modifying 
cell membranes is being widely used to increase the amount of drug absorption into the 
cytoplasm and is being used to enhance the toxicity of cisplatin (Tanaka et al. 2001; Jekunen et 
al. 1993) and doxorubicin (Chen et al. 2007) in cancer treatment. Digitonin has been shown to 
increase the uptake of peptides and (Weng et al. 2012a) increase toxicity of various plant 
secondary metabolites, even in multidrug-resistant cancer cells (Eid et al. 2012b; Chen et al. 
2007; Eid et al. 2013; Versantvoort et al. 1992; Weng et al. 2012b; Thakur et al. 2012). 
However, the molecular mechanism of digitonin action in modifying membrane permeability 
and in supporting other drugs to enter into the cells is still not fully understood. 
1.1.2 Quillaja saponin – a triterpenoid saponin 
Quillaja saponin is obtained from the evergreen soap bark tree, Quillaja saponaria (family 
Rosaceae) (Fig. 1.3), which is a native to Chile, Peru, and Bolivia. The saponin content of 
quillaja bark is around 20% by weight as by the non-refined, commercial-grade quillaja extract 
(San Martín and Briones 1999). It actually is a mixture of up to 70 different saponins, the main 
constituent being a bidesmoside of quillaic acid (Bankefors et al. 2010). The white powder 
resulting from the extract of quillaja bark provokes sneezing. Its first taste is sweet, then bitter 
at the end. Quillaja saponin is soluble in water and produces stable foam at high 
concentrations. The name quillaja is derived from the Chilean quillean = to wash; for centuries 
quillaja bark has been used by natives as shampoo and soap (van Setten and van de Werken 
1996). Quillaja saponin has been successfully exploited in a wide variety of commercial 
applications in foods, agricultural products, cosmetics, and pharmaceuticals. Based on its 
natural surfactant properties, quillaja saponin has been used as foaming and emulsifying 
agents in beverages and foods and as a wetting and cleaning agent in lipstick and shampoo. 
Based on its ability to form micelles, quillaja saponin has been used to produce low-cholesterol 
foods (San Martín and Briones 1999). Quillaja saponin extract from soapbark has been 
approved as an ingredient in the food and beverages industry by the United States FDA (Food 
and Drug Association) under Title 21 CFR 172-510, FEMA (Flavor and Extract Manufacturers 
Association) number 2973 and has also been approved by the European Union under code  
E 999 for the same purpose. 
10 
 
 
 Quillaja saponin exerts various biological and pharmacological activities with a long history 
of use by Andean peoples as medicinal herbs for treating coughs, bronchitis and other 
diseases of the upper respiratory tract, antirheumatic drug and externally used to treat skin 
problems such as eczema (Wink et al. 2008). Recent research indicates that quillaja saponin 
has a great potency in activating the mammalian immune system, leading to a significant 
interest for applying it as a vaccine adjuvant. The chromatographic fractions and derivatives of 
quillaja saponin have shown strong adjuvant properties and are variously being employed as 
immune-stimulating complexes (ISCOMs). The derivative QS-21 is a particularly potent ISCOM 
with a capacity of stimulating both the Th1 immune response and producing cytotoxic 
T lymphocytes (CTL) against exogenous antigens, making them an ideal candidate for use in 
subunit vaccines and vaccines directed against intracellular pathogens, e.g., therapeutic cancer 
vaccines (Sun et al. 2009a; Kensil et al. 1991; Wu et al. 1992; Marciani et al. 2000; Ragupathi et 
al. 2011). Application of QS-21 in cancer treatment showed promising results in the clinical 
trial phase for different cancer types. For instance, immunizing with sTn(c)-KLH plus QS-21 and 
with mucin-1 keyhole limpet hemocyanin plus QS-21 in high-risk breast cancer patients boosts 
the vaccination effect (Gilewski et al. 2007; Gilewski et al. 2000). Application of QS-21 allows a 
reduction of the antigen dose applied to the patients (Evans et al. 2001). The chromatographic 
fraction of quillaja saponin can also act as an anticancer agent and also could increase the 
toxicity of other secondary metabolites in killing cancer cells (Herrmann and Wink 2011). The 
use of mixtures of quillaja saponin in medical applications has become common nowadays. 
The molecular mechanism of the interactions and activity of quillaja saponin in inducing cell 
membrane permeability has not been completely understood. 
The notable biological and pharmacological activity of quillaja saponin results from its 
unique chemical structure. The basic component is quillaic acid, a triterpene of predominantly 
30 carbon atoms substituted with oligosaccharides attached at C-3 and C-28. The 
oligosaccharide at C-3 is almost always a branched trisaccharide composed of either β-D-GlcpA 
bearing β-D-Galp at its O-2 position or β-D-Xylp or α-L-Rhap at its O-3. Many quillaic acid-based 
saponins have been isolated from the quillaja saponin mixture differing only in that the C-3 
oligosaccharide contains either Xylp or Rhap. The common backbone of the C-28 
oligosaccharide is a disaccharide, α-L-Rhap-(1→2)-β-D-Fucp, which is extended in most 
compounds by different sugar residues. The fucose O-3 and O-4 can be acylated by either an 
acetyl or a fatty acyl group (Fig. 1.3). Until now, more than 70 different structures of saponins 
from Quillaja saponaria have been reported and potentially many more minor components 
await to be discovered (Kite et al. 2004; Bankefors et al. 2011; Bankefors et al. 2010). 
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Commercial quillaja saponin extract (Carl Roth, Sigma, a.o.) is a heterogeneous 
mixture of various aglycones with different sugar moieties, the main aglycone being quillaic 
acid. The identity and quality control of the commercial quillaja saponin have been evaluated 
only by comparative HPLC fingerprints. Precise quantification of the individual contained 
substances of these extracts has not been performed, as individual components of the extracts 
are not marketed as pure substances (San Martín and Briones 2000; Thalhamer and 
Himmelsbach 2014).  
The commercial quillaja saponin extract has mostly been considered and used as being 
a “triterpenoid bidemosidic saponin” in respect to the majority of substances contained 
therein (Bachran et al. 2006; Wojciechowski et al. 2014a; Gilabert-Oriol et al. 2013) and as 
supported by previous mass spectra from several studies (Nord and Kenne 1999; Guo et al. 1998; 
Kite et al. 2004; Bankefors et al. 2010; Wang et al. 2008; van Setten and van de Werken 1996)
1
. 
 A commonly used fraction of the quillaja saponin extract employed in vaccine adjuvant field is 
Quil A, which contains QS-21, a triterpenoid bidesmosidic saponin (C92H148O46; MW 1988.9) 
(Kirk et al. 2004). 
 
 
 
 
 
 
 
 
 
Fig 1.3. Quillaja saponin (left) from Quillaja saponaria (plant and flowers, right) (Bankefors et al. 2011; 
Flores-Toro and Amigo 2013) 
 
 
 
 
 
__________________ 
1 At a later stage in this Ph.D. project, we questioned whether the effects of the employed commercial 
“quillaja saponin” were actually attributable to the bidesmosidic saponins and reanalyzed our MS 
spectra to find that it in deed contained around 5% monodesmosides (see Results, p. 75). This finding is 
relevant for explaining the results and the according proposed mode of action as by the biophysical 
measurements performed by the author (see Discussion, p. 110).  
R
o 
= H/rhamnose/xylan 
R
1
 = H/xylan/xylan-apiose/xylan-xylan 
R
2
 = H/glucose 
R
3
 = H/rhamnose/glucose/GlcAc/Ac/Fa-Ara-Rha 
R
4
 = Ac/Fa-Ara/MeBu 
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 The surfactant properties of quillaja saponin were investigated by Mitra and Dungan 
(1997). Quillaja saponin forms aggregates into micelles at concentrations above the critical 
micelle concentration (CMC) which is in the range of 0.5 to 0.8 g/l at 298 K. Below the CMC, 
quillaja saponin forms a saturated interfacial layer. The CMC value will increase along with 
elevated temperature and pH while increased concentrations of salt decrease the CMC. An 
increase of temperature decreases the intrinsic viscosity, suggesting substantial dehydration 
of the micelles at higher temperature (Mitra and Dungan 1997). A recent report showed that 
quillaja saponin occupies an area per molecule close to 1 nm2. Based on measurements of 
surface tension isotherm and comparing with molecular dimensions, one can deduce that the 
hydrophobic triterpenoid rings of the saponin molecules lie parallel to the air-water interface, 
with the hydrophilic glycoside tails protruding into the aqueous phase. Upon small 
deformation, the saponin adsorption layers exhibit a very high surface dilatational elasticity 
(280 ± 30 mN/m), a much lower shear elasticity (26 ± 15 mN/m), and a negligible true 
dilatational surface viscosity (Stanimirova et al. 2011). Both authors mention that different 
quillaja saponin fractions from different commercial sources yield results that differ to a 
certain extent. 
1.2 Saponins – biological and pharmacological activities  
The main biological functions of saponins are still not fully understood. In plants, they play a 
role in defense (Francis et al. 2002). Many saponins from different plant extracts have been 
shown to be toxic to various types of organisms, from Gram-negative and Gram-positive 
bacteria (Oyekunle et al. 2006; Sparg et al. 2004; Avato et al. 2006) to different classes of 
yeasts, like Candida albicans, Candida glabrata, Candida parapsilosis, Candida tropicalis, and 
Cryptococcus neoformans (Yang et al. 2006; Zhang et al. 2006; Coleman et al. 2010), they are 
antimolluscicidal (Ekabo et al. 1996; Woldemichael and Wink 2001), act against insects (De 
Geyter et al. 2007; Chen 2008) and various parasites like trypanosomes and Leishmania 
donovani (Santos et al. 1997; Wink 2012), are antiviral, as shown for herpes simplex type 1 
(HSV-1) and HIV (Sparg et al. 2004; Kinjo et al. 2000; Yang et al. 1999; Simões et al. 1999; Ikeda 
et al. 2005), and are poisonous to fish (Francis et al. 2002) and mammals (Francis et al. 2002; 
Sparg et al. 2004). Saponins affect various metabolic pathways in animal systems; for instance, 
saponins increase the dietary uptake of nonabsorbed substances by increasing the 
permeability of intestinal mucosal cells (Johnson et al. 1986; Sparg et al. 2004). Saponins 
accelerate cholesterol metabolism in the liver causing a drop of the cholesterol level in the 
blood serum (Stark and Madar 1993; Sparg et al. 2004). Saponins have the ability to act as 
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adjuvants to stimulate the immune system and enhance antibody production, one of the more 
interesting effects of saponins (Song and Hu 2009; Sparg et al. 2004). 
 Saponins are key ingredients in traditional Chinese medicines (TCM), together with 
polyphenols. For example, saponins from ginseng root (Panax ginseng) have been used in 
various pharmacological approaches worldwide (Park et al. 2005; Sparg et al. 2004). In 
mammalian cells, saponins affect various pathways at the molecular level, providing different 
interesting pharmacological activities: anticancer (Lacaille-Dubois and Wagner 1996; Podolak 
et al. 2010), anti-inflammatory (Li and Chu 1999), antiallergic (Akagi et al. 1997), 
immunomodulating (Song and Hu 2009), antihepatotoxic (Hikino et al. 1985), antidiabetic 
(Yang et al. 2010), cardiovascular (Somova et al. 2003), acting on the central nervous (Matsuda 
et al. 1999) and endocrine systems, and other miscellaneous effects (Lacaille-Dubois and 
Wagner 1996). 
 In analogy to the case of glucosinolates, Wink et al. have proposed that bidesmosidic 
saponins are stored in vacuoles that are cleaved by glycosidases upon wounding of the plant, 
yielding cytotoxic monodesmosides; thus, the stored bidesmosides, as biologically and 
pharmacologically relatively inactive substances, may function as “prodrugs” for the 
production of highly toxic monodesmosides for the purpose of a damage-induced mechanism  
of defense of the organism (Wink and Schimmer 2010; Wink and van Wyk 2008). 
1.2.1 Saponins act against cancer cells  
A large number of saponins with different chemical structures have been isolated from nature. 
Variations of the aglycone structure and different combinations with sugar molecules make 
saponins a group of highly variable compounds, each substance showing specific properties 
and biological activities. At the molecular level, saponins act by affecting membranes, various 
biochemical pathways, cellular organelles and cellular signals. The molecular activities of 
saponins have mostly been observed in cancer cell systems, where cytotoxicity has been found 
to be the dominant effect. Within the last decade, their cytotoxicity on different cancer cell 
lines has become one of the main tools in elucidating structure-activity relationships (SAR). 
The cytotoxicity of most saponins is generally lower than that of such reference compounds as 
etoposide, paclitaxel, doxorubicin, or cisplatin; this applies to both types, triterpenoid and 
steroid saponins (Podolak et al. 2010).  
 Saponins induce cell death by different means via the extrinsic pathway, which affects the 
stability of the plasma membrane and inhibits drug efflux, and via the intrinsic pathway, which 
induces different types of cell stress, affects cellular signals resulting in DNA damage, 
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disrupting the cell cycle, causing detachment from the cellular matrix, hypoxia, and loss of cell 
survival factors. The intrinsic pathway involves the release of proapoptotic proteins that 
activate the caspase enzyme from mitochondria but also depends on the balance between 
pro- and anti-apoptotic proteins from the Bcl-2 superfamily (Xu et al. 2009; Podolak et al. 
2010). An overview of the molecular activities of saponins is displayed in Fig. 1.4 (Bachran et 
al. 2008; Podolak et al. 2010; Fuchs et al. 2009). 
 
Fig. 1.4. Cellular effects of saponins. The different molecular pathways contributing to the anti-
tumorigenic properties of various saponins. Note that a number of pathways are observed only for 
certain cell lines and certain saponins (adapted from Bachran et al. 2008; Podolak et al. 2010; Fuchs et al. 2009). 
 
 One individual saponin can target several molecular pathways while inducing cell death. 
For example, saikosaponins, a group of triterpenoid saponins from Bupleurum species, exert 
their effect of inducing cell death in several ways. Saikosaponin-A inhibits cell growth of 
HepG2 hepatoma cells by upregulating gene expression of the cyclin-dependent kinase 
inhibitors p-15INK4b and p-16INK4a, both specific inhibitors of cyclin-dependent kinase 4/6 (Wu 
and Hsu 2001; Wen-Sheng 2003). It inhibits the proliferation of MDA-MB-231 and MCF-7 
breast cancer cell lines in a dose-dependent manner, however by affecting different apoptosis 
pathways. In MDA-MB-231 cells, apoptosis is independent of the P53/p21 pathway and is 
accompanied by an increased ratio of Bax to Bcl-2 family, higher c-myc levels, and activation of 
caspase-3. Apoptosis in MCF-7 is initiated by Bcl-2 and involves the p53/p21-dependent 
pathway and is accompanied by an increased level of c-myc (Chen et al. 2003). It also acts as 
an immunosuppressive it potently suppresses Con A-stimulated IL-2, IFN-γ, and TNF-α, also 
causing G0/G1 arrest of activated T cells through downregulating of CDK6 and cyclin D3 and 
upregulating p27kip (Sun et al. 2009b).  
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 Small modifications of the chemical structure of saponins affect their mechanism of action. 
For example, varying the sugar molecule at C-3 of the triterpene aglycone of saikosaponin 
leads to different molecular activities (Ashour and Wink 2011). The apoptosis mechanism 
induced by saikosaponin-D is different from that of saikosaponin-A, where the apoptotic effect 
of saikosaponin-D may be partly mediated by increases in the c-myc and p53 mRNA level 
accompanied by a decrease in the Bcl-2 mRNA level (Hsu et al. 2000). Saikosaponin-C shows no 
correlation with cell growth inhibition but induces endothelial cell migration, capillary tube 
formation, and angiogenesis by activating matrix metalloproteinase-2 (MMP-2), vascular 
endothelial growth factor (VEGF), and the p42/p44 mitogen-activated protein kinase (MAPK, 
ERK) (Shyu et al. 2004). 
1.2.2 Saponins act on membranes 
Saponins strongly affect cell membranes due to their amphiphilic properties. In particular, they 
cause rupturing of red blood cells. This hemolytic activity has been used to detect the presence 
of saponins in plant extracts and drugs. Chiefly RBCs have been used to investigate the 
mechanism of action of saponins on membranes (Baumann et al. 2000). The first visualization 
of the associated effects was reported by Dourmashkin et al. (1962) in a study on Rous sarcoma 
virus inactivated by “saponin” (referring to Saponin pure white/Saponinum album, Merck, a 
Gypsophila extract) (Weng et al. 2011). High concentrations of “saponin” damages the outer 
membrane of the virus, chicken liver cells, as well as human and guinea pig erythrocytes, 
creating holes (pits) with a diameter of 85 Å. The authors observed that membrane cholesterol 
plays a role in saponin activity. They also found that digitonin and “saponin” acted differently 
on membranes: “saponin” created holes (pits), while digitonin disrupted the membranes 
without forming holes (pits). Their experiments also confirmed that both “saponin” and 
digitonin specifically interact with membrane cholesterol (Dourmashkin et al. 1962).  
 The effect of pore formation in the membrane by saponins has become a point of interest. 
This effect is clearly related to the presence of cholesterol. “Saponin” forms a complex with 
cholesterol causing the removal of cholesterol from the membranes and thus leading to pore 
formation. The interaction of cholesterol with the lipophilic heads of saponin occurs at a 1 : 1 
molar ratio; a ring-shaped construct is formed by twenty “saponin” molecules in a circular 
arrangement with a distinguishable space between each lipophilic headgroup. This was the 
first suggested model of interaction between “saponin” and membrane cholesterol (Bangham 
et al. 1963; Glauert et al. 1962) and a starting point for elucidating the basic molecular 
mechanism of activity of saponins in membranes. Results from several studies point to various 
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factors affecting the activity of saponins in perturbing membranes, such as the influence of 
membrane composition, especially those containing sterols (Gögelein and Hüby 1984; Armah 
et al. 1999; Keukens et al. 1992; Nishikawa et al. 1984; Rosenqvist et al. 1980; Stine et al. 2006; 
Walker et al. 2008; Böttger and Melzig 2013), different type of saponin aglycone resulting in 
different degrees of toxicity (Gauthier et al. 2011; Oda et al. 2000; Takechi and Wakayama 
2003; Voutquenne et al. 2002; Chwalek et al. 2006; Wang et al. 2007b), the number of sugar 
chains attached to the aglycone (monodesmosidic or bidesmosidic) (Woldemichael and Wink 
2001; Voutquenne et al. 2002), the length of the sugar chains as well as the types and linkage 
variants of the incorporated sugar units that affect saponin activity in the membranes (Armah 
et al. 1999; Chwalek et al. 2006; Nishikawa et al. 1984; Takechi and Wakayama 2003). 
However, due to the enormous variability of chemical structures of saponins and different 
experimental setups, conflicting conclusions have not allowed for a full understanding of 
structure-activity relationships of saponins till now. 
1.2.3 Models of saponin action on membranes 
Studies on the mechanisms of action of saponins on membranes have been conducted for well 
over 50 years and several models of action have been suggested. The effects of saponins on 
membranes are strongly related to the presence of cholesterol. Various methods and 
techniques have been used to elucidate the mechanisms of interaction of saponins with 
membranes. Erythrocytes have frequently been used as a natural membrane model and 
several other artificial membrane models like liposomes, supported lipid bilayers, and 
membrane monolayers have also been employed to understand the action of saponin. 
 The different proposed models of interaction of saponins with membranes are specific to 
the particular type of investigated saponin. The type of aglycone and number of sugar side 
chains strongly affects the mode of action. The most prominent models of saponin action on 
membranes are shortly summarized below. 
1.2.3.1 Model of Doursmashkin-Glauert (1962) 
The first model of action of saponins on membranes was suggested by Glauert et al. (1962; see 
also Bangham et al. 1963), based on experiments by Doursmashkin et al. (1962). Their electron 
microscopic observations indicated that “saponin” disrupts cell membranes of the Rous 
sarcoma virus, erythrocytes, and other mammalian cells forming pores with a hexagonal 
pattern. The hexagonal pores were reported to form by spontaneous interaction of “saponin” 
with cholesterol. Complexes between “saponin” and cholesterol in the membrane are 
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followed by association of these complexes into “two-dimensional micellar-type structures” 
within the membrane. 
 Based on close inspection of the electron micrographs of the Rous sarcoma virus and 
erythrocyte membranes after “saponin” treatment they suggested that the pores are 
constructed by twenty saponin molecules in a circular arrangement with a distinguishable 
space between each lipophilic headgroup forming a ring-like structure having a central 
hydrophilic pore, approximately 90 Å in diameter, that contain the sugar moieties of the 
saponin molecules. The interaction of the cholesterol molecules with the saponin aglycone 
(lipophilic headgroup) occurs at a 1 : 1 ratio on the outside of the circular structure (Fig. 1.5) 
(Glauert et al. 1962; Dourmashkin et al. 1962; Bangham et al. 1963).  
 
Fig. 1.5. Hypothetical micellar-type arrangement of saponin molecules with cholesterol, producing a 
hole (pit/pore) in the membrane;  cholesterol,  "saponin" (Glauert et al. 1962). 
1.2.3.2 Model of Nishikawa (1984) 
Nishikawa et al. (1984) suggested a mechanism of interaction of saponins with membrane 
sterols that induces membrane perturbation based the observed induction of hemolysis and 
liposomal damage by digitonin (steroid saponin). The role of the sugar moieties in digitonin 
was also studied using various digitonin analogs and desglucodigitonin.  
 The important role of membrane cholesterol in digitonin activity was confirmed. The 
interaction and activity of digitonin and their analogs in the liposomal membrane completely 
depends on the presence of cholesterol. The ratio of digitonin bound to cholesterol in the 
liposomal membrane was close to 1 : 1. Digitonin-cholesterol complexes caused membrane 
lateral-phase separation which formed domains rich in “cholesterol-digitonin” resulting in 
membrane damage. The sugar chain is involved in the interaction of digitonin with cholesterol. 
Removal of sugar moieties from digitonin caused loss of hemolytic activity, thus no longer 
being able to damage liposomal membranes. 
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 Their proposed mechanism of interaction of digitonin molecules with the membrane 
bilayer begins with digitonin accessing and binding with cholesterol in the membrane, then 
continuing with the formation of domains rich in “digitonin-cholesterol” complexes at a 1 : 1 
ratio, increasing membrane permeability, and finally leading to membrane rupturing 
(Nishikawa et al. 1984). 
1.2.3.3 Model of Keukens (1995) 
From a series of observations on the activity of several glycoalkaloids in inducing membrane 
rupture, Keukens et al. (1995) suggested a molecular mechanism of membrane disruption by 
glycoalkaloids with cholesterol playing a key role as the binding target in the membrane. The 
interaction process of the glycoalkaloids with the membrane bilayer is shown in Fig. 1.6. The 
process begins with the insertion of the glycoalkaloid into the membrane surface (step 1), the 
aglycone part of the glycoalkaloid then reversibly binds to the membrane sterol at a ratio of 
1 : 1 (step 2); when the glycoalkaloid-cholesterol complexes reach a certain density in the 
membrane (step 3), cooperative sugar-sugar interactions of the sugar chains of the 
glycoalkaloid initiate the formation of a stable irreversible matrix of glycoalkaloid-cholesterol 
complexes (step 4). Since the glycoalkaloid immobilizes cholesterol in the outer layer, 
cholesterol from the inner layer will probably flip to compensate for the “lost” cholesterol. 
During the formation of the matrix structure, the membrane layer will bud due to the fact that 
glycoalkaloid-cholesterol complexes with relatively large polar head groups do not have a 
cylindrical shape (step 5). The phospholipids in the inner layer of the membrane bilayer 
opposing the matrix get enclosed in the final structure during separation from the membrane 
and forming an internal purely phospholipid monolayer (step 6). The three-dimensional 
structure of the sugar chains leads to tubular structures which cause faster growth of the 
matrix in one direction.  
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Fig. 1.6. Model of Keukens et al. (1995). Membrane disruption by glycoalkaloids (GA) – (1) GAs arriving 
at the membrane; (2) insertion of GAs into the membrane; (3) GAs bind to cholesterol; (4) irreversible 
formation of stable GA-Chol complexes by sugar-sugar interactions; (5) budding; (6) final tubular 
structure with GA-Chol layer on the outside and pure PC layer on the inside. GA = glycoalkaloid; Chol = 
cholesterol; PC = phosphatidylcholine. 
1.2.3.4 Model of Armah (1999) 
The triterpenoid saponin, avenacin A-1, was used to induce membrane permeability of 
artificial membranes, phospholipid monolayers, planar lipid bilayers, and liposomes providing 
new insights into the molecular mechanisms of interaction of saponins with membranes. 
Avenacin A-1 leads to pore formation in membranes. The mechanism of membrane pore 
formation by avenacin A-1 generally follows a similar route as the models of Nishikawa 
(Sect. 1.2.3.2) and Keukens (Sect. 1.2.3.3). The activity of avenacin A-1 in altering the lateral 
movement of the membrane bilayer strongly depends on the presence of cholesterol, even 
though it can insert into cholesterol-free membranes, while not inducing any changes in that 
case. The mechanism of interaction of avenacin-A1 with the membrane bilayer begins with the 
insertion of the aglycone portion into the membrane surface (step 1); it then binds to 
membrane cholesterol. The intact sugar chain of avenacin A-1 is required for reorganization of 
membrane cholesterol, which results in a reduction of the lateral diffusion coefficient (step 2). 
The final step is the formation of trans membrane pores causing an increase in membrane 
permeability. The mechanism by which this occurs is currently not understood. The authors 
20 
 
 
speculated that after avenacin A-1 and cholesterol form complexes, the free sugar chains of 
avenacin A-1 interact, causing aggregation in the avenacin A-1–cholesterol region. This may 
lead to rearrangement of the bilayer lipids and lead to pore formation (step 3) (Fig. 1.7). The role 
of the sugar chains of saponins is essential in the process of pore formation (Armah et al. 1999). 
 
Fig. 1.7. Model of Armah et al. (1999). Pore formation by avenacin A-1. (A) insertion of saponin into the 
membrane; (B) saponin binds to cholesterol; (C) aggregation of saponin-cholesterol complexes leads to 
pore formation by membrane structure rearrangement. 
1.2.3.5 Model of Lin and Wang (2010) 
Lin and Wang (2010) presented a mechanical study on the hemolytic activity of the steroidal 
saponin, dioscin, using coarse-grained molecular dynamics (CGMD) simulations (Fig. 1.8). The 
dioscin-cholesterol complex is energetically more favorable than the cholesterol-cholesterol 
complex. The data supported previous experimental results on the essential role of cholesterol 
in membrane activity induced by saponins. The saponin appears to have two effects; firstly, 
the saponin penetrates and migrates to the lipid raft domain, the region enriched with 
cholesterol and sphingomyelin in the membrane, and then binds to cholesterol. This 
“abstraction” of cholesterol seizes the latter from interacting with sphingomyelin, which then 
causes disruption of the lipid raft microdomains. Secondly, the accumulation of saponin-
cholesterol in the lipid raft microdomain will change membrane morphology because saponin 
molecules do not have the compact shape as other lipid-raft components. The accumulation of 
saponin-cholesterol at the lipid-raft domain causes severe curvature of the lipid bilayer, 
eventually leading to the lysis of erythrocyte membranes.  
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Fig. 1.8. Model of Lin and Wang (2010). Snapshots of CGMD simulations of the interaction of dioscin 
with the bilayer membrane. (a) Membrane bilayer without saponin; (b) penetration of saponin (green) 
into the membrane and binding to cholesterol; (c) membrane disruption caused by interaction of 
saponin with cholesterol; (d) accumulation of saponin-cholesterol at lipid raft domains (not shown) 
causes changes of membrane morphology (blue: cholesterol; red: phosphatidylcholine). 
 
1.2.3.6 Model of Lorent (2013) 
The latest interaction model of saponins with membranes has been proposed by Lorent et al. 
(2013, 2014) from investigations of two triterpenoid saponins, α-hederin (with two sugar 
moieties) and δ-hederin (with only one sugar moiety), that permeabilize the membranes of 
multi- and unilamellar vesicles. The molecular process leading to membrane permeability by 
hederins is linked to membrane curvature and is characterized by three steps; firstly, insertion 
of hederin into the external leaflet of the bilayer membrane which does not involve 
cholesterol; the interaction occurs between the negatively charged carboxyl function of the 
genin with the positively charged choline head group of the phospholipids. Secondly, after the 
initial stage, hederin binds to cholesterol. The formation of saponin-cholesterol disrupts the 
phospholipid/cholesterol matrix and changes the thermotropic characteristics of the 
membrane. The sugar moieties of hederin enhance the interaction of the saponin with 
cholesterol, shielding cholesterol from water, and preventing polar interactions between 
cholesterol and phospholipids. In a third step, α- and δ-hederin induce membrane curvature 
resulting in pore formation and budding. The membrane effect strongly depends on the sugar 
moieties of the saponin – α-hederin leads to pore formation, while δ-hederin only leads to 
budding (Lorent et al. 2013, 2014) (see Fig. 1.9).  
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Fig. 1.9. Model of Lorent et al. (2013). Interaction of α-hederin and δ-hederin with GUVs.  
(A) Membrane bilayer; (B) insertion of saponin into the external leaflet of the bilayer membrane;  
(C) membrane damage; (D) pore formation (α-hederin); (E) slight negative curvature in the direction of 
the membrane plane; (F) inhomogeneous distribution of α-hederin causing rolled rims; (G and H) 
intermediate curvature of δ-hederin results in budding. 
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1.2.4 Saponins enhance the toxicity of other drugs 
The natural amphiphilic properties of saponins give them the ability to reduce membrane 
permeability due to their interaction with other membrane amphiphilic molecules such as 
phospholipids and sterols. Interactions of saponins with membrane lipid components can 
reduce the surface tension and cause pore formation (Böttger et al. 2012). The membrane 
perforation effect of saponins is strongly related with their chemical structure especially the 
number of sugar moieties attached to the aglycone. Interaction of saponins with two sugar 
chains (bidesmosidic) with membrane cholesterol may cause pore formation (Gimpl et al. 
1997). Therefore, the bidesmosidic saponins induce less hemolytic activity and membrane 
permeability than monodesmosidic saponins (Woldemichael and Wink 2001).   
 Formation of membrane pores by saponins is not specific or restricted to particular kinds of 
cells. The pore-forming effect of saponins is often used to render membranes more accessible 
to polar substances for enhancing drug efficacy. Many articles reported synergistic or additive 
effects of combined application of saponins with other antitumor drugs. This combination 
strategy offers improved options in cancer treatment. As an example, the cytotoxicity of the 
well-known cancer drug cisplatin has been synergistically increased by combining it with 
several saponins, such as the triterpenoid jenisseensoside saponins from campions (Silene 
spp.) (Gaidi et al. 2002) and saponins from Panax notoginseng (Yu et al. 2012; Zhang et al. 
2013). Several triterpene saponins failed to increase the cytotoxicity of cisplatin, like the 
saponins from ox knee (Achyranthes bidentata) (Mitaine-Offer et al. 2001), the saponins from 
Albizia adianthifolia (Haddad et al. 2002), and the saponins from Muraltia heisteria (Elbandy et 
al. 2002). This shows that only certain saponins with specific structural features are able to 
enhance the cytotoxicity of cisplatin. 
 Ginsenosides are group of saponins obtained from ginseng plants (Panax spp.) and have 
been used frequently in combination with other chemotherapeutics to enhance their 
anticancer activity. Ginsenoside Rh2 synergistically supports the inhibitory effect of paclitaxel 
(Taxol™) in the prostate cancer cell model LNCaP (Xie et al. 2006). Ginsenoside Rg1, 
ginsenoside Rg3 and Rh1 significantly increased the toxicity of mitoxantrone and doxorubicin, 
which inhibit drug efflux, on drug-insensitive cell lines (Jin et al. 2006; Wang et al. 2006). 
Ginsenoside Rg3 increased effectiveness of cisplatin and docetaxel by inhibited NF-κB activity 
in prostate and colon cancer cells (Kim et al. 2009; Kim et al. 2010). A Notoginseng flower 
extract has enhanced the antiproliferation effect of 5-fluorouracil (5-FU) in colorectal cancer cells 
and thus reducing the applicable effective dose of 5-FU in cancer treatment (Wang et al. 2007a). 
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Digitonin is a steroid saponin obtained from Digitalis purpurea and has been used variously to 
improve the toxicity of many substances by increasing their passage through the cell 
membrane. Digitonin increases the cytotoxicity of epigallocatechin gallate (EGCG) against 
sporozoites but shows an additive effect on inhibiting sporozoite motility by increasing the 
permeability of Plasmodium sporozoite membranes (Hellmann et al. 2010). Digitonin 
synergistically increases the cytotoxicity of cisplatin by permeabilizing the plasma membrane 
of ovarian and lung cancer cell lines (Tanaka et al. 2001; Jekunen et al. 1993). Digitonin 
increases the uptake of carboplatin by liver tumor cells after intra-arterial administration with 
a resulting increase of cytotoxicity (Lindnér et al. 1997). In the combination with secondary 
metabolites, digitonin synergistically enhances the toxicity of several phytochemicals 
(phenolics, terpenoids, and alkaloids) towards sensitive cancer cell lines and interestingly also 
multidrug-resistant (MDR) cells containing high amounts of P-glycoprotein in the membrane 
because certain steroid saponin may also be natural substrates for P-glycoproteins (Herrmann 
and Wink 2011; Eid et al. 2012a; Park et al. 1996; Zhou et al. 2004). Interestingly, digitonin has 
led to enhanced toxicity even in combination with more than two secondary metabolites, 
administered simultaneously (Eid et al. 2012b).  
 The ability of saponins to facilitate nontargeted drug molecules to pass through the cell 
membrane may result in increased side effects. The combination of saponins with highly 
specific targeted drugs may constitute an approach to reducing these side effects. Saponinum 
album (or simply “saponin” Merck) (Weng et al. 2011), a triterpene saponin extract from 
Gypsophila paniculata, dramatically increases the toxicity of saporin, a ribosome inactivating 
protein (RIP), which specifically is linked to epidermal growth factor (EGF) via a cleavable 
molecular adapter forming a chimeric toxin. The application of nontoxic concentrations of 
Saponinum album enhanced the cytotoxicity of the chimeric toxin by 3500-fold to more than 
100,000-fold, depending on the cell line. In order to ascertain whether this significant 
enhancing effect on drug toxicity is only restricted to Saponinum album or can also be found 
with other saponins, different types of saponins with different structures were tested. Analysis 
of the enhancing effect of different structures of saponins has shown that bidesmosidic 
triterpenoid saponins with an aldehyde function at the C-4 position, like Saponinum album and 
quillaja saponin, synergistically increased the cytotoxicity of the chimeric toxin. Quillaja 
saponin enhanced the cytotoxicity of the toxin in a similar way with respect to both non-
targeted and targeted cells, while Saponinum album only increased the cytotoxicity towards 
targeted cells. The exact mechanism of toxin enhancement by saponins remains unclear to 
date (Fuchs et al. 2009; Bachran et al. 2006, 2008, 2009).  
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1.3 Drug interactions with lipid membranes 
Understanding the mode of action at the molecular level of the interaction of substances or 
drugs with the cell membrane is of primary importance in pharmacological science. Many 
substances with a wide range of biological and pharmacological applications and with various 
chemical structures and possessing diverse properties potentially modulate different activities 
at the membranes, such as crossing or binding to components of the lipid membrane. 
Biological membranes are very complex and vary tremendously in respect to their 
composition. They form a carefully balanced environment and any changes that are caused by 
the interaction with other substances will affect the overall function and integrity of the 
membranes. However, it is quite difficult to investigate and elucidate the molecular 
mechanisms of drug interactions with biological membranes due to their high degree of 
complexity (Seddon et al. 2009; Bernsdorff et al. 1999; Lucio et al. 2010; Bourgaux and 
Couvreur 2014).   
 To investigate the molecular activity of substances on the membrane system, it is necessary 
to understand the critical aspects of membrane structure and its properties. Biological 
membranes are dynamic structures composed of a diverse set of lipid components such as 
phospholipids, glycolipids, sterols, and proteins. The fundamental structural component of all 
biological membranes is the lipid bilayer which is made up of two opposing layers of lipid 
molecules, where the hydrophilic polar head is directed outwards towards the aqueous phase 
and lipophilic tails pointing at the interior of the two layers. The hydrophobic interior of lipid 
bilayers acts as a barrier to limit the movement of polar molecules and ions in or out from the 
cell. The membrane's structural integrity protects the cell against various adverse external 
factors, in particular against toxic chemical compounds and xenobiotics. In the more general 
sense, the regulation and controlling of molecule movement through the cell membrane is 
vital in maintaining cell functions (Yeagle 2012; Seddon et al. 2009; Lucio et al. 2010). The 
membrane's role is not limited only to cell compartments, to protect the cell, and to transport 
molecules, but goes well beyond those functions as by the presence and functions of the 
diverse constituent membrane proteins. These are involved in various cell functions such as 
cell signaling (which allows cells to communicate, receive signals, and to sense their 
environment); to transport molecules and ions across the membranes; providing cell adhesion 
which allows cells to interact with each other; and the activity and properties of membrane-
bound enzymes which are involved in various biochemical pathways and also implicated in a 
number of disease pathologies. Membrane proteins have become important targets in drug 
discovery (Lucio et al. 2010; Seydel and Wiese 2009). 
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1.4 Cholesterol and its functions in membranes 
Another essential substance of eukaryotic membranes is cholesterol, a weakly amphiphilic 
molecule. Cholesterol plays a crucial role in membrane organization, modulating cell 
membrane dynamics, and affecting the functions of membrane proteins through three major 
molecular mechanisms: i) regulating the function of membrane proteins through specific 
interactions of sterol-proteins inside the membranes; ii) regulating the internal properties of 
the lipid bilayer of the cell membranes; and iii) modifying the lateral distribution of cell 
membrane components (Yeagle 2012). The relative amounts of cholesterol and phospholipids 
can change membrane fluidity and affect cell membrane curvature (Bacia et al. 2005). 
Cholesterol is distributed inhomogeneously in the domains of biological and artificial 
membranes and interacts with a subset of membrane lipids and proteins (Rukmini et al. 2001; 
McMullen and McElhaney 1996; Gimpl et al. 1997). Cholesterol can move between the two 
leaflets of a bilayer membrane, in a flip-flop manner. The cholesterol flip-flop process across 
lipid bilayers occurs on a very short time scale of <1 s in human erythrocytes (Steck et al. 2002; 
Kamp et al. 1995; Lange et al. 1981). Rapid cholesterol flip-flop has important implications on 
cellular and global cholesterol trafficking and also in maintaining an asymmetric distribution of 
cholesterol in the membrane (Hamilton 2003; Bennett et al. 2009). Cholesterol also can move 
and be distributed between two different and physically separate lipid vesicles through two 
general mechanism; i) between two close but separate membranes via the aqueous phase; 
desorption of cholesterol from the donor bilayer into the aqueous phase is activated by an 
increasing energy barrier in a slow process continued with collision of cholesterol with 
acceptor vesicles in a stochastic process (McLean and Phillips 1981); ii) via a water-soluble 
cholesterol intermediate at a distance between separate vesicle membranes even though the 
process is slower than the first mechanism (Yokoyama 2000; Backer and Dawidowicz 1981; 
Yeagle 2012).  
 Association of cholesterol with glycosphingolipids and protein receptors forms 
microdomains termed lipid rafts (Brown and London 1998). Lipid rafts are important elements 
in cell membrane structure, homeostasis, and most importantly in signal transduction. Lipid 
rafts are more ordered and tightly packed than the other lipid components and can freely float 
in the bilayer membrane. In general, rafts recruit proteins to new micro-environments where 
the phosphorylation state can be modified by local kinases and phosphatases resulting in 
downstream signaling (Lingwood and Simons 2010; Simons and Toomre 2000; Rajendran and 
Simons 2005). 
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 Another effect of cholesterol in the membranes is in modulating membrane permeability. 
Cholesterol causes ordering of the lipid bilayer, repairing disorder by trans-gauche 
isomerization and thus reducing bilayer permeability. Cholesterol modulates membrane 
permeability by two different mechanism; i) by changing the electrical potential difference 
across the membrane-solution interface, resulting in change of the partition of charged 
species in the membrane; ii) by changing the fluidity of the interior of the bilayer membrane 
which affects the rate of ionic transfer and the chemical partitioning of the solute within the 
membrane (Szabo 1974; Papahadjopoulos et al. 1973; Parisio et al. 2013; Yeagle 2012; Ohvo-
Rekilä et al. 2002). 
1.5 Effects of drugs on membranes, and of membranes on drugs 
Drugs can affect cell membranes in many different ways, directly or indirectly, e.g., by 
changing the conformation of acyl groups (trans-gauche), increasing the membrane surface 
(curvature), changing the phase separation, leading to domain formation (micro- 
heterogeneity), and changing the membrane thickness. They thus can lead to cell membrane 
disruption, increase membrane permeability, and affect membrane fluidity. All these effects 
are caused by the interaction between drugs and lipid membrane components like 
phospholipids and sterols. Numerous anesthetic drugs either in the gaseous form, like 
halothane and methoxyflurane, or aqueous form, like chlorpromazine and propranolol, are 
able to cause disordering of membranes (Goldstein 1984; Seydel and Wiese 2009). Certain 
anticancer drugs, like the platinum-containing agents vincristine and MRA-CN, and others such 
as doxorubicin, affect the electrical surface properties of membranes (Oakes et al. 1987). 
Other anticancer drugs affect membrane fluidity by interacting with phospholipids and 
cholesterol, e.g., doxorubicin has been shown to change membrane microviscosity (Marczak et 
al. 2006) and taxol reduces the rigidity of unsaturated lipids (Bernsdorff et al. 1999). Peptide 
toxins modulate membrane curvature. Cardiotoxin II from Naja mossambicamos strongly and 
specifically interacts with negatively charged phospholipids. The interaction strongly affects 
lipid acyl chain order and changes lipid membrane organization, modulating membrane 
curvature due to the different sizes of the hydrophobic and hydrophilic moieties of the 
peptide that leads to a rhombic shape and thus occupying large areas in the acyl chain region. 
Penetration of the peptide toxin mellitin into the acyl chain region also can cause surface 
membrane curvature (Batenburg and De Kruijff 1988).  
 Biological cell membranes can prevent polar drugs from passing the membrane or to 
become associated with them. There are several mechanisms of how membranes manage to 
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prevent drug action, such as limiting the rate of drug diffusion (Rhodes et al. 1985) or even 
completely preventing diffusion to the active site, which may cause drug resistance (Tannock 
et al. 2002; Gottesman 2002). Cancer cell membranes are able to develop a complex drug 
resistance system to prevent drugs from entering the cells, and this feature can become a 
serious problem in cancer treatment. Numerous multidrug-resistance mechanisms have 
developed in cancer cells, such as the increased drug efflux from cancer cells by ABC 
transporters with overexpression of P-glycoprotein transporter and reduction of drug uptake 
by modification or mutation of drug transporters on membrane surfaces (Gottesman 2002). 
Membranes may bind a drug and change the drug's conformation in such a way as to 
rendering it inactive (Center 1985; Luqmani 2004). 
1.6 Model membranes for studying drug-membrane interactions 
Identifying and elucidating the effect of drugs on cell membranes has become a major 
challenge in current research on biological membranes. A good understanding of drug action 
in membranes is indispensable for developing new drugs with high selectivity and toxic dose 
effectiveness and also for developing better drug-delivery systems. Such knowledge is 
indispensable to the pharmaceutical industry to avoid larger investments into effective drug 
discovery and development, which in turn increases a drug's economic value (Lucio et al. 
2010). Model membranes provide free access in constructing and mimicking biological 
membranes and allow valuable insights into membrane structure, functions, and drug-
membrane interactions. Various model membranes have been developed, from simple to 
sophisticated, with varying size, geometry, and composition and tailored with great precision 
to mimic natural membranes (Chan and Boxer 2007). At the same time, various techniques 
have been developed and applied to measure, characterize, and visualize membrane 
structures and activities for both natural and artificial membranes, such as spectroscopic and 
fluorescence techniques, X-ray scattering, calorimetry techniques, high-resolution nuclear 
magnetic resonance (NMR), microscopy, etc. (Seddon et al. 2009). Studies on drug-membrane 
interactions on membrane monolayers mostly have involved micelles and phospholipid 
monolayers as model membranes, while for studying membrane bilayers the most commonly 
employed model membranes are liposomes and supported lipids. 
Micelles are spherical aggregates of amphiphilic molecules (surfactants) occurring as colloids 
in solution. They are formed when surfactants reach a certain concentration called the critical 
micelle concentration (CMC). Micelles have circular shapes and are composed of a single layer 
in which the nonpolar part of the molecules tend to form clusters, with the polar part pointing 
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to the outside (Tanford 1974). Micelles have been used extensively as biomimetic systems in 
membrane research and for elucidating structural features of drug-membrane interactions. 
Micelles provide several advantages in drug-membrane interaction studies, such as rapid 
molecular formation in aqueous solution which facilitates incorporation of drugs, allowing to 
characterize them by various bioanalytical techniques, like NMR, Fourier transform infrared 
spectroscopy (FTIR), and circular dichroism (CD). Based on the type of amphiphilic substance, 
it is possible to form micelles with different surface charge in order to study the electrostatic 
effects of drug binding to the membrane (Lucio et al. 2010). Micelles are also widely used for 
drug delivery across membranes (Lukyanov and Torchilin 2004; Kwon and Okano 1996).  
Phospholipid monolayers (Langmuir monolayers) are model membranes that intend to mimic 
only one leaflet of the biological membrane. However, since the thermodynamic relationship 
between mono- and bilayer membranes is direct, monolayers are often used to study 
lipid/protein or lipid/drug interactions under specific conditions (Brockman 1999). Membrane 
monolayers are formed when the amphiphilic molecules arrange at the air-water interface 
where the hydrophilic part of the molecules (head group) point at the water phase and the 
hydrophobic part (tail group) towards the air. Physical characteristics of the monolayer system 
such as surface pressure, surface area, and number of molecules can be measured. Association 
or penetration of the membrane monolayer by drugs changes its thermodynamic properties. 
Membrane monolayers can also be used to visualize the change of lipid morphology at the air-
water interface using atomic fluorescence microscopy (AFM), Brewster angle microscopy 
(BAM), and cryogenic scanning and transmission electron microscopy (cryo-SEM and cryo-
TEM) (Wu et al. 2006; Seitz et al. 2011; Lucio et al. 2010) 
Liposomes are vesicular lipid bilayers encapsulating small amounts of solutions. They share 
fundamental characteristics with the biological cell membrane and are relatively easy to make. 
Therefore they have been used extensively to characterize properties of lipid bilayers and 
investigate the effects of drugs on membranes. In principle, liposomes form spontaneously 
when dry lipid films swell in excess water or buffer (Bangham and Horne 1964; Lasic 1988) 
producing multilamellar vesicles. Recently, various mechanical dispersion methods have been 
developed to produce such vesicles. Unilamellar vesicles are made by repeated extrusion of 
multilamellar vesicles under moderate pressure (≤500 lb/in2) through a polycarbonate filter, 
yielding unilamellar vesicles with uniform size (Hope et al. 1985). Applying a particular 
membrane polycarbonate pore size results in a specific size of unilamellar vesicle, e.g., a filter 
pore size of 100 nm will produce unilamellar vesicles ranging in diameter from 60–100 nm 
with trapped volumes in the region of 1–3 µl (Mayer et al. 1986). Liposomes can be classified 
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by their size and number of bilayers; this affects the amount of drug encapsulated inside the 
vesicle. Basically liposomes are classified into two groups; multilamellar vesicles and 
unilamellar vesicles. Unilamellar vesicles are further classified into giant unilamellar vesicles 
(GUVs) with diameters of 1–100 µm, large unilamellar vesicles (LUVs) with diameters from 
100 nm to a few micrometers (µm), and small unilamellar vesicles (SUVs) with diameters of up 
to 100 nm (Akbarzadeh et al. 2013). Liposomes have variously been used in studying the 
effects of drugs on membranes and the effects of drug carriers through the membrane in 
anticancer drug research (Lasic 1998; Jesorka and Orwar 2008). Liposomes are being used as a 
model in studying the effect of drugs on membrane integrity and permeability. These effects 
can be measured by increasing the amount of fluorescence dye such as calcein, which is then 
released by leakage from the membrane vesicles. This leakage can be measured directly 
without separating the liposomes from solution (Patel et al. 2009; Katsu et al. 2007). Large and 
giant vesicles can be viewed by light microscopy. 
Giant unilamellar vesicles (GUVs) are artificial, spherical bilayer membranes with diameters 
between 1–100 µm, the size range of most biological cells, and are useful models for 
mimicking biological processes at bilayer membranes (Morales-Penningston et al. 2010; Pott 
et al. 2008). GUVs are being extensively used in reconstituting membrane components for 
studying lipid domain formation and the physicochemical and mechanical properties of 
biological membranes in membrane growth, budding, fission, and fusion (Walde et al. 2010). 
GUVs can be produced with several techniques such as lipid hydration methods, the lipid-
stabilized or surfactant-stabilized method, from lipids stabilized with or without double 
emulsion, by fusion of small vesicles, from an initial planar bilayer, from lipids dissolved in 
water-miscible solvents, or from a micellar lipid solution. Details of all techniques have been 
reviewed by Walde et al. (2010).  
 GUVs are used to reveal drug-membrane interactions and investigate drug activity. 
Observations on the alteration of single GUVs in the presence of particular drugs can reveal 
the molecular mechanisms of drug action on cell membranes, as, e.g., the antimicrobial 
peptide magainin 2 which interacts with membranes, inducing membrane permeability, and 
causing pore formation with change of vesicle shape (Tamba and Yamazaki 2005). In another 
example, GUVs have been employed to visualize membrane interactions with  
(─)-epigallocatechin gallate, the main flavonoid in green tea, causing the vesicles to burst 
(Tamba et al. 2007). 
Supported lipid bilayers (SLB) are planar structures consisting of a lipid bilayer placed on a 
solid support that provides adequate stability. SLBs remain mostly intact even after applying 
31 
 
high flow rates, vibration, or in the case of the presence of pores in the membrane. The 
stability of SLBs allows an experiment to be carried out over several week or even months, an 
advantage not provided by other model membranes. The planar membrane structure allows a 
number of characterization tools to be used which are not possible in mobile or floating 
systems (Purrucker et al. 2001). Self-organization of SLBs starts with vesicle adsorption onto 
the solid support, then followed by vesicle rupture, and spreading of the lipid bilayers into 
planar membranes (Richter et al. 2006; Jing et al. 2014). The interactions and effects of drugs 
on SLBs can be characterized using several techniques, such as quartz crystal microbalance 
with dissipation (QCM-D), which allow investigation of the mechanisms of interaction in real 
time (Makky et al. 2012). Other techniques such as specular and off-specular neutron 
scattering (Schneck et al. 2009), X-ray reflectivity (XRR), and grazing-incidence X-ray 
fluorescence (GIXF) (Abuillan et al. 2013) can provide data on the physical and mechanical 
properties of SLBs and their interactions with drugs or other substances like peptides and 
proteins.  
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1.7 Aims of this study 
Saponins, as natural surfactants, display various important biological and pharmacological 
activities. In plants, saponins play an essential role in defense, protecting the plants against 
diseases and predators. They are toxic to several classes of fungi, bacteria, insects, and 
parasites. The ability of saponins to affect cell membrane structure and integrity makes them 
interesting natural products in pharmacological and medical research and therapy, in 
particular as agents for enhancing drug efficacy. Their effect on membranes strongly depends 
on their chemical structure, which is highly variable. Until recently, there has been very little 
information on the activity of saponins as drug-enhancing agents and on their molecular 
mechanisms of action on membranes. This study tries to explore the mechanisms behind the 
drug-enhancing effects of saponins. 
The key objectives of this study have been to explore: 
• the potency of saponins in increasing the efficacy of anticancer drugs in vitro 
• both a steroid saponin (digitonin) and a triterpenoid saponin (quillaja saponin) in respect 
to their capacity of enhancing drug action 
• the molecular mechanism of action of steroid and triterpenoid saponins on biological 
and artifical membranes with several biophysical methods 
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2 Materials and Methods 
2.1 Materials 
2.1.1 Chemicals for cell cultures 
DMEM (Dulbecco's Modified Eagle Medium) Gibco® by Life Technologies 
RPMI 1640 Medium Gibco® by Life Technologies 
Fetal bovine serum (FBS) Biochrom AG, Berlin 
L-Glutamine solution (200 mM, 100×) Gibco® by Life Technologies 
MEM Non-Essential Amino Acids (NAEA, 100×) Gibco® by Life Technologies 
Penicillin-streptomycin (10,000 U/ml) Gibco® by Life Technologies 
Trypan Blue solution Sigma-Aldrich 
Trypsin-EDTA (0.25%), phenol red Gibco® by Life Technologies 
Dimethyl sulfoxide (DMSO) Sigma-Aldrich 
Methylthiazoltetrazolium (MTT) Sigma-Aldrich 
NaCl Sigma-Aldrich 
KCl Sigma-Aldrich 
Na2HPO4 Sigma-Aldrich 
KH2PO4 Sigma-Aldrich 
NaOH Sigma-Aldrich 
Quillaja saponin Carl Roth GmbH, Karlsruhe 
Digitonin (≥ 98%) Sigma-Aldrich 
Verapamil Sigma-Aldrich 
Cisplatin Sigma-Aldrich 
Doxorubicin (adriamycin) Sigma-Aldrich 
 
2.1.2 Chemicals for supported lipid bilayers 
Acetone Zentralbereich Neuenheimer Feld, Heidelberg, Germany 
Alexa Flour 488 LifeTechnology/Thermo Fisher, Darmstadt, Germany 
Ammonium hydroxide Sigma Aldrich, Steinheim, Germany 
Bovine serum albumin (BSA) Sigma Aldrich, Steinheim, Germany 
Cardiolipin (heart, bovine) (CL) Avanti Polar Lipids, Inc., Alabama, USA 
Chloroform Sigma Aldrich, Steinheim, Germany 
Cholesterol Avanti Polar Lipids, Inc., Alabama, USA 
Desalting column PD-10 GE Healthcare, Garching, Germany 
Digitonin Sigma Aldrich, Steinheim, Germany 
Dil stain (dioctadecyltetramethyl-
indocarbocyanine perchlorate) LifeTechnology/Thermo Fisher, Darmstadt, Germany 
1,2-Dipalmitoyl-sn-glycero-3-
phosphocholine (DPPC) Avanti Polar Lipids, Inc., Alabama, USA 
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Ethanol Zentralbereich Neuenheimer Feld, Heidelberg, Germany 
Hellmanex Hellma GmbH, Müllheim, Germany 
Hydrogen peroxide Grüssing GmbH, Filsum, Germany 
Methanol Zentralbereich Neuenheimer Feld, Heidelberg, Germany 
Milli-Q H2O Thermo Electron LED GmbH, Niederelbert, Germany 
L-α-Phosphatidylcholine (egg, chicken) (PC) Avanti Polar Lipids, Inc., Alabama, USA 
Phospholipids B kit Wako Chemicals, Neuss, Germany 
Sphingomyelin (egg, chicken) Avanti Polar Lipids, Inc., Alabama, USA 
1-Stearoyl-2-oleoyl-sn-glycero-3-
phosphocholine (SOPC) Avanti Polar Lipids, Inc., Alabama, USA 
Texas Red-DHPE Avanti Polar Lipids, Inc., Alabama, USA 
Triton X-100 Sigma Aldrich, Steinheim, Germany 
 
2.1.3 Laboratory materials  
Cell culture flasks Cellstar® (25 and 75 cm2) Greiner bio-one GmbH, Frickenhausen 
Cell culture plates Cellstar® (96- and 24-well) Greiner bio-one GmbH, Frickenhausen 
Chamber Slide™ System, NuncLab-Tek™ II Thermo Fisher Scientific, Darmstadt, Germany 
Crytubes Greiner bio-one GmbH, Frickenhausen 
Cuvettes, disposable Carl Roth, Karlsruhe 
Eppendorf safe lock reaction tubes (1.5 and 2 ml) Eppendorf AG, Hamburg 
Falcon™ conical centrifuge tubes (15 and 50 ml) Becton Dickinson GmbH, Heidelberg 
LiChrospher® 100 RP-18 (5 µm) LiChroCART® 250-4 Merck Millipore, Darmstadt 
Pasteur pipettes Carl Roth GmbH, Karlsruhe 
Pipettes, serological, sterile (5, 10, and 25 ml) Greiner bio-one GmbH, Frickenhausen 
Precision spray plastic pak Becton Dickinson GmbH, Heidelberg 
Stericup® and Steritop™  500 ml Merck Millipore, Darmstadt 
Syringe driven filter unit (0.22 and 0.45 µm) Merck Millipore, Darmstadt 
Pipette tips, natural 200 µl Greiner bio-one GmbH 
Pipette tips, natural 1000 µl Greiner bio-one GmbH 
Petri dishes, sterile, 94,0/16 mm, with vents Greiner bio-one GmbH 
Masterblock, 96 well, 1 ml, U-bottom Greiner bio-one GmbH 
Pipette tips, natural (10, 200, and 1000 µl) Greiner bio-one GmbH 
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2.1.4 Instruments 
Autoclave CERTOCLAV KELOmat-Sterilizer Division, Traun, Austria 
Axiovert 200 M microscope Carl Zeiss Microscopy GmbH, Oberkochen, Germany 
Beckman Coulter Gold HPLC system Beckman Coulter GmbH, Krefeld, Germany 
Cabinet TT80 FRYKA Kaltechnik, Esslingen 
Centrifuge Eppendorf AG, Hamburg, Germany 
Centrifuge, Hermle ZK 364 M&S Laborgeräte GmbH, Wiesloch 
Centrifuge, J12-21, Rotor JA-14 Beckmann, München 
Centrifuge, Megafuge 1.0R Hereaus Sepatech, Wiesloch 
CO-150 cell culture incubator Brunswick Scientific, Nürtingen 
CO2 incubator B5060 EK/CO2 W.C. Heraeus GmbH, Hanau 
Confocal microscope LSM 710 Carl Zeiss Microscopy GmbH, Oberkochen, Germany 
Diaphragm vacuum pump Vacuubrand GmbH & Co., Wertheim 
DLS ZetasizerNano ZS Malvern Instruments GmbH, Herrenberg 
DPI sensor chips Farfield Sensors Ltd., Crewe, UK 
Dual polarization interferometer, Analight® BIO200 Farfield Sensors Ltd., Crewe, UK 
Heraeus oven, Model T6030 Heraeus Instrument, Hanau 
YL9100 HPLC YL Instrument Co.,Ltd., Republic of Korea 
Incubator Heraeus Holding GmbH, Hanau, Germany 
Laminar air flow, Type S-2010, Model 1.2 Heto-Holten, Allerød, Denmark 
Light microscope (inverted Nikon TMS) Nikon Corporation, Tokyo, Japan 
LCQ Duo ion trap mass spectrometer Thermo Finnigan, USA 
Lipid extruder Avanti Polar Lipids, Inc., Alabama, USA 
Liposome extruder, LiposoFast LF-1 Avestin, Ottawa, Canada 
Liquid nitrogen tank GT35 AIR LIQUIDE GmbH, Düsseldorf 
Microplate reader, Biochrom Asys UVM 340 Biochrom Ltd., Cambridge, UK 
Microplate reader, Tecan Safire 2 Tecan, Crailsheim, Germany 
Microplate reader, Tecan Infinite M200 Tecan, Crailsheim, Germany 
Multichannel pipette 8 × 200 µl Abimed, Langenfeld 
Neubauer counting chamber neoLab® Migge, Heidelberg 
pH-meter MP 120 Biometra GmbH, Göttingen 
Pipettes, PIPETMAN Classic™(2, 20, 100, 200, 1000 µl) Gilson Inc., Middleton, USA 
Pipetus® pipetting aid/controller Hirschmann Laborgeräte, Eberstadt 
Precision balance, Sartorius Basic Sartorius AG, Göttingen 
Quartz crystal microbalance with dissipation, QCM-D E4 Q-Sense/Biolin Scientific, Gothenborg, Sweden 
Silicon wafer Si-Mat Silicon Materials, Kaufering, Germany 
Sonorex ultrasonic water bath, model Super RX 514 Bandelin Electronic KG, Berlin 
Spectrophotometer Eppendorf AG, Hamburg 
Tip sonicator Misonix, Inc., Farmingdale, NY, USA 
Vacuum chamber Binder GmbH, Nehren, Germany 
Vortex, Heidolph Relax top Heidolph Instruments GmbH & Co. KG, Schwabach 
Water bath, Julabo P Julabo Labortechnik GmbH, Seelbach 
X-ray reflectometer D8 Advance, Bruker, Germany 
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2.2 Methods 
2.2.1 Cell culture 
All cancer cell lines were cultured in Dulbecco's Modified Eagle Medium (DMEM +  
L-glutamine) supplemented with 10% heat-inactivated fetal bovine serum (FBS), 5% 
penicillin/streptomycin and 5% non-essential amino acids (NEAA) at 37°C in 95% humidified 
atmosphere and 5% CO2. The cultures were split every two days when they reached 80% 
confluence using trypsin/EDTA. The cell adherence was removed by applying 3 ml of trypsin-
EDTA, then incubating for 5 min at 37°C and 5% CO2. Medium to a final volume of 10 ml was 
added to inactivate the trypsin-EDTA. Trypan Blue was added to differentiate between living 
and dead cells (10 µl TB to 100 µl of cell suspension). Numbers of living cells were counted in a 
Neubauer counting chamber, white cells in the four outer quadrants and in the inner square. 
The mean value was determined to dilute the cells with growth medium to a specific number 
as needed for the next experiment. All experiments were performed with cells in the 
logarithmic growth phase. 
2.2.2 Cell proliferation assays 
For cytotoxicity measurements the cells were seeded into 96-well plates at a density of 2 × 104 
cells/well in 100 µl medium and then grown for 24 h before treating them with saponins and 
anticancer agents. Different concentrations of saponins and anticancer agents (in DMSO) were 
applied into the culture wells which were then incubated for 24 h. The final concentration of 
DMSO in the culture medium did not exceed 0.05%. Cell viability was evaluated using 
themethylthiazolyltetrazolium (MTT) cell viability assay. The survival of cells after treatment 
with saponins and anticancer agents was quantified using MTT. The test substances were 
replaced with fresh medium containing 0.5 mg/ml MTT, then incubated for 4 h. NAD(P)H-
dependent cellular oxidoreductase enzymes from surviving cells will reduce tetrazolium dye 
salt into insoluble formazan which has a purple color. The MTT solution was removed from the 
wells and formazan crystals were dissolved in 100 µl of DMSO and then measured with a 
microplate reader (Biochrom UVM-340) at 570 nm. Experiments were repeated at least three 
times and each measurement was done as a triplicate. Controls included wells with untreated 
cells, wells with medium only, and wells with substance solution only. The cell viability was 
determined according to the formula below (Mosmann 1983). The IC50 values from each 
substance were calculated using a four-parameter logistic curve (SigmaPlot® 11.0) which 
representing 50% reduction of viability compared to the positive control. Results were 
expressed as mean and standard error (Chou 2006). 
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% cell viability = absorbance of sample-treated cells – absorbance of sample
absorbance of cells – absorbance of medium  ×  100 
 
 The nontoxic concentration of saponins against cancer cells was combined with the 
anticancer agent in order to investigate the ability of saponins to increase the toxicity of the 
anticancer agent in various cancer cell lines. The nontoxic concentration of saponins was taken 
from the IC20 values of saponins as determined in dose-dependent cytotoxicity experiments. 
Here, the IC20 value represents the concentration at which 80% of cells survive treatment with 
saponins (80% viable cells). The IC20 or any other IC value can be calculated from the IC50 
equivalently to the equation below:  
ECF  = �
F
100 –  F�√H × EC50 
 
with F being an index for a specified EC value, e.g., 20 for EC20, and H the hillslope (Zhao et al. 
2004). 
The combination of saponins with anticancer agents in various cancer cell lines can have 
synergistic, additive, or antagonistic effects. The combination index (CI) between two or more 
drugs can be calculated by: 
CI = Csap
IC50,sap
+ 
Cdrug
IC50,drug
 
 
Here, Csap and Cdrug are the variable concentrations of saponin and drug chosen in the 
combination experiments; IC50,sap and IC50,drug are the inhibitory concentrations of each of the 
substances; CI < 1 indicates synergistic, CI = 1 additive, and CI > 1 antagonistic effects (Chou 
2006; Zhao et al. 2004). 
 The effect of combining saponins with anticancer drugs can also be evaluated by calculating 
their cytotoxicity enhancement ratio (CER), dose reduction index (DRI), or reversal ratio (RR) 
value. These can show how many fold the saponins can increase the toxicity of the cancer. The 
equation below was used to calculate CER values of saponin-anticancer agent combinations 
(Chou and Chou 1988). 
CER = IC50,drug
IC50,sap+drug
 
  
For the combination experiment cells were treated in the same manner as for cell proliferation 
by the MTT cytotoxicity assay, only that the anticancer drug was mixed with saponins before 
being added to the cells. 
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2.2.3 Hemolytic activity 
Defribrinated sheep blood was centrifuged at 3000 rpm for 5 min and red blood cells were 
then resuspended in isotonic NaCl solution to obtain a 1% erythrocyte solution. Serial dilutions 
of saponins were prepared in an isotonic NaCl solution. 500 µl of sample was mixed with  
500 µl of erythrocytes in Eppendorf tubes and then incubated for 1 h at 37°C. After incubation 
the tubes were centrifuged at 1000 rpm for 5 min and then the supernatant was transferred 
into 96-well plate. The absorbance of hemoglobin in the supernatant was measured at 544 nm 
with a Biochrom UVM-340 microplate reader. As a positive control 5% Triton X-100 was 
employed and an isotonic NaCl solution as a negative control. Measurements were replicated 
three times for each saponin concentration. Hemolytic activity was calculated with the 
following formula (Herrmann and Wink 2011). 
% hemolysis = 
absorbance of sample–absorbance of blank
absorbance of positive control
 ×  100 
 
2.2.4 Preparation of lipid vesicles and entrapment of calcein 
Large unilamellar vesicles (LUVs) were prepared by hydration of a thin lipid film, according to 
the Bangham method. The desired membrane lipids, in appropriate amounts, were dissolved 
in chloroform, mixed properly in a round-bottom flask, and then dried under a stream of N2 
gas. The solvent was completely removed by keeping the sample in the vacuum desiccator 
connected to a rotary vacuum pump for more than 12 h. To prepare LUVs containing calcein, 
lipids were resuspended to a concentration of 4 mg/ml in 1 ml solution containing 80 mM 
calcein in water (pH 7.4, adjusted with NaOH) continuing with vortexing for 30 s several times 
at room temperature. Next, the lipid-calcein suspension was subjected to six cycles of freezing 
and thawing in liquid N2. Afterwards the solution was extruded 31 times through double-
stacked polycarbonate membrane (pore size, 100 nm) using a two-syringe extruder in a 
LiposoFast liposome extruder (Avestin) until the solution became transparent. The untrapped 
calcein was removed from LUVs solution through a PD-10 desalting column (GE Healthcare) 
equilibrated with outside buffer. The lipid concentration was estimated with the Phospholipids 
B kit (Wako Chemicals). Fluorescence intensities of calcein entrapment in LUVs were measured 
at room temperature at excitation wavelength 490 nm and emission wavelength 520 nm 
(García-Sáez et al. 2006). 
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2.2.5 Permeabilization of LUVs (calcein release assay) 
Permeability activity of saponins at the LUVs was determined by measuring the intensity of 
calcein fluorescence released into solution from LUVs after introduction of saponins. The black 
96-well plate was blocked with 10% bovine serum albumin (BSA) for 1 h at room temperature 
to avoid nonspecific interaction between plate material with saponins and vesicles. The BSA 
solution was removed from the plate, continuing with washing several times with sterile 
water, then dried. Following this, 100 µl of LUVs with entraped calcein was added to each well. 
Different concentrations of saponins were applied immediately before measurements with a 
Tecan Infinite M200 plate reader at fluorescence emission wavelength of 520 nm and 
excitation at 495 nm. The increased fluorescence intensity of calcein was monitored with time 
until a stationary state was reached. As a positive control 5% Triton X-100 was employed and 
buffer as a negative control. The percentage of calcein release from vesicles induced by 
saponins was calculated from: 
%R = 100 Ff – Fi
Fm –  Fj 
 
where Ff  is the calcein fluorescence intensity at a specific time after incubation with saponins, 
Fi the initial calcein intensity before adding saponins, and Fm the maximum intensity of calcein 
upon adding 5% Triton X-100 (García-Sáez et al. 2006).  
 
2.2.6 Preparation of giant unilamellar vesicles (GUVs) 
Giant unilamellar vesicles (GUVs) were prepared by the electroformation method. The desired 
lipid composition with and without cholesterol was mixed with Dil stain to visualize GUV 
membrane rims under the fluorescence microscope. The lipid mixture at 1 mg/ml in 
chloroform was spread onto two platinum wire electrodes at 5 µl per each wire and the 
solvent was evaporated for one minute. After the solvent had completely evaporated, the 
platinum wires were immersed in a chamber containing 300 mM sucrose solution and then 
the unit was connected to a power generator. The electroformation proceeded at 2.3 V and 
10 Hz for 2 h, then followed by 30 min at 2 Hz at room temperature to release the GUVs from 
the electrode wires. The 40 µl of GUVs electroformed in 300 mM sucrose were transferred to 
400 µl PBS onto an eight-chamber slide (Nunc™ Lab-Tek™ II Chamber Slide™ System) that was 
previously blocked with 2 mg/ml bovine serum albumin (García-Sáez et al. 2009). 
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2.2.7 Membrane permeability assays 
For GUVs permeabilization measurements, Alexa Flour 488 was added and mixed properly 
with PBS containing saponin solution before GUVs were added into it. The Alexa Flour 488 
fluorescence can differentiate between solution from the outside and inside of GUVs. The 
degree of permeabilization (filling kinetics) was determined by collecting pictures of several 
GUVs in different sample conditions every 20 s for 1 h. GUV images from several regions were 
taken after 2 h incubation with or without saponins to reach the final extent of vesicle 
permeabilization. Permeabilized and nonpermeabilized GUVs were counted and analyzed with 
homemade GUV detector software and ImageJ (http://rsbweb.nih.gov/ij/) (García-Sáez et al. 
2009; Apellániz et al. 2010; Hermann et al. 2014). 
 
2.2.8 Confocal microscopy (CM) and fluorescence correlation 
         spectroscopy (FCS) 
Membrane permeabilization by saponins was monitored with LSM710 microscope with a  
C-Apochromat 40×/1.2W Corr M27 water immersion objective (Zeiss, Oberkochen, Germany) 
in multitrack modus. The green channel consisted of excitation light from an Ar-ion 488 nm 
and a 505–530 nm band-pass filter. The red channel consisted of excitation light from a He-Ne 
561 nm with 633 nm excitation laser and a 650 nm long-pass filter. Fluorescence cross-
correlation spectroscopy (FCCS) measurements were performed at 22°C using a Confocor 3 
module. Photon arrival times were recorded with a hardware correlator Flex 02-01D/C 
(http://correlator.com). We repeatedly scanned the detection volume with two perpendicular 
lines through the equator of a GUV (the distance between the two lines, d, was measured by 
photobleaching on a film of dried fluorophores). The data was analyzed using homemade 
software (García-Sáez et al. 2009). We binned the photon stream in 2 μs and arranged it as a 
matrix such that every row corresponded to one line scan. We corrected for membrane 
movements by calculating the maximum of a running average over several hundred line scans 
and shifting it to the same column. We fitted average overall rows with a Gaussian and we 
added only the elements of each row between –2.5 s and +2.5 s to construct the intensity 
trace. We computed the autocorrelation and spectral and spatial cross-correlation curves from 
the intensity traces and excluded irregular curves resulting from instability and distortion. The 
auto- and cross-correlation functions were then fitted with a nonlinear least-squares global 
fitting algorithm, as described by García-Sáez et al. (2009)  and Bleicken et al. (2013). 
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2.2.9 GUV image analysis 
Permeability of GUVs is defined by influx of colored solution through the GUV membranes. 
The percentage of GUV filling was calculated according to the equation below. The threshold 
for nonpermeabilized GUVs was set to <15%. Several hundred GUVs were analyzed per 
experiment. 
�
(Ftin – F0)
(Ft
out – F0)�  × 100, 
in which Ftin is the average fluorescence intensities inside a GUV, Ftout the average fluorescence 
intensities outside a GUV, and F0 the background fluorescence at time t.  
To quantify saponin binding to GUV membranes, the fluorescence intensity at the vesicle rim 
(Frim) was calculated with ImageJ using the plug-in radial profile plot. Intensity was plotted as 
Frim/Fback, where Fback is the background intensity outside the GUVs. 
In the kinetics experiments, images were recorded every 20 s and changes in the fluorescence 
intensity inside GUVs were analyzed over time as 
FtN = (Ftin– F0)(Ftout– F0) 
FtN is the normalized fluorescence intensity at time t. 
To calculate the initial A0 and relaxed Arelax permeabilized area of individual GUVs, as well as 
the relaxation time τrelax, we used a multiexponential fitting described by: 
F(t)in
N  = 1 – –t
eτflux(t)
 
where the influx rate, τflux, decreases with time (the initial pore size relaxes to a smaller 
structure) according to 
τflux(t) = 
V
A(t) × Dm
 
where V is the vesicle volume, D the dye diffusion coefficient, m the membrane thickness, and 
A the total permeabilized area, which varies with time according to 
A(t) = Arelax + (A0 – Arelax) × –teτrelax 
Membrane thickness was assumed to be 4.5 nm. The diffusion coefficient of cyt c-al488 was 
196 μm2/s (196 ± 27 μm2/s) as calculated by fluorescence correlation spectroscopy (FCS) 
(Bleicken et al. 2013).  
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2.2.10 Size measurement by dynamic light scattering (DLS) 
In order to get an overall idea about the effects of saponins on the phospholipid bilayer 
membrane, the size change of small unilamellar vesicles was measured using a dynamic light 
scattering (DLS) technique. Different concentrations of digitonin and quillaja saponins were 
added to the suspension of vesicles with or without cholesterol incorporation and the size 
distribution was measured at room temperature before and after an incubation of 30 min. The 
900 µl of vesicle solution (0.5 mg/ml) was inserted in a disposable cuvette (Roth, Karlsruhe) 
and measured with 11 scans of 10 s in a DLS Zetasizer Nano ZS (Malvern Instruments) at 21°C. 
Afterwards 100 µl of saponins was added and after incubation for 30 min at room 
temperature, the solution was measured once more. For the control sample instead of 
saponins, 100 µl of filtered Milli-Q water was added to the vesicle solution and proceeded as 
described above. The data was analyzed using the asymmetric Gaussian function 
(ExpModGauss) multipeak fitting 2 package for IGOR PRO software (Wavemetrics, OR). 
 
2.2.11 Dual polarization interferometry (DPI) 
The effects of saponins on the structure of the bilayer were further characterized in real time 
with another sensitive technique; Dual polarization interferometry (DPI) measurements were 
performed with the Analight BIO200 (Farfield, UK), using a dual slab waveguide sensor chip 
(22 mm × 6 mm) illuminated with an alternating polarized laser beam (wavelength 632.8 nm). 
The chip consists of a four-layer dielectric stack of silicon oxynitride on a silicon wafer surface, 
which generates interference fringes at its output (integrated Young’s interferometer). Upon 
deposition of material in the region of the evanescent field close to the surface of the top 
waveguide layer, spatial changes of an interference pattern occur. The optical path length of 
the top waveguide is affected by the change in refractive index within the evanescent field. 
This causes a relative phase shift corresponding to the shift of the interference fringes. The 
excitation of the chip with two orthogonal polarization modes provides two separate 
measurements of fringe shifts. The parameters refractive index n and thickness d for an 
adsorbed isotropic single layer are fitted to the measured phase changes with a minimization 
algorithm (Cross et al. 1999, 2003). 
The anisotropy of the layer is considered by an additional parameter, birefringence, which 
describes the difference between the refractive index perpendicular and parallel to the 
surface (Mashaghi et al. 2008). The analysis is performed by fixing one of the parameters, 
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either refractive index n, thickness d, or birefringence to determine the other two. Herein a 
constant thickness corresponding to the thickness obtained by X-ray reflectivity is assumed. 
 The waveguide surfaces were cleaned according to the modified RCA cleaning procedure 
(Kern 1990). First, the surfaces were immersed and sonicated with acetone, ethanol, and 
methanol, then sonicated in a freshly prepared solution of 1 : 1 : 5 (v/v) H2O2 (30%)/NH4OH 
(30%)/H2O for 5 min and kept for another 45 min at 60°C to obtain hydrophilic surfaces. 
Finally, they were rinsed 10 times with water, thoroughly dried at 70°C and stored in a vacuum 
chamber prior to use. After waveguide insertion, calibrations were performed for ethanol 
(80%) and pure water to get a constant baseline. Liposome samples (1 mg/ml) were infused at 
a flow rate of 5 μl/min with a syringe pump followed by rinsing with buffer at the same flow 
rate at 25°C. Digitonin and quillaja saponin solution (50 µM) was infused individually at a flow 
rate of 4 μl/min exposing the lipid bilayer to the saponin for 1 h followed by rinsing at the 
same flow rate at 25°C. 
 
2.2.12 Differential scanning calorimetry (DSC) 
Differential scanning calorimetry (DSC) measurements were carried out using a VP-DSC 
calorimeter (MicroCal, Inc., Northampton, MA, USA). To ensure that thermal equilibrium was 
reached, three thermograms were recorded. The first involved heating the sample from 2°C to 
15°C at a scan rate of 5°C/h, the second involved cooling from 15°C to 2°C at a scan rate of 
5°C/h, and the third involved heating from 2°C to 15°C at a scan rate of 5°C/h. Only the result 
from the last up-scan was used. The samples used for the DSC measurements were prepared 
as 2 mM lipid suspensions of SOPC, SOPC/Chol (80:20), and SOPC/Chol (95:5) in PBS. For the 
interaction with digitonin, lipid vesicles were incubated with 50µM of digitonin for 30 min 
before starting the measurements. 
2.2.13 QCM-D experiments 
Experiments using quartz crystal microbalance with dissipation (QCM-D) monitoring were 
performed with a QCM-D E4 (Q-Sense). The QCM-D sensor allows the measurement of the 
oscillation frequency shift (Δf) of a quartz crystal and simultaneous energy dissipation change 
(ΔD). Whereas changes in resonance frequency are related to the mass of the adsorbed 
material on or removed from the sensor, changes in energy dissipation provide information on 
the viscoelastic properties of the adsorbed material. AT-cut SiO2-coated quartz crystals with a 
fundamental frequency of 5 MHz were provided by Q-Sense. These crystals were stored in 
20  M sodium dodecyl sulfate (SDS) solution between measurements. Prior to use, they were 
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thoroughly rinsed with ultrapure water/ethanol/ultrapure water, dried under N2 stream and 
treated with UV/ozone twice for 15 min, then separated by rinsing with ultrapure water 
(Makky et al. 2011).  
 The lipid SUV solution (0.2 mM in PBS) was flowed over the SiO2 crystals for approx. 10 min 
to form a stable supported lipid bilayer. Then the crystals were rinsed with PBS buffer for 15 
min to remove any unattached vesicles. Afterwards, digitonin solution (50 mM in PBS) was 
injected for 10 min and allowed to adsorb for another 20 min. After this time, the crystals 
were washed with buffer for 15 min to remove any unattached digitonin molecules on the 
supported planar bilayers. The peristaltic pump for liquid flow was set to 100 µl/min. All 
measurements on QCM-D were done with the system temperature stabilized at 25 ± 0.1°C.  
2.2.14 QCM-D modelling 
QCM-D detects materials adsorbed onto a quartz crystal surface. When a material is adsorbed 
on the crystal surface, the resonant frequency decreases with an increase in the amount of 
mass adsorbed on the crystal. 
 If the adsorbed layer is homogenous and sufficiently rigid, the frequency shift (∆f) is 
proportional to the adsorbed mass per unit surface (∆m) as described by the Sauerbrey (1959) 
equation: 
Δm = – 
C × Δf
n
 
where C is the mass sensitivity constant of the quartz (C = 17.7 ng/cm2 Hz at f = 5 MHz) and n is 
the overtone number.  
 However, if the adsorbed layer is decoupled from the quartz oscillation due to the 
viscoelastic behavior of the adlayer and/or to the associated water molecules with the layer, 
then Δf/n curves are shifted, the energy dissipation in the oscillation will increase, and the 
Sauerbrey equation will be invalid. In this case, the more advanced Voigt-Voinova (Voinova et 
al. 1999) model is often employed. In the Voigt-Voinova model, the adsorbed film is 
represented by a single Voigt element consisting of a parallel combination of a spring and a 
dashpot to represent the elastic (storage) and viscous (damping) behavior of a material, 
respectively. This model can be described as following: 
G* = G′ + iG′′ = µf + 2 πifηf  = µf (1 + 2 πifτf)  
where f is the oscillation frequency, µf the elastic shear (storage) modulus, ηf the shear 
viscosity (loss modulus), τf the characteristic relaxation time of the film (τf = ηf/µf),G*the 
complex shear modulus, G′ the storage modulus, and G′′ the loss modulus.  
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 The Voigt-Voinova model relates the measured frequency shift (∆f) and dissipation shift 
(∆D) to the thickness and viscoelastic properties (shear modulus and shear viscosity) of the 
adsorbed layer using the Q-TOOLS software (Vers. 3.0.15, Q-Sense). This model assumes the 
quartz crystal to be purely elastic, and the surrounding solution to be purely viscous and 
Newtonian. In addition, it assumes that the thickness h1 and the density ρ1 of the film are 
uniform, that the viscoelastic properties of shear modulus µ1 and viscosity η1 are frequency 
independent, and that there is no slip between the adsorbed layer and the crystal during 
shearing. The adsorbed layer is represented with an homogeneous film on the sensor surface 
using four unknown parameters (ρ1, h1, µ1, η1). Above the adsorbed film is a semi-infinite bulk 
liquid (ρ2, η2). 
Based on the fore mentioned, the relationship between QCM-D response and viscoelastic 
properties of the adsorbed layer can be explained by the following equations: 
 
 
 
 
where ρ0 and h0 are the density and thickness of the crystal,δ2 the viscous penetration depth 
of the shear wave in the bulk liquid, and ω the angular frequency of the oscillation.  
 In the present work, three overtones (third, fifth, and seventh) were used to model the 
viscoelastic properties of the adsorbed layer of digitonin using the Q-TOOLS software. The 
fixed parameters were assumed as (i) the layer thickness which was determined by XRR 
measurement, (ii) fluid viscosity, 0.001 kg/m⋅s, and (iii) fluid density 1000 kg/m3. The fitted 
parameters were (i) layer viscosity between 0.0005 and 0.01 kg/m⋅s, (ii) layer shear between 
104 and 108 Pa, and (iii) layer density between 1000 and 1800 kg/m3. In addition, when 
modelling the digitonin layer interacting with SLBs, the rigid bilayer was considered as a 
baseline. The thickness of the layer obtained from the Voigt model was multiplied by the 
density of the layer, to estimate the mass adsorbed per unit surface area.  
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2.2.15 High-energy specular X-ray reflectivity (XRR) 
To quantify the effects of saponins on solid-support lipid bilayer a highly sensitive X-ray 
reflectivity technique is used. XRR measurements were performed using a D8 Advance 
(Bruker, Germany) equipped with a sealed X-ray tube, operating with Mo Kα radiation  
(E = 17.48 keV, λ = 0.0709 nm). The incident beam was collimated by various slits, reducing the 
beam size to 200 µm in the scattering plane. Automatic attenuator settings were used to avoid 
radiation damage. The scans were completed in approximately 3 h. The Si-wafer functionalized 
with PDA was placed on the sample holder horizontally. The momentum transfer 
perpendicular to the interface is given as a function of the angle of incidence αi, qz=
4π
λ
sin αi. 
For each measurement point, the reflectivity was corrected for the beam footprint and for the 
beam intensity with the aid of an in-beam monitor. To minimize the artifacts from radiation 
damage, we carefully checked the reproducibility of the results by translating the sample 
position in the direction perpendicular to the beam. The data was fitted by using the Parratt 
formalism (Parratt 1954; Tolan 1999), with a genetic minimization algorithm implemented in 
the Motofit software package (Nelson 2006). 
2.2.16 High-performance liquid chromatography (HPLC) and liquid 
chromatography–mass spectrometry (LC/MS) 
The commercial quilllaja saponin was analyzed by YL9100 HPLC equipped with a LiChroCART 
RP18 column (5 µm, 250 × 4 mm, Merck). The mobile phase consisted of a gradient of water 
and acetonitrile, both with 0.1% formic acid. Starting from 19% acetonitrile, the gradient was 
run to 23% acetonitrile within 15 min, to 35% acetonitrile within the next 15 min, to 50% 
acetonitrile within the next 22 min, to 70% acetonitrile within the next 8 min, to 100% 
acetonitrile within the next 7 min, and remaining at this level for another 23 min. A flow rate 
of 1 ml min−1 was chosen (Thalhamer and Himmelsbach 2014). The chromatogram was 
visualized and analyzed using YL-Clarity software. 
 The composition of commercial quillaja saponin was determined by a LCQ Duo ion trap 
mass spectrometer (Thermo Finnigan, USA) fitted with an electrospray ionization (ESI) source 
and coupled to a Beckman Gold HPLC system (solvent module 125P, PDA detector 168) with a 
LiChroCART RP18 column (5 µm, 250 × 4 mm, Merck). A mobile phase gradient similar to the 
one used in HPLC was applied to the LC-MS system. The flow rate was 1 ml/min throughout 
the entire run. The absorptions were determined in background-subtracted spectra by  
32 Karat™ software (Beckman Coulter, Inc.). The ESI source was operated in negative ion mode 
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at 4.5 kV. The heated capillary temperature was 200oC. High-purity nitrogen was used as a 
sheath and auxiliary gas at a flow rate of 80 and 40 (arbitrary units), respectively. The mass 
spectrometer was set to detect ions in the range m/z 50–2000. The LCQ Duo was capable of 
performing single MS and MS2 experiments in a single chromatographic run. The most 
abundant ions were isolated and scanned for MS/MS analysis with normalized collision energy 
at 35%. The mass spectra were analyzed using Xcalibur 2.0 software and the peaks were 
identified by comparison with published data. 
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3 Results 
3.1 Potency of digitonin as a drug toxicity enhancer and mechanistic 
investigations using membrane models 
3.1.1 Cytotoxicity of digitonin and selected anticancer agents 
Cytotoxicity assays were performed for digitonin as well as for the selected anticancer agents 
berberine, cisplatin, doxorubicin, dexamethasone, and mitomycin C (Fig. 3.1). Dose response 
curves were established in the concentration range from 0.01 mM to 10 mM and IC50 and 
other IC values were determined. The cytotoxicity of the anticancer drugs in the four tested 
cancer cell lines were determined as expected (Table 3.1).  
 
Fig. 3.1. Chemical structures of the selected anticancer agents 
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Table 3.1. Cytotoxicity and IC50 values (µM) of digitonin and of five selected anticancer agents in HeLa, 
COS-7, MIA PaCa-2, and PANC-1. Data indicated as mean ± standard deviation of three independent 
experiments, each done in triplicates. 
 HeLa COS-7 MIA PaCa-2 PANC-1 
Saponin     
Digitonin (µM) 12.40 ± 3.06 11.61 ± 1.45 18.92 ± 2.39 13.41 ± 2.28 
Drugs     
Berberine 334.4 ± 8.85 508 ± 0.13 103.1 ± 0.12 160.73 ± 0.01 
Cisplatin 18.22 ± 5.5 30.37 ± 0.44 94 ± 0.12 99.20 ± 0.03 
Doxorubicin 7.91 ± 0.16 12.76 ± 7.78 20.91 ± 5.27 57.95 ± 7.57 
Dexamethasone 297 ± 0.10 340 ± 0.01 954.36 ± 0.08 1208 ± 0.25 
Mitomycin C 94.40 ± 7.50 137 ± 0.02 24.2 ± 0.06 38.03 ± 0.04 
 
3.1.2 Combining digitonin with common anticancer agents 
Experiments started by applying a calculated IC20 concentration of digitonin and observing the 
actual effects on the cell cultures. The IC20 of digitonin is as follows for the different cell lines: 
6.4 µM for HeLa, 7.7 µM for COS-7, 9.5 µM for MIA PaCa-2, and 6.5 µM for PANC-1 and these 
concentrations were used to test for enhanced toxicity of the five investigated anticancer 
agents. The cytotoxic concentrations (IC50) of the individual tested anticancer agents differs for 
each cell line: berberine is 334.4 µM for HeLa, 508 µM for COS-7, 103.1 µM for MIA PaCa-2, 
and 160.73 µM for PANC-1; cisplatin is 18.22 µM for HeLa, 30.37 µM for COS-7, 94 µM for MIA 
PaCa-2, and 99.20 µM for PANC-1; doxorubicin is 7.91 µM for HeLa, 12.76 µM for COS-7, 
20.91 µM for MIA PaCa-2, and 57.95 µM for PANC-1; dexamethasone is 297 µM for HeLa, 
340 µM for COS-7, 954.36 µM for MIA PaCa-2, and 1208 µM for PANC-1; and mitomycin C is 
94.40 µM for HeLa, 137 µM for COS-7, 24.2 µM for MIA PaCa-2, and 38.03 µM for PANC-1. 
 Anticancer agents in combination with a nontoxic concentration of digitonin generally 
increased the response of the cancer cell lines. The cytotoxicity enhancement ratio (CER) for 
each anticancer agent with digitonin was calculated by comparing IC50 values of the individual 
drugs with the IC50 of combined drug + digitonin for each cell line (Figs. 3.2a–d, 3.3 and 
Table 3.2). In general, digitonin enhanced the toxicity of all anticancer agents in all tested 
cancer cell lines. Among the combinations, dexamethasone + digitonin stands out: CER 3.75 in 
PANC-1 (IC50 from 1208 to 322.13 µM), 2.39 in MIA PaCa-2 (IC50 from 954.36 to 399.8 µM), and 
1.04 in COS-7 (IC50 from 340 to 327.2 µM), while digitonin did not increase the cytotoxicity of 
dexamethasone in the HeLa cell line. 
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 To interpret the type of interaction between anticancer agent and saponin, the 
isobologram method was used for determining the combination index (CI) to see whether the 
interaction is synergistic, additive, or antagonistic. The results indicate that the interaction of 
digitonin and anticancer drugs is mostly synergistic –the synergistic effect of the combination 
of digitonin+dexamethasone on the pancreatic cancer cell lines PANC-1 and MIA PaCa-2 being 
particularly strong, with CI values of 0.59 and 0.81, respectively (Fig. 3.4 and Table 3.2).  
 
Table 3.2. Effects of digitonin (IC20) + anticancer agents in HeLa, COS-7, MIA PaCa-2, and PANC-1 as 
reflected by the combination index (CI) and cytotoxicity enhancement ratios (CER). Data are expressed 
as means ±SD of cell viability for three independent experiments. The IC20 of digitonin was 6.4 µM in 
HeLa, 7.7 µM in COS-7, 9.5 µM in MIA PaCa-2, and 5.6 µM in PANC-1.  
IC50 (µM) of anticancer agents + IC20 (µM) digitonin 
 HeLa  
(6.4 µM) CI CER 
COS-7 
(7.7 µM) CI CER 
MIA PaCa-2  
(9.5 µM) CI CER 
PANC-1 
(5.6 µM) CI CER 
 Berberine 208 ± 0.03 1.03 1.61 345 ± 0.17 1.16 1.47 58.00 ± 0.03 0.96 1.78 126.8 ± 0.33 1.11 1.27 
 Cisplatin 11.77 ± 8.39 1.05 1.55 15.19 ± 2.54 0.99 2.00 46.35 ± 0.01 0.89 2.03 88.36 ± 0.02 1.22 1.12 
 Doxorubicin 6.41 ± 0.37 1.22 1.23 6.86 ± 5.17 0.98 1.86 12.06 ± 8.21 0.97 1.73 31.26 ± 4.94 0.86 1.85 
 Dexamethasone 568 ± 0.14 1.35 0.52 327.2 ± 0.08 1.45 1.04 399.8 ± 0.08 0.81 2.39 322.13 ± 0.32 0.59 3.75 
 Mitomycin C 38.95 ± 5.76 0.82 2.42 57.52 ± 0.01 0.9 2.38 19.3 ± 0.03 1.19 1.25 22.13 ± 0.1 0.91 1.72 
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 (a)  HeLa 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.2a. Dose response curves in HeLa to the anticancer agents berberine, cisplatin, dexamethasone, 
doxorubicin, and mitomycin C (black data points) and their combination with IC20 concentrations of digitonin 
(6.4 µM) (white data points). Data are expressed as means ±SD of cell viability from three independent 
experiments, each done in triplicates.  
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(b)  COS-7 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.2b. Dose response curves in COS-7 to the anticancer agents berberine, cisplatin, dexamethasone, 
doxorubicin, and mitomycin C (black data points) and their combination with IC20 concentrations of digitonin 
(6.4 µM) (white data points). Data are expressed as means ±SD of cell viability from three independent 
experiments, each done in triplicates.  
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(c)  MIA PaCa-2 
 
 
                               
                               
                               
                               
         
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.2c. Dose response curves in MIA PaCa-2 to the anticancer agents berberine, cisplatin, dexamethasone, 
doxorubicin, and mitomycin C (black data points) and their combination with IC20 concentrations of digitonin 
(6.4 µM) (white data points). Data are expressed as means ±SD of cell viability from three independent 
experiments, each done in triplicates.  
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(d)  PANC-1 
 
      
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.2d. Dose response curves in PANC-1 of the anticancer agents berberine, cisplatin, dexamethasone, 
doxorubicin, and mitomycin C (black data points) and their combination with IC20 concentrations of digitonin 
(6.4 µM) (white data points). Data are expressed as means ±SD of cell viability from three independent 
experiments, each done in triplicates. 
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Fig. 3.3. Cytotoxicity enhancement ratios (CER) of anticancer drugs enhanced by digitonin in HeLa, COS-7, 
MIA PaCa-2, and PANC-1. CER values higher than 1 (dashed line) show the ability of digitonin to increase drug 
toxicity in the cancer cell lines. The cytotoxitiy enhancement profiles by digitonin differ in each case. 
 
 
Fig. 3.4. Combination index (CI) values of digitonin (IC20) with anticancer drugs in HeLa, COS-7, MIA PaCa-2, 
and PANC-1. CI < 1 = synergistic; CI 1 = additive; CI > 1 = antagonistic. 
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3.1.3 Digitonin increases the toxicity of ricin  
Ricin from the seeds of Ricinus communis (castor bean) is a very toxic type-II ribosome-inactivating 
protein (RIP). Its high cytotoxicity is due to its immunotoxic, antiviral, antifungal, and insecticidal 
bioactivity and promises to have a potential as an anticancer agent. Mossinger et al. (1951) 
investigated the activity of ricin on rat sarcomas leading up to phase-I clinical studies (Fodstad 1984). 
Ricin is composed of an A-chain as the catalytic component and a B-chain as a sugar-specific lectin 
making it a nonpermeable RIP protein requiring other substances for delivery through the cell 
membrane. Saponins interact with cell membranes and can be used to deliver ricin into cells. Saponin 
from Agrostemma githago L. (corn cockle) increases the cytoxicity of the ribosome-inactivating lectin 
agrostin (Hebestreit et al. 2006; Melzig et al. 2005; Hebestreit and Melzig 2003). We explored the 
effect of digitonin in enhancing the toxicity of ricin.  
 Ricin was extracted from castor beans and identified with SDS-PAGE by submitting the aqueous 
fraction to gel electrophoresis, which confirmed the presence of ricin. The concentration of ricin was 
determined by Bradford assay. The toxic concentration of ricin in HeLa, COS-7, MIA PaCa-2, and 
PANC-1 was assessed by MTT assay with IC50 concentrations of 75.20, 99.9, 62.7, 297.15 ng/ml, 
respectively. The toxic and non-toxic concentration of digitonin was also determined for these cancer 
cell lines.  
 Digitonin enhances the toxicity of ricin in the cancer cell lines by more than 1.5-fold. The highest 
toxicity enhancements of ricin by digitonin were in the HeLa and MIA PaCa-2 cell lines with CER 
values of 5.41 (IC50 decreased from 75.2 to 13.9 ng/ml) and 5.13 (IC50 decreased from 62.7 to 
12.2 ng/ml), respectively (Figs. 3.5 and 3.6). The combination of ricin with digitonin in HeLa,  
MIA PaCa-2, PANC-1 shows synergistic effects with CI values of 0.59, 0.59, and 0.90, respectively, the 
interaction with COS-7 is additive with a CI value of 1.04 (Fig. 3.7). Table 3.3 summarizes the 
cytotoxicity data of the individual substances and their combination. 
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Fig. 3.5. Dose response curves of ricin in HeLa, COS-7, MIA PaCa-2, and PANC-1. Cytotoxicity of ricin (black 
data points) and its combination with IC20 concentrations of digitonin (6.4 µM for HeLa; 7.7 µM for COS-7; 9.5 
µM for MIA PaCa-2; 5.5 µM for PANC-1) (white data points). Data are expressed as means ±SD of cell viability 
from three independent experiments, each done in triplicates. 
 
 
Fig. 3.6. Cytotoxicity enhancement ratio (CER) for ricin + digitonin in HeLa, COS-7, MIA PaCa-2, and PANC-1. 
CER values higher than 1 (dashed line) show the ability of digitonin to increase drug toxicity in the cancer cell 
lines. The cytotoxicity enhancement profiles by digitonin differ in each case. 
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Fig. 3.7. Combination index (CI) values of digitonin (IC20) + ricin in HeLa, COS-7, MIA PaCa-2, and PANC-1;  
CI < 1 = synergistic; CI 1 = additive; CI > 1 = antagonistic. 
 
Table 3.3. Cytotoxicity of digitonin, of ricin, and of the combination of both in HeLa, COS-7,  
MIA PaCa-2, and PANC-1 cancer cell lines. The combined effect is shown by the combination index (CI) and 
cytotoxicity enhancement ratio (CER). Data are expressed as means ±SD of cell viability for three independent 
experiments. 
 
IC50 (µM) of anticancer agents + IC20 (µM) of digitonin 
 HeLa CI CER COS-7 CI CER MIA PaCa-2 CI CER PANC-1 CI CER 
Saponins             
Digitonin (IC50/ µM) 12.40±3.06   11.61±1.45   18.92±2.39   13.41±2.28   
Digitonin (IC20/ µM) 6.4   7.7   9.5   5.6   
Ricin (ng/ml) 75.20±0.01   99.9±0.04   62.70±0.01   297.15±0.25   
Ricin + digitonin 
(ng/ml) 13.9 ± 0.05 0.59 5.41 55.2 ± 0.02 1.04 1.80 12.2 ± 0.1 0.59 5.13 171.1 ± 0.5 0.90 1.73 
 
3.1.4 Digitonin ruptures RBCs 
The activity of digitonin on natural cell membranes was examined with RBCs. Defebrinated sheep red 
blood cells were mixed with digitonin and the effect on the cell membranes was determined by 
photometrically measuring hemoglobin leakage out from the RBCs. Salt solution 0.9% and water 
were used as negative and positive controls. Digitonin affected sheep RBC membranes and rupturing 
them at an IC50 concentration of 0.0151 mM (Fig. 3.8). 
59 
 
 
Fig. 3.8. Dose-dependent hemolytic effect of digitonin on sheep RBCs. Dose-ranging experiments were 
performed from 0.1 to 0.001 mM of digitonin. RBC rupturing occurred at IC50 0.0151 mM. Data are expressed as 
means ±SD of hemolytic activity for three independent experiments. 
 
3.1.5 Digitonin causes calcein leakage 
Calcein leakage experiments were performed to investigate the specific interaction of digitonin with 
cell membrane components and to quantify the extent of membrane permeabilization caused by 
digitonin via its ability to induce leakage of lipid vesicles. Several large unilamellar vesicles (LUVs) 
were prepared all differing in the composition of the membrane lipids phosphatidylcholine (PC), 
sphingomyelin (SM), cardiolipin (CL), and cholesterol (Chol) in four different ratios: 100% PC, PC/Chol 
(80/20), PC/SM/Chol (40/40/20), and PC/CL (80/20). LUVs were incubated with different 
concentrations of digitonin and the release of calcein into the extravesicular solution was 
determined by fluorescence spectroscopy. 
 The results clearly indicate that digitonin specifically interacts with cholesterol in membranes to 
induce vesicle leakage and releasing entrapped calcein to the solution. The intensity of extra 
vesicular calcein fluorescence in the 100% PC and PC/CL (80/20) cases did not increase after 
incubation with digitonin for 24 h (Fig. 3.9).  
 Digitonin immediately interacts with cholesterol-containing membranes inducing membrane 
leakage within less than 2 min, then remaining stable for more than one hour, as indicated by the 
steady level of extravesicular calcein fluorescence (Fig. 3.10). 
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Fig. 3.9. Calcein release from different LUVs induced by digitonin. Data are expressed as means ±SD of 
hemolytic activity for three independent experiments. PC: phosphatidylcholine; CL: cardiolipin; Chol: 
cholesterol; SM: sphingomyelin. 
 
 
Fig. 3.10. Kinetics of calcein release of PC/Chol (80:20) LUVs induced by digitonin. Intensity of fluorescence of 
calcein released from LUVs by 0.01 mM digitonin was measured continuously every 120 s for 1 h. The inset 
shows the percentage of calcein release in the range time of 0–10 min. 
 
3.1.6 Calcein release depends on membrane cholesterol concentration 
Cholesterol plays an important role in the effect of digitonin on the cell membrane. We determined 
the extent to which cholesterol concentration has an effect on digitonin's ability to induce membrane 
leakage as indicated by the intensity of calcein release (Fig. 3.11). 
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Fig. 3.11. Cholesterol concentration and effect of digitonin causing membrane leakage. PC vesicles with 
different concentrations of cholesterol were incubated with 0.1 mM digitonin for 1 h. Data are expressed as 
means ±SD of percentage of calcein release for three independent experiments.  
 
3.1.7 Digitonin affects vesicle size only in the presence of cholesterol 
To reveal possible interactions and effects of digitonin on vesicle membranes in terms of shape 
changes of vesicles with and without cholesterol we applied dynamic light scattering (DLS).  
1-Stearoyl-2-oleoyl-sn-glycero-3-phosphocholine (SOPC) vesicles without and with 20% cholesterol 
were prepared and incubated with different concentrations of digitonin for 30 min, then measured 
by DLS. Shape and size of vesicles without cholesterol are similar between digitonin-treated and 
untreated cases, indicating that digitonin can not bind to the vesicle membranes (Fig. 3.12a). In the 
presence of cholesterol, shape and size of vesicles changed with increasing concentration of 
digitonin, and vesicle size dramatically changed when applying digitonin 100 µM (Figs. 3.12b–d).  
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Fig. 3.12. DLS profile of vesicle sizes with and without cholesterol after incubating with different 
concentrations of digitonin. Black dotted line represents control without digitonin and red dotted line without 
digitonin. SOPC vesicles (a) no cholesterol + 50 µM digitonin; (b) 20% cholesterol + 10 µM digitonin; (c) 20% 
cholesterol + 50 µM digitonin; (d) 20% cholesterol + 100 µM digitonin.   
a 
b 
c 
d 
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3.1.8 Digitonin affects GUV membrane permeability and integrity 
         in the presence of cholesterol 
Fluorescence microscopy was employed to further investigate the interaction and permeabilization 
effect of digitonin on giant unilamellar vesicles (GUV) with a diameter of up to 100 µm. Dil stain was 
used to mark GUV membranes and Alexa Flour 488 fluorescence for coloring the extravesicular 
solution of GUVs. Membrane permeabilization was visualized by monitoring the presence of dye 
inside of GUVs (black circle). The kinetics and degree of membrane permeabilization can be 
quantified for individual vesicles.  
 PC-GUVs were prepared either with or without cholesterol. The membrane permeabilization 
effect of digitonin was monitored for 60 min. Figures 3.12 show the effects of digitonin on GUV 
membranes, without (Figs. 3.13a,b) and with cholesterol (Figs. 3.13c,d); (a) without cholesterol, 
shortly after adding the drug and (b) same, after 1 h of incubation; here, digitonin apparently cannot 
permeabilize the GUV membranes as these are still intact and there is no sign of influx through the 
membrane into the GUVs (black interior). (c) However, in the presence of cholesterol, digitonin 
affects membranes immediately; (d) after 10 min all GUVs were filled with green solution and most 
membranes were disrupted. 
 Membrane permeabilization and kinetics can be calculated by comparing the fluorescence 
intensity inside the individual GUVs with the background in the chosen incubation time. The degree 
of GUV filling represents the specific interaction between digitonin and the lipid membrane and also 
can be used to reveal the mechanism of membrane permeabilization. Different concentrations of 
digitonin were applied to determine their ability to induce membrane permeabilization with and 
without incorporated cholesterol. The results show that digitonin can induce membrane rupture only 
in the presence of cholesterol in an all-or-none mechanism and that the concentration greatly affects 
digitonin's ability to cause membrane disruption (Fig. 3.14).  
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Without Cholesterol 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
With Cholesterol 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.13. GUV membrane permeabilization by digitonin. (a) PC-GUVs shortly after applying 20 µM digitonin, 
(b) PC-GUVs after incubating with 20 µM digitonin for 60 min, (c) PC/Chol (80:20) GUVs shortly after applying 
20 µM digitonin, (d) PC/Chol (80:20) GUVs after incubating with 20 µM digitonin for 10 min. Solution bathing 
GUVs (green), interior of GUVs (black), GUV membranes (red).  
(a) PC–GUV + 20 µM digitonin, 0 min (b) PC–GUV + 20 µM digitonin, 60 min 
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Fig. 3.14. GUV filling upon incubating GUVs with different concentrations of digitonin. (a) PC-GUV with 
digitonin incubation 60 min, (b) PC/Chol (80:20)-GUV with digitonin incubation 10 min. 
 
3.1.9 Visualizing the disrupting effect of digitonin on individual 
         PC/Chol (80:20) GUVs 
The permeabilization kinetics was quantified by monitoring the permeability of individual GUVs in 
real time. The images were captured every 20 s for 1 h. The filling rate of PC/Chol-GUVs incubated 
with digitonin was very fast and most of them were filled after 10 min of incubation. The interaction of 
digitonin and cholesterol not only caused permeabilization but also led to vesicle rupturing (Fig. 3.15). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.15. Time dependence of individual PC/Chol (80:20)-GUV response to 20 µM digitonin. Left images show 
GUV without digitonin as a control during the incubation time. The other images show time lapse interaction of 
20 µM digitonin with PC/Chol (80:20)-GUV. Scale bars 20 nm.  
0 20 40 60 80 100
0
20
40
60
80
100
%
 G
U
Vs
 fi
llin
g
Degree of GUV filling
 control
 Digitonin 1 µM
 Digitonin 5 µM
 Digitonin 10 µM
 Digitonin 20 µM
0 20 40 60 80 100
0
20
40
60
80
100
%
 G
U
Vs
 fi
llin
g
Degree of GUV filling
 control
 Digitonin 1 µM
 Digitonin 5 µM
 Digitonin 10 µM
 Digitonin 20 µM
Without Cholesterol With Cholesterol 
66 
 
 
3.1.10 Quantifying structural changes of supported lipid bilayer by 
           digitonin 
In order to quantify the interaction of digitonin with cell membranes with and without cholesterol we 
applied four different techniques: 1) quartz crystal microbalance with dissipation (QCM-D),  
2) high-energy specular X-ray reflectivity (XRR), 3) dual polarization interferometry (DPI), and  
4) differential scanning calorimeter (DSC). 
3.1.10.1 QCM-D 
QCM-D provides information about the interaction of digitonin with membranes based on changes in 
frequency and dissipation. Changes in frequencies give information about mass and thickness of the 
lipid membrane due to substance adsorption, changes in dissipation indicate structural changes 
(rigidity) during the interaction.  
 Supported lipid bilayer (SLB) membranes were constructed by rupturing SOPC and SOPC/Chol 
(80:20) liposomes on the surface of SiO2 quartz crystals. The absorption of lipid vesicles on the 
surface was detected by decrease of frequency to ΔfSOPC = −50 Hz for and ΔfSOPC/Chol = −68 Hz for pure 
SOPC and SOPC/Chol SLB membrane respectively, coupled with increasing dissipation values to 
ΔDSOPC = 3.7 × 10−6 and ΔDSOPC/Chol = 4.1 × 10−6. When the absorption of lipid vesicles reaches a critical 
density, they fuse to form planar membranes with release of water from inner space of the vesicles, 
resulting in increased frequency and decreased dissipation values. A frequency increase to Δf = −26 Hz 
and dissipation decrease to ΔD = 0.01 × 10−6 for both systems, with these values remaining constant 
for 20 min, indicates the formation of a stable lipid bilayer membrane on the surface of the SiO2 
quartz crystal chip (Keller and Kasemo 1998) (Figs. 3.16a,b). 
 Digitonin (50 µM) was injected onto both SLB systems. There was no significant change of 
frequency and dissipation in pure SOPC membrane (Fig. 3.16c) suggesting the SLB membrane 
remains intact and unaffected in the presence of digitonin. However, applying digitonin onto the 
SOPC/Chol (80:20) membrane led to a significant decrease in frequency from Δf = −26 Hz to 
Δf = ∼ −15.5 Hz and an increase in dissipation from ΔD = 0.01 × 10−6 to ΔD = ∼5 × 10–6 and this value 
did not return to the initial state after rinsing with PBS buffer (Fig. 3.16d). These data indicate that 
digitonin permanently binds to cholesterol membranes and that this interaction is irreversible. 
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Fig. 3.16. QCM-D response to changes of frequency (Δf) (black line) and dissipation (ΔD) (red line) of SOPC 
liposomes with time at 35 MHz following the injection of 50 µM digitonin (a) SLB formation from SOPC 
liposomes, (b) SLB formation from SOPC/Chol (80:20) liposomes, (c) application of digitonin onto SOPC bilayer 
showsno significant change, (d) application of digitonin onto SOPC/Chol bilayer leads to dramatical change in 
both Δf and ΔD. Arrows indicate introduction of vesicles and digitonin and rinsings with buffer. 
 
 To deeper understand the mode of interaction of digitonin with the cholesterol membrane, the 
three normalized change overtones (n = 3, 5, 7) in frequency (Δf) and dissipation (ΔD) were plotted 
and the results show no overlap, indicating that the absorbed digitonin forms a viscous layer with 
cholesterol on the membrane significantly altering the its mechanical characteristics. We used the 
Voigt-Voinova model to describe membrane mechanics with fitted experimental results and the best 
fit (black lines) yielding the change in adsorbed mass, the shear modulus (µ1), and shear viscosity (η1) 
(Fig. 3.17). The measurements and fitting results from three overtones supported the validity of this 
model of interaction of digitonin with cholesterol membrane with ΔmQCMD ∼735 ng/cm2 and density 
∼1638 kg/m3 for the digitonin layer. The layer thickness used for the fitting was obtained by X-ray 
reflectivity measurements and set to be 45 Å for pure SOPC membrane and 47 Å for SOPC/Chol 
(80:20) membrane (the parameters from the best-fit models are summarize in Table 3.4). 
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Fig. 3.17. Normalized change in frequency (∆fn) and dissipation (∆D) as a function of time, recorded for the 
three overtones (blue: n = 3, red: n = 5, and green: n = 7; f0 = 5 MHz). The black lines correspond to the best fits 
based on the Voigt model for the three overtones; h0 = 3.34 × 10
−4 m; ρ0 = 2650 kg/m
3; ρ2 = 1000 kg/m
3 and 
η2 = 1 × 10
−3 kg/m.s. T = 25.0 ± 0.1°C. 
 
The shear viscosity of the digitonin layer, being 1.2 mPa∙s, is equal to that of water and 10 times 
lower than that of the supported membranes (>20 mPa∙s) (Takagi et al. 1982). This value might be 
correlated to the hydrating water coupled to the five sugar moieties of digitonin, which was also 
reported for highly hydrated proteins (Larsson et al. 2003) and DNA (Malmström et al. 2007). 
 
Table 3.4. Model parameters from QCM-D for the supported planar bilayer and the digitonin layer. The layer 
thickness (d) used for the fit was obtained by X-ray reflectivity measurements and was set at 45 Å and 47 Å for 
digitonin and SOPC/Chol layers, respectively.  
* The mass value within parenthesis refers to the Sauerbrey equation using n =7, i.e., 35 MHz. 
 
3.1.10.2 High-energy specular X-ray reflectivity (XRR) 
The model of interaction between digitonin and cholesterol membrane obtained from the previous 
experiment requires further confirmation by structural data. Therefore, we used high-energy XRR 
(17.48 keV) at the solid/liquid interface to resolve the fine structure of the supported membranes. 
This technique provides information on thickness (d), electron density, and root-mean-square 
roughness (σ) in each region of the membrane, which can be used to deduce characteristic changes in 
the structure, enabling description of the exact mechanism of the effect of digitonin on the membrane. 
Layer ∆m [ng/cm2] d [Å] ρ [g/cm3] η [mPa∙s] µ [kPa] 
Digitonin 735 ± 45 45 1.64 ± 0.10 1.1 ± 0.1 70 ± 6 
SOPC/Chol 490 (465 ± 20)* 47 1.05 > 10 > 1000 
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 Digitonin (50 µM) was applied to solid-supported lipid bilayer with and without cholesterol in the 
SOPC membrane for 1 h. The curves were fitted with the 5-slab model, having outer headgroups, 
alkyl chains, inner headgroups, water reservoir, and SiO2 layer. The best-fit results (red line) together 
with the experimental results (black line) were plotted in same curve (Fig. 3.18). In the membrane 
system without cholesterol, digitonin treatment consistently provided no noticeable change of shape 
according to the experiment data and fit results (Table 3.5). 
 However, in presence of cholesterol, digitonin clearly induced membrane alteration, as indicated 
by a decrease of the SLD value of the outer headgroup layer from 11.9 × 10–6 Å–2 to 9.1 × 10–6 Å–2 and 
also the SLD value of the alkyl chains layer from 7.3 × 10–6 Å–2 to 6.8 × 10–6 Å–2, suggesting that 
digitonin does not only adsorb on the membrane surface, but also removes some molecules from the 
membrane. This condition appears to be caused by complex formation of digitonin-cholesterol 
(Nishikawa et al. 1984). The thickness of the digitonin layer (d ∼45 Å) roughly corresponds to the 
double of the molecular length of the digitonin molecule (l ∼20 Å), and its high SLD value (7.4 × 10–6 Å–2) 
suggests that this layer consists of dense aggregates of sterol and aglycone. The other fact was that 
the formation of a digitonin layer possessing a roughness of σ ∼6 Å causes no significant change in 
the roughness of the other interfaces. Our fine-structural analysis has demonstrated for the first time 
that digitonin does not destroy the structural integrity of membranes, which is in a clear contrast to 
the previous studies suggesting the destruction of membranes by the formation of defects or surface 
micelles (Nishikawa et al. 1984; Gögelein and Hüby 1984). New features observed at qz <0.1 Å–1 can 
better be interpreted as the formation of an "additional layer (slab)", rather than assuming the 
structural change of the existing membrane (Table 3.6).  
 
Table 3.5. XRR best-fit parameters (χ2 ≤ 0.05) for a pure SOPC membrane (see Fig. 3.18a) in the absence and 
presence of 50 µM digitonin. 
 Without digitonin With digitonin 
SOPC d [Å] 
SLD 
[10–6 Å–2] 
σ [Å] d [Å] 
SLD 
[10–6 Å–2] 
σ [Å] 
Outer headgroup 10.6 11.8 4.5 10.9 11.9 4.9 
Alkyl chain 24.6 7.4 3.8 23.8 7.3 3.9 
Inner headgroup 9.1 11.6 3.3 9.3 11.9 3.9 
Water 3.1 9.4 3.5 3.3 9.4 3.4 
SiO2 10.1 18.6 3.1 10.1 18.6 3.4 
      d = thickness, σ = roughness, SLD = scattering length density 
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Fig. 3.18. High-energy specular X-ray reflectivity (XRR) spectra showing the fine structure of supported 
membranes. (a) Pure SOPC membrane in the absence (black) and presence (red) of 50 µM digitonin. (b) SOPC 
membrane incorporating 20 mol% cholesterol in the absence (black) and presence (red) of 50 µM digitonin. 
The experimental errors are within the symbol size. The solid lines represent the best model fits to the data. 
 
 
 
Table 3.6. XRR best-fit parameters (χ2 ≤ 0.02) for SOPC/Chol membrane incorporating 20 mol% cholesterol 
(see Fig. 3.17b) in the absence and presence of 50 µM digitonin. 
 Without digitonin With digitonin 
SOPC/Chol d [Å] 
SLD 
[10–6 Å–2] 
σ [Å] d [Å] 
SLD 
[10–6 Å–2] 
σ [Å] 
Digitonin – – – 44.8 7.4 5.9 
Outer headgroup 12.9 11.9 4.1 10.1 9.1 4.2 
Alkyl chain 25.6 8.0 3.9 27.3 6.8 3.4 
Inner headgroup 10.1 11.8 3.9 10.1 9.7 3.2 
Water 3.1 9.4 3.3 3.3 9.4 3.4 
SiO2 10.1 18.6 3.4 10.1 18.6 3.4 
       d = thickness, σ= roughness, SLD = scattering length density 
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3.1.10.3 Dual polarization interferometry (DPI) 
The conformational changes occurring during interaction of digitonin with the cholesterol membrane 
were analyzed in real time using dual polarization interferometry (DPI). DPI monitors changes in 
thickness, refractive index, mass, and birefringence of thin films during adsorption of digitonin onto 
the lipid membrane. Diverse information on membrane conformations has been provided by 
previous measurements, such as change in mass by QCM-D and membrane thickness by XRR, but DPI 
can provide the birefringence value Δn = n0 – ne, which differs from the ordinary and extraordinary 
refractive indices. For understanding supported membranes, birefringence (Δn) data can offer a 
perspective on the ordering of alkyl chains (Mashaghi et al. 2008; Lee et al. 2010).  
 Real-time monitoring phase changes in TM and TE wave guide ΔΦTM (black) and ΔΦTE (green) 
during formation of a pure SOPC and SOPC/Chol (80:20) membrane are shown in Fig. 3.18. An 
increase in phase (ΔΦ
SOPC
TM  ∼14 rads, ΔΦ  
SOPC
TE ∼11 rads and ΔΦ
SOPC-Chol
TM  ∼13 rads, ΔΦ  
SOPC-Chol
TE ∼9 
rads) suggests the formation of a supported lipid bilayer (Mashaghi et al. 2008; Lee et al. 2010). 
Membranes with cholesterol present slightly different parameters from pure SOPC membranes, 
which can be related to the fact that alkyl chains assume a liquid ordered phase in the presence of 
cholesterol (Figs. 3.19a,b). 
 The 50 µM digitonin solution was applied to the pure SOPC membrane causing a slight change in 
phase, but the signal returned to the initial level after rinsing with PBS buffer (ΔΦSOPC ∼0.1 rads). This 
suggests that the pure SOPC membrane remained intact in the presence of 50 µM digitonin (Fig. 3.19c) 
and this seems consistent with previous measurements (calcein leakage, permeability GUV, QCM-D, 
XRR). Otherwise in the SOPC/Chol (80:20) membrane, the presence of 50 µM digitonin caused an 
obvious change in membrane phase. The final phase shifting after rinsing with PBS buffer 
(ΔΦ
SOPC-Chol
TM  ∼2.7 rads, ΔΦ  
SOPC-Chol
TE ∼2.5 rads) was higher than the initial value (Fig. 3.19d). 
 The best parameters from DPI measurement for the SOPC/Chol (80:20) membrane with and 
without applied digitonin are presented in Table 3.7. To obtain the structural parameters of the layer 
prior to the injection of digitonin, the thickness of the lipid membrane was fixed at d = 47 ± 2 Å, 
taking the value obtained by XRR. We found that the injection of digitonin led to a significant 
increase in the mass (ΔmDPI = 70 ± 7 ng/cm2) as well as the average density (Δρ = 0.15 ± 0.01 g/cm3). 
Taking Δm obtained by QCM-D (ΔmQCMD = 685 ± 47 ng/cm2), the fraction of the hydrating water  
H (in wt%) can be calculated as: 
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This result seems to be consistent with the shear viscosity and shear modulus values, which are close 
to those of water (Table 3.4). 
 
Fig. 3.19. Real-time phase changes of SLBs in TM and TE waveguide mode ΔΦTM (black) and ΔΦTE (green) of (a) 
a pure SOPC membrane and (b) a SOPC/Chol membrane prior to the incubation with digitonin, confirming the 
formation of supported membranes. (c) The injection of 50 µM digitonin resulted in a minor phase shift in the 
case of pure SOPC membrane, (d) while the membrane with cholesterol exhibited a pronounced phase shift 
even after rigorous rinsing. 
 
Table 3.7. DPI best-fit parameters for SOPC/Chol (80:20) membranes in the absence and presence of 50 µM 
digitonin. A constant thickness obtained from XRR was taken for the calculation. 
Layer RI d (Å) Birefringence ΔmDPI (ng/cm2) Δρ (g/cm
3) 
Digitonin 1.36 45 0 70 ± 7 0.15 ± 0.01 
SOPC/Chol 1.45 47 0.01 377 ± 5 0.80 ± 0.01 
 
3.1.10.4 Differential scanning calorimeter (DSC) 
XRR measurements have shown that digitonin does not only absorb onto the membrane surface but 
also removes cholesterol from the membrane core, as shown by a decreased SLD value of alkyl 
chains during contact with digitonin. However, it is technically almost impossible to quantitatively 
assess the significance of digitonin-cholesterol interactions. For this purpose, we used differential 
scanning calorimeter (DSC) to investigate thermotropic phase diagrams of the membrane in the 
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presence of cholesterol and digitonin. Figure 3.20 presents DSC scans of SOPC membranes 
incorporating (a) 0 mol%, (b) 5 mol%, and (c) 20 mol% of cholesterol in the absence (black line) and 
presence (red line) of digitonin 50 µM. 
 Figure 3.20a confirms the fact that digitonin specifically only interacts with cholesterol in the 
membrane. The DSC scan of pure SOPC membrane (black line) shows a very sharp endothermic peak 
at Tm = 6.0°C and ΔH = 3.9 kcal/mol, corresponding to the main thermotropic transition from the gel 
phase to the liquid crystalline phase. In the presence of digitonin (red line) the transition 
temperature remains almost identical but the onset of the phase transition appears at a slightly 
lower temperature. Nevertheless, the broadening of the transition peak and the decrease in the 
transition enthalpy remained below 6%, suggesting that the pure SOPC membranes remain almost 
intact in the presence of 50 µM digitonin. 
 However, in the case of liposomes containing cholesterol, the thermal behavior of the mixtures 
was significantly affected by the addition of digitonin. The membrane containing 5 mol% cholesterol 
showed a peak at 4.8°C accompanied by a subpeak (shoulder) at around 6.0°C and the transition 
enthalpy decreased to ∆H = ∫CpdT = 3.9 kcal/mol which relates to partial mixing of SOPC and 
substitutional impurity (cholesterol). The major peak at 4.8°C coincides with the transition of 
SOPC/Chol and the peak at 6.0°C with the transition of SOPC. The presence of 5 µM digitonin 
resulted in significant change in the weight balance between these two peaks, whereas the first peak 
(4.8°C) decreases and the second peak (6.0°C) becomes sharper. This means an increase in the ratio 
of pure SOPC fraction, while a decrease in the ratio of the SOPC/Chol complex fraction. The 
enhancement level ratio of pure SOPC fraction was caused by partial removal of cholesterol by 
digitonin from the SOPC/Chol membrane (Fig. 3.20b). 
 The incorporation of cholesterol into SOPC bilayer at 20% (mol%) suppressed the phase transition 
of SOPC (Fig. 3.20c) which caused the endothermic peak to become diminished due to the formation 
of another monophase, called the liquid-ordered phase, where alkyl chains are ordered but do not 
take all-trans conformation because cholesterol acts as a substitutional impurity (Cevc 1993). 
Interestingly, in the presence of 50 µM digitonin, the endothermic peak appears at 5.4°C, called 
“recovery” peak. The emergence of a “recovery” peak can be explained as displacement of 
cholesterol molecules by digitonin from the SOPC membrane with leads to an increasing level of the 
pure SOPC fraction as detected by a peak at around 6°C.  
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Fig. 3.20. DSC scans of SOPC liposomes with (a) 0 mol%, (b) 5 mol%, (c) and 20 mol% cholesterol in the 
absence (black line) and presence (red line) of 50 µM digitonin.  
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3.2 Quillaja saponin as a drug toxicity enhancer – mechanistic 
 investigations with membrane models 
3.2.1 Bidesmosides and monodesmosides in commercial quillaja 
         saponin extract 
Commercial quillaja saponin (DAB, Carl Roth, Karlsruhe) was submitted to HPLC and LC/MS to 
identify and quantify the saponins contained in the extract. The peak pattern of the HPLC was 
revealed to be similar to data reported in the literature (Kensil et al. 1991; San Martín and Briones 
2000; Thalhamer and Himmelsbach 2014). The typical chromatographic peak pattern of the quillaja 
saponin extract starts at approximately RT 20 min, with numerous peaks up to 40 min. An intense 
peak that is not related to quillaja saponin was recorded at RT 5–20 min. The chromatogram intensity 
within the quillaja saponin retention time area (20–40 min) was lower than the intensity of the non-
quillaja saponin area (5–20 min), which indicates that the amount of quillaja saponin in the extract 
was low. The HPLC peaks were identified using MS, as comparative individual standards of quillaja 
saponin compounds are not available (Fig. 3.21). 
 
 Peak labeling Retention time (min) [M─H]─ (m/z) 
1 6.4 1057.36 
2 7.5 925.32 
3 8.5 970.17 
4 10.5 1099.37 
5 13.1 1349.35 
6 16.1 1357.15 
7 20.6 1151.27 
8 22.0 971.41 
9 23.6 1353.60 
10 24.5 1673.69 
11 26.0 1191.59 
12 28.22 1757.75 
13 32.5 1825.66 
14 33.5 1972.57 
 
 
 
 
Fig. 3.21. Quillaja saponin – HPLC chromatogram with [M─H]─ (m/z) values (insert). 
 
 LC/MS was applied to identify the individual saponins from the complex mixture of the above 
commercial quillaja saponin extract. The LC system was run similarly as applied for HPLC. Ions were 
detected in negative and positive modes. The negative mode showed better detection and 
fragmentation than the positive mode. The total ion current (TIC) run showed an opposite pattern 
with significantly higher intensity of the quillaja saponin than the non-quillaja saponin area (Fig. 3.22). 
76 
 
 
This result indicates that most of the quillaja saponin compounds are weak chromophores that can 
not be detected by ultraviolet (UV) (Kite et al. 2004).   
 In order to trace and identify the type of saponins inside the quillaja extract, Xcalibur 2.0 software 
was used to identify and calculate the molecular formula for each distinctive peak from all regions 
and the according MS2 spectra were analyzed if available. The MS spectra of quillaja saponin extract 
bear characteristic ions in the region 800–1000 m/z, here referred to as “A ions”, that result from 
fragmentation of bidesmosides from which the oligosaccharide chain at C28 has been cleaved. The A 
ions represent the triterpenoid aglycone with a trisaccharide sugar attached to C3 with a varying R0 
component (Fig. 1.3). The quillaic aglycone is represented by the A ion at m/z 955 or 969, pointing to 
the occurrence of quillaic acid (Q) and a Xyl or Rha at R0 position. The A ion at m/z 971 or 985 (or 62 
less on occasion, 909 or 923, indicating further loss of H2O and a carboxyl residue at C28), indicates 
22β-hydroxyquillaic acid (Q-OH) as the aglycone. The A ion at m/z 853 points to phytolaccinic acid (P) 
and 895 represents O-23 acetylated phytolaccinic acid (P-Ac) (Wang et al. 2008; Kite et al. 2004; 
Bankefors et al. 2011). There were some other ion products with m/z values higher than 1100 which 
do not have A ions of quillaja aglycones but representing the mere quillaic acid ion at m/z 485 or 483 
resulting from MS2 fragmentation of the 1560.19 precursor at RT 41.10 min. Each m/z peak from 
MS1 and MS2 was compared with the literature and the complete list mass data of the commercial 
quillaja extract is presented in the Appendix (p. 125) of this dissertation. In order to identify the 
presence of monodesmosidic saponins in the extract, the ions with m/z below 1000 in the MS1 and 
MS2 spectra were analyzed in more detail to identify the according precursors. Precursors lower than 
1000 are assumed to originate from actual monodesmosides and not fragmentation products of 
bidesmosides. 
 The complete analysis of ions from the MS1 and MS2 spectra of the employed quillaja saponin 
extract shows that the majority of saponins contained are triterpenoid bidesmosides (>95%) and 
approx. 5% monodesmosides. The previously reported triterpenoid bidesmosides identified in our 
studies are listed in Table 3.8. The monodesmosides now being reported for the first time from 
commercial quillaja saponin (DAB, Carl Roth, Karlsruhe) are listed in Table 3.9. In total, 19 
monodesmosides were identified, with five compounds in the quillaja saponin retention time area 
and the others in the non-quillaja saponin area. The MS2 fragmentation data show that the 
precursors originate from monodesmosides with m/z values of less than 1000. 
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Fig. 3.22. Quillaja saponin – mass spectrometry. Total ion current (TIC) chromatogram from RT 0–80 min. 
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Table 3.8. Triterpenoid bidesmosidic saponins in commercial quillaja saponin extract (DAB, Carl Roth) 
RT sample 
(min) 
[M–H]– 
(m/z) 
A ion 
(m/z) Aglycone 
Substituents 
R0 R1 R2 R3 Fa  Ac 
24.52 1674.71 955 Q p p-p h    
25.6 1511.63 955 Q p p-p     
25.77 1565.71 939        
26.99 1861.8 955 Q p p-p h dh  1 
27.09 1716.83 955 Q p p-p h   1 
27.14 1716.07 955 Q p p-p h   1 
27.49 1699.58 955 Q p p-p  dh  1 
27.65 1773.6 971 Q-OH p p-p h   2 
28.22 1757.75 955 Q p p-p h   2 
28.28 1553.56 955 Q p p-p    1 
28.96 1903.56 955 Q p p-p h dh  2 
29.12 1475.75 895 P-Ac   h   3 
29.3 1948.72 955 Q p p-p h dh  a 
29.88 1683.63 955 Q p p-p   Fa/2  
30.16 1475.65 895 P-Ac   h   3 
30.16 1757.71 955 Q p p h h  2 
30.38 1871.71 955 Q p p-p   Fa-OH  
30.92 1987.84 955 Q p p-p   Fa-p  
31.6 1476.63 895 P-Ac   h   3 
31.71 1856.75 955 Q  p-p   Fa-p  
31.91 1987.87 955 Q p p-p   Fa-p  
32.51 1897.74 955 Q p p-p   Fa 1 
33.7 1559.68 895 P-Ac   h   5 
34.54 1580.64 939 deOH Q p p-p    2 
35.2 1559.73 895 P-Ac   h   5 
 
Aglycones:  
  P = phytolaccinic acid 
  P-Ac = phytolaccinic acid acetylated at O-23 
  Q = quillaic acid 
  Q-OH = 22β-hydroxyquillaic acid 
  deOH = dehydroxy quillaic acid 
 Substituents:  
  p = pentose 
  h = hexose 
  dh = deoxyhexose 
  Fa = fatty acyl 
  Ac = acetyl
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Table 3.9. Monodesmosidic saponins in commercial quillaja saponin extract 
RT sample 
(min) [M–H]
– (m/z) MS2 Precursor 
Relative 
percentage in 
sample 
2.95 780.82 311.13; 405.00; 466.61; 536.08; 602.02; 688.49; 720.06  1.016 
16.17 745.12 373.24; 457.02; 599.13; 640.91  0.836 
22.48 639.29 231.17; 325.21; 467.25; 509.23; 621.23  9.478 
28.85 711.36 665.34; 711.20  5.441 
29.4 793.42 306.93; 405.58; 485.42; 513.38; 567.39; 661.39; 731.47; 770.76  3.298 
43.09 553.25 485.41; 523.36; 552.59  0.316 
43.59 649.11 405.31; 477.08; 581.08; 605.07; 649.23; 695.92; 871.05 871.11 0.576 
47.92 539.41 471.36; 492.91; 574.62; 963.43 963.43 0.343 
49.5 607.19 539.40; 589.28; 715.77  0.485 
62.77 757.45 349.94; 462.16; 699.19; 711.12; 739.29; 756.40; 774.52  0.758 
62.84 731.43 269.21; 307.30; 390.88; 494.19; 575.53; 713.30; 730.41  0.620 
62.95 593.4 187.15; 200.92; 337.02; 423.14; 524.98; 593.41  0.681 
63.8 761.42 305.01; 337.48; 390.81; 466.20; 649.22; 661.02; 761.30  0.602 
64.63 691.42 285.15; 413.20; 533.39; 601.16; 672.23; 691.52; 828.29 828.29 0.653 
64.93 726.56 243.81; 311.21; 446.96; 465.25; 584.31; 690.51; 796.57 796.57 0.426 
65.11 727.21 264.22; 463.47; 584.26; 699.65  0.498 
66.36 593.38 187.08; 201.18; 337.09; 423.21; 593.37; 611.06; 812.09; 970.90 970.90 0.603 
66.57 693.39 277.37; 413.18; 519.28; 665.47; 692.61; 892.81 892.81 0.538 
66.63 745.57 236.17; 260.13; 335.61; 422.92; 489.31; 505.01; 727.33, 745.81  0.485 
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3.2.2 Quillaja saponin enhances the toxicity of five common 
         anticancer drugs 
The activity of quillaja saponin as a toxicity enhancer for berberine, cisplatin, dexamethasone, 
doxorubicin, and mitomycin C was explored in HeLa, COS-7, MIA PaCa-2, and PANC-1 cancer 
cell lines by the same procedure as for digitonin. Cell viability was measured by MTT assay. 
 Cytotoxicity data was obtained for quillaja saponin alone and in combination with the five 
selected anticancer drugs applied to four cancer cell lines (Fig. 3.23 and Table 3.10.). The IC50 
values of quillaja saponin for all four cancer cell lines range around 100 µg/ml; the IC50 values 
of the employed anticancer agents are listed in Table 3.1. Quillaja saponin increased the 
cytotoxicity by each of the selected anticancer drugs on all of the cancer cell lines (Fig. 3.24). 
Quillaja saponin enhances the toxicity of cisplatin in HeLa, COS-7, and MIA PaCa-2 with CER 
values of 8.24, 4.37, 5.2, respectively, but only slightly increases toxicity of cisplatin in PANC-1 
with a CER value of 1.3. The toxicity of mitomycin C also significantly increased in combination 
with quillaja saponin, CER values for HeLa, COS-7, MIA PaCa-2, and PANC-1 being 7.69, 7.18, 
2.55, and 1.7, respectively. For doxorubicin the highest toxicity was measured in MIA PaCa-2 
with CER increasing to 6.95, continued by PANC-1, COS-7, and HeLa with CERs of 3.36, 3.26, to 
1.7, respectively. The cytotoxicity of berberine was only slightly increased by quillaja saponin 
with a CER of max. 2.92 in COS-7.  
 The obtained combination index (CI) values show that cisplatin with quillaja saponin has a 
synergistic effect on HeLa, COS-7, and MIA PaCa-2; for doxorubicin we find synergistic effects 
in all tested cell lines; mitomycin C has a synergistic effect on HeLa, COS-7, and MIA PaCa-2; 
and berberine has a synergistic effect only on COS-7; other combinations showed antagonistic 
effects (Fig. 3.25). 
Table 3.10. Quillaja saponin alone and in combination with anticancer drugs – effects on HeLa, COS-7,  
MIA PaCa-2, and PANC-1. 
IC50 (µM) of anticancer agents + IC20 (µM) of quillaja saponin 
 HeLa CI CER COS-7 CI CER MIA PaCa-2 CI CER PANC-1 CI CER 
Saponins             
Quillaja saponin (IC50) 103.95±9.91   105.80±26.62   109.49±9.10   98.21±11.57   
Quillaja saponin (IC20) 35   44   66   68   
Drug             
Berberine 260±0.03 1.10 1.29 174±0.04 0.75 2.92 73.00±0.09 1.30 1.41 61.30±0.1 1.07 2.62 
Cisplatin 2.21±1.85 0.45 8.24 6.95±3.61 0.63 4.37 18.06±0.01 0.79 5.20 76.53±0.01 1.46 1.30 
Doxorubicin 4.64±0.16 0.91 1.70 3.80±0.78 0.70 3.36 3.01±2.74 0.74 6.95 17.80±1.80 0.99 3.26 
Dexamethasone 298.8±0.04 1.39 0.99 216.8±0.10 1.04 1.57 904.5±1.61 1.54 1.06 301.11±0.04 1.03 4.01 
Mitomycin C 12.27±11.5 0.45 7.69 19.07±5.02 0.54 7.18 9.50±0.02 0.99 2.55 22.33±0.5 1.27 1.70 
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(a)   HeLa 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.23a. Dose response curves in HeLa to the anticancer agents berberine, cisplatin, dexamethasone, 
doxorubicin, and mitomycin C (black data points) and their combination with IC20 concentrations of 
quillaja saponin (35 µg/ml) (white data points). Data are expressed as means ±SD of cell viability from 
three independent experiments, each done in triplicates. 
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(b) COS-7  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.23b. Dose response curves in COS-7 to the anticancer agents berberine, cisplatin, 
dexamethasone, doxorubicin, and mitomycin C (black data points) and their combination with IC20 
concentrations of quillaja saponin (44 µg/ml) (white data points). Data are expressed as means ±SD of 
cell viability from three independent experiments, each done in triplicates. 
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(c)   MIA PaCa-2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.23c. Dose response curves in MIA PaCa-2 to the anticancer agents berberine, cisplatin, 
dexamethasone, doxorubicin, and mitomycin C (black data points) and their combination with IC20 
concentrations of quillaja saponin (66 µg/ml) (white data points). Data are expressed as means ±SD of 
cell viability from three independent experiments, each done in triplicates.  
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(d)  PANC-1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.23d. Dose response curves in PANC-1 to the anticancer agents berberine, cisplatin, 
dexamethasone, doxorubicin, and mitomycin C (black data points) and their combination with IC20 
concentrations of quillaja saponin (68 µg/ml) (white data points). Data are expressed as means ±SD of 
cell viability from three independent experiments, each done in triplicates. 
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Fig. 3.24. Cytotoxicity enhancement ratios (CER) of anticancer drugs enhanced by quillaja saponin  
in HeLa, COS-7, MIA PaCa-2, and PANC-1. CER values higher than 1 (dashed line) show the ability of 
quillaja saponin to increase drug toxicity in the cancer cell lines. The cytotoxicity enhancement profiles 
by quillaja saponin differ in each case. 
 
 
Fig. 3.25. Combination index (CI) values of quillaja saponin (IC20) with anticancer drugs in HeLa, COS-7, 
MIA PaCa-2, and PANC-1. CI < 1 = synergistic; CI 1 = additive; CI > 1 = antagonistic. 
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3.2.3 Quillaja saponin significantly increases the toxicity of ricin 
Quillaja saponin significantly enhances effect of ricin in all tested cancer cell lines. The lowest 
level of ricin toxicity enhancement was measured with a CER of 2.54 (IC50 from 62.70 to 
24.70 ng/ml) in MIA PaCa-2 and the highest of CER 76.85 (IC50 from 99.9 to 1.3 ng/ml) in  
COS-7. The toxicity enhancement in PANC-1 and HeLa were found with a CER of 11.57 (IC50 
from 297.15 to 22.50 ng/ml) and 13.11 (IC50 from 75.20 to 6.50 ng/ml), respectively (Figs. 3.26 
and 3.27). As quillaja saponin increases membrane permeability, ricin will pass through the cell 
membrane more easily, explaining the strong cytotoxicity enhancement effect. Quillaja 
saponin and ricin interact synergistically as indicated by combination indexes (CI) of less than 1 
(Fig. 3.28). Table 3.11 summarizes the cytotoxicity data of the individual substances and their 
combination. 
 
Fig. 3.26. Dose response curves of Ricin in HeLa, COS-7, MIA PaCa-2 and PANC-1. Cytotoxicity of ricin 
(black data points) and its combination with IC20 concentrations of quillaja saponin (35 µM for HeLa; 44 
µM for COS-7; 66 µM for MIA PaCa-2; 68 µM for PANC-1) (white data points). Data are expressed as 
means ±SD of cell viability from three independent experiments, each done in triplicates. 
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Fig. 3.27. Cytotoxicity enhancement ratio (CER) for quillaja saponin + ricin in HeLa, COS-7, MIA PaCa-2, 
and PANC-1. CER values higher than 1 (dashed line) show the ability of quillaja saponin to increase drug 
toxicity in the cancer cell lines. The cytotoxicity enhancement profiles by quillaja saponin differ in each 
case. 
 
Fig. 3.28. Combination index (CI) values of quillaja saponin (IC20) + ricin in HeLa, COS-7, MIA PaCa-2, 
and PANC-1; CI < 1 = synergistic; CI 1 = additive; CI > 1 = antagonistic. 
 
Table 3.11. Quillaja saponin + ricin – effect on HeLa, COS-7, MIA PaCa-2, and PANC-1. 
IC50 of anticancer agent + IC20 of quillaja saponin 
 HeLa CI CER COS-7 CI CER MIA PaCa-2 CI CER PANC-1 CI CER 
Saponins             
Quillaja saponin  
(IC50 µg/ml) 
103.95±9.91   105.80±26.62   109.49±9.10   98.21±11.57   
Quillaja saponin  
(IC20 µg/ml) 
35   44   66   68   
Ricin (ng/ml) 75.20±0.01   99.9±0.04   62.70±0.01   297.15±0.25   
Ricin+quillaja saponin  
(ng/ml) 6.50 ± 0.04 0.41 11.57 1.3 ± 0.01 0.42 76.85 24.7 ± 0.04 0.99 2.54 22.50 ± 0.3 0.49 13.21 
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3.2.4 Quillaja saponin ruptures RBCs 
The hemolytic activity of quillaja saponin was examined with defebrinated sheep RBCs. 
Quillaja saponin can disrupt erythrocyte membranes causing release of hemoglobin, which can 
be detected photometrically. The concentration of quillaja saponin inducing 50% RBC lysis is 
0.3507 mM. The hemolytic effect of quillaja saponin is not as strong as that of digitonin (Fig. 3.29). 
 
Fig. 3.29. Quillaja saponin – dose-dependent hemolytic effect on sheep RBCs. Dose-ranging 
experiments were performed from 0.1 to 0.001 mM of quillaja saponin. RBC rupturing occurred at  
IC50 0.3507 mM. Data are expressed as means ±SD of hemolytic activity for three independent 
experiments. 
 
3.2.5 Quillaja saponin causes calcein leakage 
The activity of quillaja saponin to induce membrane leakage was measured for different lipid 
compositions of LUVs applying the same preparatory and experimental procedures as for 
digitonin (see Sect. 3.1.5). The results show that the effect of quillaja saponin on membranes 
also depends on the presence of cholesterol. Calcein fluorescence in LUV membranes without 
cholesterol remained unchanged upon addition of quillaja saponin (Fig. 3.30), while in LUVs 
containing cholesterol quillaja saponin addition immediately induced membrane leakage 
(<4 min) and calcein fluorescence remained constant for more than 1 h (Fig. 3.31).  
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Fig. 3.30. Calcein release from different LUVs induced by quillaja saponin. Data are expressed as 
means ±SD of hemolytic activity for three independent experiments. PC: phosphatidylcholine;  
CL: cardiolipin; Chol: cholesterol; SM: sphingomyelin. 
 
 
Fig. 3.31. Kinetics of calcein release of PC/Chol (80:20) LUVs induced by quillaja saponin. Intensity of 
fluorescence of calcein released from LUVs by 0.1 mM quillaja saponin was measured continuously 
every 120 s for 1 h. The inset shows the percentage of calcein release in the range time of 0–10 min.  
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3.2.6 Influence of cholesterol concentration on calcein release 
The effect of cholesterol on membrane response to quillaja saponin was investigated by 
monitoring the percentage of calcein release at different concentrations of cholesterol in the 
liposomes. The results confirm that the level of cholesterol in the membrane greatly affects 
membrane rupture induced by quillaja saponin (Fig. 3.32). In "pure-PC" LUVs, the intensity of 
calcein fluorescence increased only slightly after adding quillaja saponin. Thus one can assume 
that quillaja saponin interacts to a minor extent with phosphatidylcholine to induce 
membrane leakage.  
 
Fig. 3.32. Membrane leakage caused by quillaja saponin depending on cholesterol concentration.  
PC vesicles with different concentrations of cholesterol were incubated with 0.1 mM quillaja saponin for 
1 h. Data are expressed as means ±SD of percentage of calcein release for three independent 
experiments. 
 
3.2.7 Quillaja saponin affects vesicle size with or without cholesterol 
Dynamics light scattering (DLS) measurements were carried out to elucidate the effect of 
quillaja saponin in increasing membrane permeability. Quillaja saponin does not cause 
substantial size changes to liposomes. The obtained DLS data provides additional evidence 
that quillaja saponin interacts only slightly with membranes that do not bear cholesterol. 
Quillaja saponin at 50 µM slightly affected SOPC vesicle size (Fig. 3.33a). Possibly, quillaja 
saponin may lead to membrane perforation allowing buffer solution to enter the vesicles and 
increase their size. With cholesterol present in the vesicle membranes, quillaja saponin also 
did not induce significant size change of the vesicles (Figs. 3.33b–d). These data corroborate 
the assumption that interaction of quillaja saponin with membranes in the absence or 
presence of cholesterol leads to membrane perforation. 
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Fig. 3.33. DLS profile of vesicle sizes with and without cholesterol incubated with different 
concentrations of quillaja saponin. Black data points represent control without quillaja saponin and red 
data points without quillaja saponin. SOPC vesicles (a) no cholesterol + 50 µM quillaja saponin; (b) 20% 
cholesterol + 10 µM quillaja saponin; (c) 20% cholesterol + 50 µM quillaja saponin; (d) 20% cholesterol + 
100 µM quillaja saponin.  
a 
b 
c 
d 
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3.2.8 Quillaja saponin strongly affects GUV membrane 
         permeability and integrity in the presence of cholesterol 
The interaction of quilllaja saponin with membranes and the associated induced 
permeabilization can be nicely studied with giant unilamellar vesicles (GUV). Thus, GUVs with 
and without cholesterol were prepared by electroformation. The green fluorescing dye Alexa 
Flour 488 was used to visualize the interaction of quillaja saponin with the GUV membrane. 
The dye permeates the membrane and enters the GUVs in response to quillaja saponin. The 
effect can be observed by monitoring the shape change of GUVs. The results were consistent 
with the correspondingly obtained calcein leakage and DLS data. In the non-cholesterol 
vesicles, quilllaja saponin induced permeability of only few GUVs after 1 h of incubation; about 
10% of GUVs were filled with green solution (Fig. 3.34a,b). However, in the presence of 
cholesterol all GUVs were filled after 1 h of incubation (Figs. 3.34c,d). As the vesicles remained 
intact, this supports the assumption that quilllaja saponin leads to pore formation. The 
membrane permeabilization effected by quillaja saponin is presented in Fig. 3.35.   
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Fig. 3.34. GUV membrane permeabilization by quillaja saponin. (a) PC-GUVs shortly after applying 
50 µM quillaja saponin, (b) PC-GUVs after incubating with 50 µM quillaja saponin for 60 min,  
(c) PC/Chol (80:20) GUVs shortly after applying 50 µM quillaja saponin, (d) PC/Chol (80:20) GUVs after 
incubating with 50 µM quillaja saponin for 60 min. Solution bathing GUVs (green), interior of GUVs 
(black), GUV membranes (red).  
(b) PC–GUVs + 50 µM quillaja saponin 60 min 
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Fig. 3.35. GUV filling upon incubating GUVs with different concentrations of quillaja saponin.  
(a) PC-GUV with quillaja saponin, incubation 60 min, (b) PC/Chol (80:20)-GUV with quillaja saponin, 
incubation 60 min. 
 
3.2.9 Visualizing the disrupting effect of quillaja saponin on 
         individual PC/Chol (80:20) GUVs 
Close-up views of the effect of 50 µM quillaja saponin in causing membrane permeabilization 
in individual GUVs with 20% membrane cholesterol content were recorded in real time. GUV 
filling started shortly after adding quillaja saponin to the system; the diffusion process takes 
about 20 min to be completed (Fig. 3.36). GUVs remained intact after complete diffusion, 
indicating that quillaja saponin does not induce membrane rupture. Based on these GUV 
observations, we conclude that quillaja saponin leads to small pores in the GUV membranes, 
especially when they contain cholesterol. 
 
0 20 40 60 80 100
0
20
40
60
80
100
%
 G
U
V
s 
fil
lin
g
Degree of GUV filling
 Control
 Q. sap 20µM
 Q. sap 30µM
 Q. sap 40µM
 Q. sap 50µM
Without  Cholesterol 
With Cholesterol 
95 
 
 
Fig. 3.36. Time dependence of individual PC/Chol (80:20)-GUV response to 50 µM quillaja saponin. 
Left images show GUV without digitonin as a control during the incubation time. The other images show 
time lapse interactions of 50 µM quillaja saponin with PC/Chol (80:20)-GUV. Scale bars 20 nm. 
 
3.2.10 Quantifying structural changes of supported lipid 
           bilayers by quillaja saponin 
In order to quantify the interaction of quillaja saponin with cell membranes with and without 
cholesterol we applied two different techniques: quartz crystal microbalance with dissipation  
(QCM-D) and high-energy specular X-ray reflectivity (XRR). 
 
3.2.10.1 QCM-D 
The absorption of quillaja saponin into supported lipid bilayer membranes was quantified by 
measurements using quartz crystal microbalance with dissipation (QCM-D). The same system 
and procedure used for digitonin was also applied with quillaja saponin (see Sect. 3.1.10.1). 
The quality of both types of SLB membranes was evaluated by their response to frequency and 
their dissipation. The frequency increased to Δf = −26 Hz from ΔfSOPC = −50 Hz and ΔfSOPC/Chol = 
−68 Hz for pure SOPC and SOPC/Chol SLB, respectively. Also, constant dissipation values of ΔD 
= 0.01 × 10−6 were measured for both systems, dropping from ΔDSOPC = 3.7 × 10−6 and 
ΔDSOPC/Chol = 4.1 × 10−6, respectively. These values indicate the formation of stable lipid bilayers 
on the quartz crystal chip surface (Figs. 3.37a,b). 
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 The 50 µM quillaja saponin was introduced to the pure SOPC bilayer membrane and onlys 
light positive changes in frequency and negative changes in dissipation were recorded after 
rinsing with buffer. A higher concentration of 250 µM quillaja saponin was applied to amplify 
the effect. During the injection process, the frequency increased to Δf = ∼ +2 Hz and 
dissipation decreased to ΔD = ∼0.5 × 10–6, but after buffer rinsing the frequency dropped to  
Δf = ∼ +1 Hz and the dissipation value increased to close to the initial value of ΔD = ∼0.3 × 10–6. 
These results indicate an interaction of quillaja saponin with the SOPC membrane and there 
was a small mass change in the bilayer. The positive value of Δf indicates that small amounts 
of mass were being removed by buffer rinsing. The decreased dissipation value, finally being 
close to the initial value, indicates that no change in membrane conformation had taken place 
(membrane remained rigid) (Fig. 3.37c). Because of the weak dissipation response of the 
adsorbed layer, the Kelvin-Voigt viscoelastic model was applied to describe the interaction 
instead of the Sauerbrey equation model. Unfortunately, the obtained fitting result with the 
Kelvin-Voigt viscoelastic model provided unrealistic data, probably because of the low 
absolute dissipation value caused by the presence of water in the bilayer membrane. The 
same problem was also reported by other researchers (Wojciechowski et al. 2014b). 
 At the SLB membrane with cholesterol, neither frequency nor dissipation was changed by 
adding 50 µM quillaja saponin; while 250 µM quillaja saponin, caused the frequency to 
increase to Δf = ∼ +2 Hz remaining constant after buffer rinsing and the dissipation decreased 
to ΔD = ∼0.5 × 10–6; at 1 mM quillaja saponin the frequency increased to Δf = ∼ +6.52 Hz and 
remained constant after rinsing, the dissipation dropped to ΔD = ∼ −1 × 10–6 and then 
increased to near initial value ΔD = ∼ −0.3 × 10–6. These results indicate that the interaction of 
quillaja saponin with cholesterol leads to mass changes in the membrane. The higher values of 
positive frequency suggest that the bilayer membrane losses significant mass at 1 mM quillaja 
saponin and final rinsing. The higher dissipation values at 250 µM quillaja saponin suggest that 
the quillaja saponin-cholesterol complex makes the membrane less rigid. However, the 
dissipation returning to close to the initial value after final rinsing in the case of 1 mM quillaja 
saponin suggests that the membrane becomes more rigid (Fig. 3.37d). The data on Δf and ΔD 
suggest that the quillaja saponin-cholesterol complex leads to pore formation by pulling up 
the cholesterol from the membrane causing the membrane to lose mass and allowing more 
water to enter the intermembrane space which in turn would make the membrane less rigid.  
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Fig. 3.37. QCM-D response to changes of frequency (Δf) (black line) and dissipation (ΔD) (red line) of 
SOPC liposomes with time at 35 MHz following the injection of 50 µM, 250 µM, and 1 mM quillaja 
saponin (a) SLB formation from SOPC liposomes, (b) SLB formation from SOPC/Chol (80:20) liposomes, 
(c) application 50 mM and 250 µM quillaja saponin onto SOPC bilayer and show slightly significant 
change, (d) application of 50 µM, 250 µM, and 1 mM quillaja saponin onto SOPC/Chol bilayer and 
injection of 50 µM show no significant change in both Δf and ΔD. Injection of 250 mM and 1 mM of 
quillaja saponins leads to significant change in both Δf and ΔD. Arrows indicate introduction of vesicles 
and quillaja saponin and rinsings with buffer.  
 
3.2.10.2 High-energy specular X-ray reflectivity (XRR) 
In order to observe changes in the structure of supported bilayer membranes in the presence 
of quillaja saponin we employed high-energy specular X-ray reflectivity (XRR). Four layers of 
supported lipid membrane bilayers on SiO2 surface were prepared using the same procedure 
as previously applied for digitonin (see Sect. 3.1.10.2). Changes occurring in the membranes in 
terms of thickness (d), electron density, and root mean square (rms) roughness (σ) were used 
to characterize the mechanism membrane binding of quillaja saponin. 
 XRR best-fit curves were obtained for 50 µM quillaja saponin in the solid-supported lipid 
bilayer membrane consisting of pure SOPC (Fig. 3.38a). The curves were fitted with the 5-slab 
model, having outer headgroups, alkyl chains, inner headgroups, water reservoir, and SiO2 
layer. The scattering length density (SLD) profiles from the best-fit results were also 
determined. Quillaja saponin applied to pure SOPC membranes induces changes in the outer 
headgroups of the membrane whose density increased from 9.7 Å to 10.8 Å, roughness from 
4.0 Å to 5.3 Å, and a slightly increased SLD value from 11.4 × 10–6 Å–2 to 11.7 × 10–6 Å–2.  
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The SLD values from the alkyl chains decreased from 8.8 × 10–6 Å–2 to 11.7 × 10–6 Å–2. These 
data suggest that quillaja saponin adsorbs to the head groups of the lipid membrane as shown 
by the increased density and roughness. This interaction also induced changes in the inner 
headgroup layer in which the density decreased from 8.8 Å to 8.5 Å, SLD decreased from  
11.9 × 10–6 Å–2 to 11.3 × 10–6 Å–2, and roughness from 3.9 Å to 3.7 Å. This indicates that the 
space between the headgroups increased, making the membrane more permeable (data 
summarized in Table 3.12). 
 The presence of 50 µM quillaja saponin in the SOPC/Chol membrane caused slight changes 
in membrane conformation (Fig. 3.38b). In the outer headgroup of the bilayer membrane the 
density increased from 10.0 Å to 10.8 Å, the SLD increased only slightly from 11.4 × 10–6 Å–2 to 
11.5 × 10–6 Å–2. Interestingly, the surface roughness decreased from 6.3 Å to 5.8 Å which 
indicates that the number of molecules in the lipid headgroup layer increased, but the 
membrane surface becomes more smooth. We thus assume that quillaja saponin penetrates 
down to the alkyl chains. Changes occurring in the alkyl chains appear to prove this 
assumption as density increased from 23.8 Å to 25.4 Å, SLD increased from 7.4 × 10–6 Å–2 to 7.7 
× 10–6 Å–2, and roughness from 4.2 Å to 4.4 Å. These data indicate that quillaja saponin locates 
in the alkyl chain layer bound to cholesterol there, increasing the space between complex 
quillaja saponin-cholesterol and SOPC. Changes also occur in the inner headgroups where the 
density decreased from 8.7 Å to 8.4 Å, SLD slightly increased from 11.9 × 10–6 Å–2 to 11.0 × 10–6 
Å–2, and no change occurred in roughness, indicating that the quillaja saponin-cholesterol 
complex is big enough to force additional distance between headgroups of inner layer. The 
distance formed between headgroups in the outer and inner layer increases membrane 
permeability forming small pores of sizes ranging around 1 Å–2. These small pores are 
permanent but the membrane remains intact, as shown by our GUV experiments (the 
according data for the SOPC/Chol SLB membrane are summarized in Table 3.13). 
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Fig. 3.38. High-energy specular X-ray reflectivity (XRR) spectra showing the fine structure of supported 
membranes. (a) Pure SOPC membrane in the absence (black) and presence (red) of 50 µM quillaja 
saponin. (b) SOPC membrane incorporating 20 mol% cholesterol in the absence (black) and presence 
(red) of 50 µM quillaja saponin. The experimental errors are within the symbol size. The solid lines 
represent the best-fit model to the data. 
 
Table 3.12. XRR best-fit parameters (χ2 ≤ 0.05) for a pure SOPC membrane (see Fig. 3.38a) in the 
absence and presence of 50 µM quillaja saponin. 
 
Without quillaja saponin χ2< 0.01 With quillaja saponin χ2< 0.04 
SOPC d [Å] 
SLD 
[10–6 Å–2] 
σ [Å] d [Å] 
SLD 
[10–6 Å–2] 
σ [Å] 
Outer headgroup 9.7 11.4 4.0 10.8 11.7 5.3 
Alkyl chain 25.6 8.8 4.4 26.0 7.5 4.4 
Inner headgroup 8.8 11.9 3.9 8.5 11.3 3.7 
Water 3.1 9.4 3.1 3.1 9.4 3.3 
SiO2 10.1 18.6 3.5 10.2 18.6 3.5 
d = thickness, σ = roughness, SLD = scattering length density 
 
Table 3.13. XRR best-fit parameters (χ2 ≤ 0.02) for SOPC membrane incorporating 20 mol% cholesterol 
(see Fig. 3.38b) in the absence and presence of 50 µM quillaja saponin. 
 
Without quillaja χ2< 0.04 With quillaja χ2< 0.05 
SOPC/Chol d [Å] SLD [10–6 Å–2] σ [Å] d [Å] 
SLD 
[10–6 Å–2] σ [Å] 
Outer headgroup 10.0 11.4 6.3 10.8 11.5 5.8 
Alkyl chain 23.8 7.4 4.2 25.4 7.7 4.4 
Inner headgroup 8.7 11.9 3.9 8.4 11.0 3.9 
Water 3.3 9.4 3.3 3.4 9.4 3.3 
SiO2 10.3 18.6 3.5 10.2 18.6 3.5 
d = thickness, σ = roughness, SLD = scattering length density  
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4 Discussion 
 4.1. Cytotoxicity of saponins 
Saponins exert a broad spectrum of biological and pharmacological activities in various 
organisms – from membrane activity, targeting metabolic pathway, affects cellular signals 
resulting in DNA damage (Lacaille-Dubois and Wagner 1996; Fuchs et al. 2009). Their 
anticancer properties have been intensively studied in various cancer cell lines and different 
mechanisms of action have been revealed. Saponins act at the extracellular and intracellular 
level on tumor cells. At the extracellular level, saponins affect membrane permeability and 
structure and also inhibit membrane proteins leading to drug efflux inhibition. Inside the cells 
they can induce apoptosis and cell cycle arrest (Podolak et al. 2010). As saponins increase 
membrane permeability, this effect may be used to enhance drug toxicity in a synergistic way 
(Bachran et al. 2009; Eid et al. 2012a; Herrmann and Wink 2011; Bachran et al. 2006). The 
degree of cytotoxicity and membrane permeability enhancing activity of saponins is 
determined by both the aglycone type (whether steroid or triterpenoid) and by the number of 
sugar moieties (Chwalek et al. 2006; Wang et al. 2007b).  
 In this study, we have tested the cytotoxicity and membrane permeability enhancing effect 
of both steroid and triterpenoid saponins as represented by digitonin and quillaja saponin, 
respectively, in five selected cancer cell lines. As a single drug, digitonin is more than 5 times 
as toxic as quillaja saponin. Low concentrations of digitonin affect cells both on the extra- and 
intracellular levels. The steroid aglycone exerts its strong anticancer effect via modulation of 
multiple cell signaling factors leading to inhibition of cell proliferation, blocking cell-cycle 
signaling in the G0/G1 phase, inducing apoptosis, modulating cyclooxygenase and 
lipoxygenase, and inhibiting fatty acid synthase (FAS), all observed in the case of diosgenin 
(Trouillas et al. 2005; Raju and Mehta 2008). Digitonin, as a monodesmosidic saponin, has 
strong detergent properties due to its ability to insert itself into the membrane and form a 
complex with cholesterol, which can disturb membrane permeability (Wink 2008). Quillaja 
saponin is a mixture of bidesmosidic saponins with small amounts of monodesmosides. The 
bidesmosides bear two sugar chains attached to C-3 and C-28 of the triterpenoid aglycone, 
making it less toxic than the monodesmosidic saponin. The high polarity of the sugar moiety of 
quillaja saponin allegedly prevents this bidesmosidic saponin from reaching the cytoplasm 
(Podolak et al. 2010). 
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4.2. Saponins enhance the toxicity of selected antitumor 
       agents and ricin 
The capacity of saponins to affect membranes and increase their permeability has been used 
to improve the cytotoxicity of antitumor drugs (Bachran et al. 2006; Gaidi et al. 2002) and 
natural products in a synergistic way (Eid et al. 2012a; Herrmann and Wink 2011). In nature, 
the synergistic effect between saponins and polar molecules show in Agrostemma githago 
seed which contain lectin and Agrostemma saponins. Lectins are very toxic polar compounds 
with a quite low cytotoxicity if applied as a single drug. However, when lectins are combined 
with Agrostemma saponins the cytotoxic effect is dramatically increased (Hebestreit and 
Melzig 2003). This phenomenon offered an interesting new focus in cancer treatment for 
combining saponins with other antitumor drugs. This enhancing effect of saponins is strongly 
related to the type of aglycone and number of sugar moieties in their structures.  
 To explore the role of the molecular structure in regard to the cytotoxicity-enhancing 
effect, we tested the monodesmosidic steroid saponin, digitonin, and the bidesmosidic 
triterpenoid saponin, quillaja saponin, with selected antitumor drugs on selected cancer cell 
lines. The application of a nontoxic concentration of the saponins (IC20 concentration) 
increased the toxicity of selected drugs more than two-fold. On average, the cytotoxicity 
enhancement ratio (CRE) of digitonin was around 1.5 with a maximum of 3.75 for 
dexamethasone in PANC-1. In combination with ricin, the highest CER was around 5.4 in  
MIA PaCa-2 and HeLa cell lines and only 1.5 for COS-7 and PANC-1. In combination with 
several classes of secondary metabolites, the average CRE by digitonin was also in the range of 
1.3 to 2.3 in drug-resistant human cancer cell lines and drug-sensitive cell lines (Eid et al. 
2012a). The combination of digitonin with two secondary metabolites generally led to CER 
values in the range of 1 to 5, only particular combinations displayed higher values (Eid et al. 
2012b). Digitonin increased the toxicity of cisplatin by 4.4-fold to 6.5-fold depending on the 
concentration of digitonin (Jekunen et al. 1993). The combination index values from our 
results and related literature indicate that digitonin mostly influences the cytotoxicity of other 
anticancer agents in a synergistic way but that some combinations have additive and 
antagonistic effects depending on the substance and the type of cells (Eid et al. 2012a,b; 
Hellmann et al. 2010; Herrmann and Wink 2011). This suggests that the toxicity enhancing 
capability of digitonin is determined by the applied concentration of digitonin in combination, 
the drugs' properties, and cell type. The monodesmosidic steroid saponin digitonin is very 
toxic to the cell membrane and appears to rupture the membrane completely.  
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 Otherwise, bidesmosidic triterpenoid saponin quillaja saponin presented better 
enhancement effect than digitonin. The average cytotoxicity enhancement ratio show by 
quillaja saponin higher than 6-folds but they are much selected with the substances. Quillaja 
saponin increased the toxicity of cisplatin, doxorubicin, and mitomycin-C by more than 5-fold 
from individual treatment, but only slightly increased the toxicity of berberine and 
dexamethasone. Quillaja saponin significantly increased the toxicity of ricin by more than  
75-fold in COS-7 and more than 10-fold in HeLa and PANC-1. Combinations of quillaja saponin 
with anticancer drugs and ricin yielded CER values above 2 and thus synergistic effects. These 
effects of quillaja saponin are similar to those reported for 'Saponinum album' from 
Gypsophila paniculata L. (baby’s breath), Caryophyllaceae, a mixture of chiefly bidesmosidic 
triterpenoid saponins, which has been shown to enhance the toxicity of the saporin chimeric 
toxins Sap-3 and SA2E in breast cancer cell lines by more than 1000-fold. The aglycones of 
both quillaja saponin and 'Saponinum album' are triterpenes with an aldehyde function at the 
C-4 position, which seems to be critical for the synergistic action. Bidesmosidic saponins have 
shown to be more active as enhancer agents than monodesmosidic saponins (Bachran et al. 
2006; Fuchs et al. 2009). The drug enhancement activity of quillaja saponin depends on the 
drug's characteristics and cell type. 
4.3 Saponins cause membrane leakage in the presence of cholesterol 
To reveal the mechanism of saponin action on membrane activity we tested the hemolytic 
activity and role of cholesterol for digitonin and quillaja saponin.  
 Red blood cells (RBC) are a suitable natural model in evaluating the effect of saponins on 
biological membranes. Saponins disrupt RBCs and this hemolytic activity depends on the 
chemical structure of the applied saponin (aglycones and sugar moieties). Many studies have 
shown that steroid saponins have stronger hemolytic effects than triterpenoid saponins 
(Nakamura et al. 1979). Both aglycone types are strongly hemolytic if they have only one sugar 
chain attached at C-3 (monodesmosidic) rather than two sugar chains (bidesmosidic) 
(Woldemichael and Wink 2001). Our results support this finding: the monodesmosidic 
digitonin shows 30-times higher hemolytic activity than the bidesmosidic quillaja saponin. 
 Cholesterol plays a special role in the action of saponins on cell membranes. Saponins 
target cholesterol and upon binding leads to membrane leakage with change in membrane 
permeability or pore formation allowing free diffusion to and from the cytoplasm (Böttger and 
Melzig 2013; Hu et al. 1996; Yu et al. 1984; Gögelein and Hüby 1984; Li et al. 2005; Seeman et 
al. 1973; Shany et al. 1974; Armah et al. 1999). We used unilamellar vesicles as a membrane 
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model to further elucidate the mechanism of this effect. We confirm that cholesterol is the 
target for saponins in the membrane. Saponins did not appear to interact with other lipid 
membrane components such as to phosphatidylcholines, sphingomyelin, or cardiolipin. Both 
saponin aglycones induced a permeability change of LUV membranes containing cholesterol. 
The sugar chain seems play a crucial role in hemolytic activity, the monodesmoside being 
more active in the membrane than the bidesmoside. The rate of membrane permeability 
induced by the saponins was relatively fast depending on saponin and cholesterol 
concentrations in the membrane. One of the main functions of cholesterol in lipid bilayers and 
biological membranes is in maintaining the membrane lipids in the liquid-ordered state 
causing the membrane to be laterally more condensed with increased packing density of the 
phospholipids. This increases the mechanical strength and decreases the permeability of the 
membranes (Ohvo-Rekilä et al. 2002; Yeagle 2012). Saponin can very easily change the 
structure of membranes that contain a high amount of cholesterol, as, e.g., RBCs with 45 mol% 
cholesterol. Hemolysis and calcein release data suggest the ratio of the interaction complex of 
saponin:cholesterol as being 1:1 (Mitra and Dungan 2001; Akiyama et al. 1980; Yu and Choi 
1986). This may explain the different observed effects of saponins on the different kinds of 
cancer cell lines. 
 Saponins not only affect membrane permeability but also change the membrane size. 
Digitonin clearly does not penetrate or change the size of pure phosphatidylcholine vesicles. In 
contrast, in the presence of cholesterol, the digitonin-cholesterol complex increased 
membrane permeability allowing buffer to enter the vesicles, dramatically changing vesicle 
size. Quillaja saponin, in contrast, only induces a slight permeability change on pure 
phosphatidylcholine vesicles, as the triterpenoid aglycone of quillaja saponin is glycosylated at 
both C-3 and C-28 (Hu et al. 1996). The quillaja saponin-cholesterol complex causes the 
membrane to become more permeable while vesicle size is retained, i.e., small pores are 
formed that allow diffusion, while the membrane remains intact. 
4.4 Digitonin and quillaja saponin permeabilize the membrane 
      by different modes 
Giant unilamellar vesicles (GUV) are suitable for microscopic real-time monitoring of saponin-
cholesterol interactions (Walde et al. 2010; Tamba et al. 2007; Tamba and Yamazaki 2005; 
Pott et al. 2008). We observed the response of single GUVs when exposed to various 
concentrations of saponins. The results support the data obtained from hemolytic and calcein 
leakage experiments. Cholesterol is clearly shown as the target for saponin and the effect of 
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inducing membrane permeability in GUVs depends on the concentration of saponin. The 
results revealed different modes of action between digitonin and quillaja saponin regarding 
increased membrane permeability. 
 Digitonin acted by an all-or-none mechanism: in the absence of cholesterol no observable 
morphological changes of vesicles where exposed even at a high concentration of ≥ 20 µM 
digitonin and even after more than 60 min. In contrast, inclusion of cholesterol in membranes 
leads to complex formation with digitonin leading to permanent pores and subsequent 
complete filling of vesicles. Strong permeability was displayed at concentrations above 10 µM 
digitonin, where all vesicles had filled with green solution. The pore size as induced by the 
digitonin-cholesterol complex appears to be bigger than 2 nm based on the free diffusion of 
Alexa 488 dye having a diameter of 1.4 nm (Bleicken et al. 2013; Weber et al. 2004; Geddes). 
This explains the selectivity of substance passage through the cholesterol membrane by the 
action of digitonin. 
 Digitonin leads to increased vesicle size, and at higher concentrations to membrane 
rupture. GUV rupturing was monitored in real time. Interestingly, vesicles start to rupture 
after filling is complete, the vesicles then deflate as the solution seeps out from the vesicles. 
The pores formed by the digitonin-cholesterol complex seem to be retained for a longer 
period of time but with diameters of much more than 2 nm, leading to structural membrane 
instability. The membranes start to reorganize to become stable again forming small compact 
vesicles at the end. Increased levels of cholesterol in the membranes of above 20% will cause 
the vesicles to suddenly burst (Menger and Keiper 1998). This result may explain the 
limitations of using digitonin as a toxicity enhancer: membranes are totally destroyed at higher 
concentrations of digitonin and cholesterol. 
 This is the first time that permeability effects caused by quillaja saponin have been 
visualized in GUVs. Quillaja saponin only slightly induces membrane permeability (less than 
10%) in pure phosphatidylcholine vesicles (Hu et al. 1996), while strong activity is found in the 
presence of cholesterol. Membrane permeability starts to be effected at a concentration of 
20 µM quillaja saponin, at 50 µM quillaja saponin all vesicles had filled with green solution 
(external vesicles solution). The quillaja saponin-cholesterol complex also formed stable and 
long-lived pores like digitonin. Interestingly, GUVs remain intact and are still visible after 
complete filling with green solution, which is not the case for digitonin. It seems that the 
quillaja saponin-cholesterol complex forms smaller pores (≤ 2 nm) than digitonin. Therefore it 
become advantages for quillaja saponin because they could allow the substances passing 
through membrane as much as possible without being limited to their own concentration and 
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cholesterol which led total rupture of vesicles like digitonin. This may also explain the effect of 
quillaja saponin to increase the toxicity of the selected anticancer drugs and ricin over 
digitonin. The smaller pore size induced by quillaja saponin leads to selective permeability 
making it a good candidate for drug toxicity enhancement. 
 In order to further understand the mechanical interaction between both types of saponins 
with cholesterol in the membrane, we observed further physical changes occurring in 
supported lipid bilayers (SLB) in the presence or absence of cholesterol caused by saponins. 
Increase in mass of SLBs after adding saponins are followed by changes in film mechanics. 
These were determined by quartz crystal microbalance with dissipation (QCM-D) while further 
characteristics of the membrane components were obtained by high-energy specular X-ray 
reflectivity (XRR). Conformational changes of the membrane were monitored by dual 
polarization interferometry (DPI). Changes of membrane thermodynamics were observed by 
differential scanning calorimetry (DSC). 
 In the absence of cholesterol, the bilayer membrane remained almost intact with each of 
the saponins. The activity of digitonin in the membrane is highly dependent on the presence of 
cholesterol. No structural changes were found in the bilayer membrane during and after 
incubation with digitonin. However, quillaja saponin showed transient interactions with the 
membranes. A very small fraction of membrane components was removed during the rinsing 
process, which most likely means that quillaja saponin interacts with SOPC and extracting it 
from the SLB membrane, thus causing the membrane to lose some mass while the membrane 
conformation remains intact (Fig. 3.37c). The fine structural analysis by XRR indicated that 
quillaja saponin remains on the membrane surface as indicated by increased density, SLD, and 
roughness of the outer headgroups of the SLB. The alkyl chain and inner headgroup part 
appears to be pulled out to the surfaces, condensing the middle and inner part of the bilayer 
(Fig. 3.38a). The interaction between quillaja saponin and SOPC was not strong enough to 
remove all lipids from the bilayer membrane but strong enough to interfere with membrane 
stability to the point of slightly increasing its permeability (Hu et al. 1996). 
 In the presence of cholesterol, both saponins interfere with membrane stability with 
different modes of action.  
 Digitonin strongly interacts with cholesterol causing the membrane to become more 
viscous and elastic, as indicated by increased membrane mass (∆f) and less rigidity (∆D) 
(Fig. 3.16d). XRR data shows that digitonin does not lead to significant membrane rupturing 
but causes cholesterol to rise to the membrane surface from the as indicated by decreased 
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SLD of the alkyl chains. The digitonin-cholesterol complex forms an additional layer on the 
membrane surface with a thickness of 45 Å and being rougher at the outermost interface with 
the bulk (Fig. 3.18b and Table 3.6). DSC was used to verify if cholesterol is removed from the 
inner membrane by formation of digitonin-cholesterol; in fact, this is clearly indicated by the 
reappearance of the main-phase transition of SOPC which can be explained by the removal of 
substitutional impurities (cholesterol molecules) that initially suppressed the phase transition 
by sustaining the system in the liquid-ordered phase. This was further verified by experiments 
with membranes incorporating 5 mol% cholesterol (Fig. 3.20). The strong digitonin-cholesterol 
complexes formed gaps between the alkyl chains and the inner head groups causing the 
solution to easily pass through the membrane in both directions, but making the membrane 
more unstable. The membrane bilayer with rearranged lipid molecules plus digitonin-
cholesterol complexes forms stable structures in the form of small compact vesicles. In GUVs 
the complete process of digitonin-cholesterol interaction could be nicely observed, from the 
increased membrane permeability to the shrinking vesicle size forming stable membrane 
structures (Fig. 3.15). At high cholesterol-digitonin concentrations, the vesicles burst (Menger 
and Keiper 1998). The data clearly explains the ability of digitonin to destroy cell membranes. 
Rather than inducing pore formation (Dourmashkin et al. 1962) it causes hemitubular or 
tubular structures (Elias et al. 1978); pore formation does not seem to be attributable to the 
cell permeabilizing activity of digitonin. In addition, at higher digitonin concentrations tubules 
will bud from membranes and eventually cause membrane disruption (Miller and Torreyson 
1977; Graham et al. 1967). Thus, digitonin does not qualify as a toxicity-enhancing agent. 
 Quillaja saponin shows a different mechanism of interaction with membrane cholesterol 
resulting from the combined effect of mono- and bidesmosides. The monodesmosides form 
complexes with cholesterol that accumulate on the outer membrane layer. This leads to gaps 
or pores that allow the bidesmosides to penetrate the membrane, which in turn stabilizes the 
pores. This scenario is supported by our QCM-D data which shows a loss of mass (positive ∆f) 
of the bilayer membrane in the presence of high amounts of quillaja saponin with the 
membrane structure remaining steady over time, indicating the release of some of the 
monodesmoside-cholesterol complexes from the membrane, with the empty space being 
filled by bidesmosides. The membrane structure remaining steady over time, indicating that 
the absorption of quillaja saponin into the inner membrane does not cause dramatic structural 
changes. Data of ∆f and ∆D show that quillaja saponin effects cylindrical pores in the 
membranes which allow more water to enter the intermembrane spaces and making the film 
less rigid (Wang et al. 2011). XRR shows that quillaja saponin inserts into the inner membrane 
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and remaining there The resulting membrane surface becomes smoother and the space 
between polar groups at the outer and inner part of the bilayer membrane increase to around 
1 Å–2 which is large enough for water and small molecules to freely enter the vesicles, the 
membrane remains intact for a longer period of time, as visualized by GUV (Fig. 3.36). The XRR 
data do not show the presence of large pores in the membrane, as indicated by the increased 
density of the inner head group layer by additional water (Wu et al. 2005). These observations 
can explain the permeability effect of quillaja saponin. Quillaja saponin thus has a potential to 
serve as a toxicity-enhancing agent, as also shown from cytotoxicity experiments using drug 
combinations. Bidesmosidic triterpenoid saponins were reported to form pores in the 
membranes in correlation with cholesterol content (Armah et al. 1999; Li et al. 2005; Lorent et 
al. 2013, 2014; Böttger and Melzig 2013), to reduce surface tension (Böttger et al. 2012), and 
effect membrane permeability more than steroid saponins (Gilabert-Oriol et al. 2013). Pore 
formation is strongly influenced by the presence of both sugar chains at C-3 and C-28 attached 
to the aglycone. Removing one sugar chain will lead to complete loss of pore-forming ability of 
triterpenoid saponins (Armah et al. 1999; Keukens et al. 1995). The aldehyde function at C-4 is 
critical for the toxicity-enhancing effect (Bachran et al. 2006).  
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4.5 Quillaja saponin – An issue of bidesmosides vs. monodesmosides 
Commercial quillaja saponin (DAB, Carl Roth) contains several triterpenoid saponins composed 
of four types of aglycones: quillaic acid, 22β-hydroxyquillaic acid, phytolaccinic acid, and O-23 
acetylated phytolaccinic acid. The type and number of saccharides attached to the aglycones vary. 
 A total of 70 saponins have been identified from quillaja saponin extract. Many of them are 
structurally similar, making it difficult to separate them by conventional HPLC. A further 
complication in trying to isolate the individual components is that quillaja saponins are weak 
chromophores. Pure standards of the individual components are not available. The identity 
and quality of commercial quillaja saponin have been evaluated only by comparative HPLC 
fingerprints. Tandem LC/MS has been used to reveal the components of quillaja saponin 
extracts (Thalhamer and Himmelsbach 2014; Kite et al. 2004; San Martín and Briones 2000). 
 The majority of saponins in commercial quillaja saponin extract are bidesmosides (>95%), 
and monodesmosides occur at a concentration of less than 5%. The latter finding is 
remarkable in that monodesmosides in commercial quillaja saponin have never been reported 
to date. Previous to our findings, quillaja saponin extract has always been considered to 
consist of bidesmosidic triterpenoid saponins such as QS–7 (C83H130O46; m/z 1861.7), QS–17 
(C104H168O55; m/z 2297.03), QS–18 (C98H158O51; m/z 2150.9) and QS–21 (C92H148O46; m/z 
1987.9), used as immunological adjuvants (Kensil et al. 1996; Kensil et al. 1997; Thalhamer and 
Himmelsbach 2014). Due to the limitations of detection of the LCQ Duo ion trap mass 
spectrometer with maximum mass detection to m/z 2000, precursors of QS–17 and QS–18 can 
not be detected. Precursors of QS–7 and QS–21 were detected and their relative amounts in 
the extract were 6.6% and 14.5%, respectively.  
The detected monodesmosides are pure substances – The monodesmosides occurring in the 
quillaja saponin extract may very well contribute to the overall activity of the extract. While 
bidesmosides are hemolytically inactive, monodesmosides strongly interact with cholesterol 
and destroy the cell membranes (Woldemichael and Wink 2001; Wink 2008; Hu et al. 1996). 
The presence of both bidesmosides and monodesmosides in the quillaja saponin extract may 
be responsible for its bioactivity and pharmacological effects. 
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4.6 Saponins and bilayer membranes – proposed mechanisms 
      of interaction 
Based on our observations, we propose two different mechanisms of interaction for the 
steroid saponin digitonin and for the triterpenoid saponin quillaja saponin with cholesterol in 
bilayer membranes.  
4.6.1 Digitonin requires cholesterol to effect bilayer membranes 
Interaction and activity of digitonin in the membrane highly depends on the presence of 
cholesterol. Digitonin cannot interact and affect membranes which do not contain cholesterol. 
However, digitonin penetrates into membranes containing cholesterol and binds to 
cholesterol molecules. The cholesterol then migrates from the hydrophobic core region to the 
outer polar group region in the form of digitonin-cholesterol complex. This does not cause the 
membrane to rupture. The sterical hindrance between saccharide residues in these aggregates 
may induce changes in the curvature of the membrane's outer layer leading thus to an 
increase in membrane permeability. Increasing amounts of cholesterol in the membrane will 
cause the membrane to more easily rupture in the presence of digitonin (Fig. 4.1). 
  
Fig. 4.1. Digitonin – model of interaction of digitonin with bilayer membrane in the absence (a) and 
presence (b) of cholesterol. 
110 
 
 
4.6.2 Quillaja saponin affects bilayer membranes without 
         cholesterol, increases membrane permeability, but leaves 
         the membrane intact 
The discovery of monodesmosides in the commercial quillaja extract opens a new perspective 
in understanding the activities of quillaja saponin on membranes. The monodesmosides and 
bidesmosides appear to act together in causing membrane permeability. Monodesmosides are 
known to interact with cholesterol, and bidesmosides lack this ability (Woldemichael and Wink 
2001). Bidesmosidic triterpenoid saponins can induce slight permeability changes of liposomal 
membranes without cholesterol (Fig. 4.2a). Type and number of attached sugar moieties to 
the triterpenoid aglycone play a great role in causing membrane permeability (Hu et al. 1996). 
The long polar sugar chains of quillaja saponin at C-28 interact with the hydrophilic top layer of 
the membrane slightly increasing the permeability, but the interaction is not as strong in the 
absence of cholesterol.  
As proposed in Fig. 4.2b, the monodesmosides from quillaja saponin insert themselves 
within the lipophilic layer of the membrane and bind to cholesterol molecules there. The 
monodesmoside-cholesterol complexes move upward and some are released from the 
membrane. Thereafter, three different scenarios may apply: i) The bidesmosides may access 
the membrane and start filling the empty spaces created by the monodesmoside-cholesterol 
complexes; the lipophilic region would now become stabilized by the two sugar chains 
attached to the triterpenoid aglycone; the two sugar chains of the bidesmosides would force a 
distance between lipid molecules at the outer and inner polar head layer, thus leading to an 
increase in membrane permeability, while the membrane remains intact. ii) The 
monodesmoside-cholesterol complex could allow the bidesmosides to slip into the membrane 
with their sugar chains pointing upward. iii) The bidesmosides could alternatively form 
complexes with monodesmosides and cholesterol forcing a distance between the 
phospholipids and increase membrane permeability while the membrane remains intact. 
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Fig. 4.2. Quillaja saponin – model of interaction of quillaja saponin with bilayer membrane in the 
absence (a) and presence (b) of cholesterol. 
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Appendix 
Quillaja saponin (DAB, Carl Roth GmbH) – data from mass spectral analysis (M, monodesmoside) 
No RT Sample (min) 
[M–H]– 
(m/z) 
A ion 
(m/z) MS2 Precursor Note 
1 1.76 1658.69  1462.03; 1469.11; 1559.10; 1802.11 1802.11  
2 2.01 1649.83  
919.24; 1022.41; 1218.79; 1445.27; 
1646.65; 17336.32; 1882.57 1882.57  
3 2.95 780.82  
311.13; 405.00; 466.61; 536.08; 602.02; 
688.49; 720.06  M 
4 3.13 1641.51  
541.10; 940.99; 1080.80; 1195.56; 1245.67; 
1307.11; 1580.48; 1701.61 1701.61  
5 3.37 986.82  451.15; 927.20   
6 3.49 1007.33 925 340.69; 454.97; 633.30; 779.32; 861.30; 925.25; 970.59   
7 3.66 510.84  254.99; 331.33; 483.16   
8 4.32 1923.81  
683.08; 750.65; 855.54; 954.08; 1055.23; 
1236.83; 1454.94; 1563.38; 1664.91; 
1819.50; 1854.22; 1996.35   
9 4.72 239.15  178.97; 220.99; 275.11   
10 4.83 1085.05  
593.09; 611.49; 784.71; 830.62; 844.92; 
1025.13; 1048.18   
11 4.89 1730.3  
1028.13; 1078.72; 1176.00; 1281.07; 
1342.06; 1424.75; 1479.88; 1631.69; 
1683.03; 1928.47 
1928.47  
12 5.01 1793.86  
845.01; 1244.97; 1406.15; 1509.04; 
1599.81; 1720.26; 1924.77 1924.77  
13 5.07 856.84  
536.84; 557.20; 663.14; 680.86; 773.62; 
809.99; 826.64; 1118.12 1118.12  
14 5.13 1676.98  
1014.18; 1064.92; 1169.08; 1258.96; 
1477.07; 1529.16; 1585.84; 1743.68 1743.68  
15 5.28 413.18  
149.04; 195.12; 217.12; 234.59; 305.09; 
394.85   
16 5.33 843.02  451.36; 625.11; 647.17; 662.97; 877.11   
17 5.51 842.89  451.36; 625.11; 647.17; 662.97; 877.11   
18 5.68 685.38  
247.00; 343.18; 423.17; 467.29; 489.20; 
667.18   
19 5.8 581.4  
203.05; 233.05; 387.01; 419.18; 535.07; 
566.12   
20 6.08 626.59  461.69; 542.89; 558.85; 575.57   
21 6.14 969.51  
626.89; 742.66; 789.54; 890.50; 901.92; 
923.14   
22 6.2 872.92  606.74; 655.30; 723.70; 827.05; 845.53   
23 6.26 942.96  
428.99; 483.06; 618.87; 632.95; 718.89; 
779.09; 900.24; 924.14; 1689.76 1689.76  
24 6.32 1071.11 925 487.08; 762.49; 779.52; 925.29; 1089.53 1089.53  
25 6.39 1220.02  
525.13; 645.13; 893.28; 927.36; 1073.32; 
1118.11   
26 6.45 1219.28  
438.70; 524.98; 747.41; 927.18; 1073.29; 
1118.35   
27 6.51 1203.39  893.35; 1057.25; 1141.10   
28 6.63 1057.36 925 307.02: 441.04; 585.38; 765.35; 911.28; 925.24, 937.18   
29 7.28 925.27  
341.34; 453.26; 615.33; 761.33; 779.30; 
805.14   
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30 7.7 1057.37  
381.13; 587.29; 731.32; 893.28; 911.28; 
925.24; 937.25   
31 8.05 925.24  
307.17; 455.26; 615.58; 761.44; 779.31; 
805.23   
32 8.53 925.32  
307.02; 487.28; 761.36; 779.28; 824.93; 
970.80   
33 9.19 927.29 985 306.99; 398.81; 599.17; 633.13; 779.25; 878.39; 985.86; 1201.81 1201.81  
34 9.31 1071.42  
473.31; 713.10; 779.40; 925.23; 1445.05; 
1802.55 1802.55  
35 9.71 1057.38  
381.34; 585.33; 765.36; 911.28; 925.21; 
937.36; 1082.50 1082.5  
36 10.21 1217.19  
357.20; 473.29; 617.20; 713.36; 763.23; 
859.17; 925.13; 964.88; 1071.22; 1424.13 1424.13  
37 10.27 1262.56  954.21; 1115.11; 1219.24   
38 10.43 1350.45  
507.14; 585.41; 747.27; 845.21; 910.99; 
991.29; 1057.41; 1203.23; 1263.56; 
1567.33; 1710.98   
39 10.49 1099.37  
632.99; 779.17; 953.34; 1057.33; 1094.52; 
1422.09; 1545.79; 1748.50 1748.5  
40 10.61 1054.68  1212.71; 1265.25; 1539.95 1539.95  
41 10.74 1009.2  
1009.72; 1051.11; 1156.58; 1180.82; 
1418.65; 1990.48 1990.48  
42 10.8 1136.47  1130.87; 1888.25 1888.25  
43 11.05 967.31  
301.38; 529.27; 701.02; 821.18; 921.04; 
1098.95 1098.95  
44 11.54 925.31  
307.14; 487.11; 633.34; 779.30; 805.07; 
1336.62   
45 11.84 755.05  
562.88; 685.41; 708.88; 772.25; 1049.14; 
1101.77; 1177.14; 1238.73 1238.73  
46 12.13 1349.36  
423.32; 743.67; 895.13; 1057.36; 1203.33; 
1368.54; 1671.75 1671.75  
47 12.38 925.29  
306.89; 450.96; 761.27; 779.28; 860.69; 
1047.50; 1394.22 1394.22  
48 13.06 1349.36  
469.55; 587.01; 925.41; 1057.44; 1203.34; 
1246.24, 1500.49; 1892.39 1892.39  
49 13.8 925.17  
307.12; 454.85; 633.17; 779.27; 877.73; 
1167.95; 1697.51; 1816.15 1816.15  
50 14.05 1217.15  
470.75; 633.35; 889.19; 925.30; 1071.25; 
1116.62; 1499.17 1499.17  
51 14.05 1263.44 955 453.99; 639.85; 955.15; 1217.01; 1291.02; 1612.69; 1707.94; 1840.24; 1940.43 1940.43  
52 14.61 1217.36  
487.35; 578.90; 779.16; 925.26; 951.05; 
1071.27; 1116.97; 1288.57 1288.57  
53 15.46 1349.33 895 441.29; 779.49; 895.47; 1057.37; 1203.34; 1245.27 1245.27  
54 15.52 1350.38  
487.29; 747.01; 925.31; 1057.40; 1203.44; 
1248.44; 1535.97 1535.97  
55 16.17 745.12  373.24; 457.02; 599.13; 640.91  M 
56 16.2 1357.15  
1163.79; 1224.33; 1272.26; 1412.18; 
1584.44; 1711.82; 1767.84; 1958.59 1958.59  
57 16.2 1217.32  
373.21; 778.69; 925.25; 1071.19; 1193.37; 
1369.47 1369.47  
58 16.57 1071.3  779.38; 925.19; 1088.71; 1331.87; 1766.62 1766.62  
59 17.02 1295.16  920.65; 1272.33; 1447.65 1447.65  
60 17.58 1217.36  
359.15; 633.12; 779.29; 925.29; 951.52; 
1071.28; 1115.99; 1372.39 1372.39  
61 18.38 1279.24  908.02; 1104.25; 1132.11; 1315.46 1315.46  
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62 20.14 1151.27  782.17; 1018.27; 1093.51; 1774.89 1774.89  
63 20.14 1297.25  
486.13; 871.33; 928.11, 1115.77; 1150.75; 
1289.14; 1488.66; 1906.45 1906.45  
64 20.63 1414.86 853 
645.17; 709.21; 853.82; 1040.28; 1132.55; 
1302.04; 1341.38; 1367.67; 1634.63; 
1894.15 
1894.15  
65 21.05 1561.14  
525.67; 545.30; 650.19; 849.61; 872.09; 
888.46; 1059.72; 1196.44; 1312.66; 
1384.23; 1413.63; 1470.13; 1509.34; 
1703.68; 1845.68; 1956.75 
1956.75  
66 21.72 985.65  
301.21; 449.40; 483.34; 501.40; 595.44; 
641.35; 787.35; 805.41; 923.46; 967.40  
A ion 
fragmentation 
67 22.25 971.41  
274.97; 355.43; 439.44; 483.67; 501.60; 
595.60; 641.63; 777.57; 839.51; 909.49; 
953.47   
68 22.37 1428.98  
632.38; 845.36; 871.28; 921.90; 944.81; 
1054.50; 1189.16; 1236.64; 1285.38; 
1396.66; 1498.40; 1643.28; 1884.02; 
1974.44 
1974.44  
69 22.48 639.29  231.17; 325.21; 467.25; 509.23; 621.23  M 
70 22.54 1515.55  
503.61; 615.34; 707.44; 827.50; 974.52; 
1105.58; 1237.60; 1369.67; 1426.52; 
1505.64   
71 22.71 1383.51  
438.90; 499.12; 645.18; 707.29; 737.16; 
1075.40; 1147.49; 1237.48; 1293.44   
72 22.92 1353.62  
469.20; 615.23; 665.47; 811.28; 1053.54; 
1075.37; 1117.43; 1207.58; 1263.36   
73 23.56 1398.99  
638.21; 659.37; 782.38; 836.45; 1237.31; 
1282.33; 1326.45   
74 23.79 1353.54 985 483.22; 615.26; 707.38; 985.29; 1075.43; 1221.50; 1263.36, 1399.08 1399.08  
75 23.84 1398.86  
467.26; 576.91; 625.32; 659.14; 709.41; 
870.69; 942.96; 1045.27; 1158.24; 1251.44; 
1325.73; 1377.74   
76 23.96 1221.47 985 439.21; 555.13; 645.22; 749.32; 925.21; 985.27; 1075.44; 1131.34; 1190.48   
77 24.01 1266.95  484.11; 822.03; 835.98; 968.90   
78 24.13 1221.47 985 422.75; 483.23; 545.42; 707.32; 730.45; 853.04; 985.10; 1075.43; 1131.34   
79 24.46 1207.55  
392.39; 451.05; 469.20; 541.20; 665.35; 
737.38; 793.27; 971.54; 1075.45; 1117.46   
80 24.52 1674.71 955 495.69; 579.25, 823.46; 955.53; 1205.54; 1344.80; 1541.47; 1651.49   
81 24.57 1673.69 955 485.30; 579.40; 823.48; 955.59; 1151.61; 1344.09; 1541.58; 1656.36   
82 24.68 1877    
No MS2 
data 
83 24.74 1399  
554.74; 575.31; 708.88; 842.78; 947.07; 
1097.70; 1119.33; 1267.69; 1355.24; 
1954.35 
1954.35  
84 25.14 1191.56 955 483.34; 545.36; 615.28; 637.48; 823.66; 894.81; 955.54; 1101.38; 1173.20   
85 25.6 1511.63 955 485.42; 579.44; 823.49; 955.54; 1042.64; 1241.48; 1379.47; 1493.60 1493.6  
86 25.77 1565.71 939 
512.35; 681.06; 844.22; 939.69; 1095.76; 
1255.91; 1421.60; 1463.55; 1503.55; 
1532.60   
87 25.93 1191.59  
423.06; 483.14; 615.19; 913.44; 964.44; 
1059.42; 1101; 1146.94   
88 25.93 1237  711.38; 729.11; 1208.65   
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89 26.66 1105.01  580.07; 971.83; 1008.46   
90 26.72 1059.45  969.19   
91 26.99 1861.8 955 
539.61; 743.26; 906.40; 955.48; 971.37; 
1245.97; 1555.51; 1700.69; 1730.58; 
1843.57; 1921.37 
1921.37  
92 27.09 1716.83 955 
485.29; 579.47; 823.58; 955.49; 1116.66; 
1312.55; 1553.02; 1584.39; 1698.18; 
1861.55 
1861.55  
93 27.09 1863.52 955 
537.18; 553.42; 743.19; 905.34; 955.54; 
1233.25; 1332.69; 1611.53; 1729.53; 
1843.44; 1922.10   
94 27.14 827.3  
246.10; 469.30; 545.40; 733.23; 781.28; 
827.16   
95 27.14 1716.07 955 
485.29; 579.47; 823.58; 955.49; 1116.66; 
1312.55; 1553.02; 1584.39; 1698.18; 
1861.55   
96 27.2 827.26 955 247.20; 503.53; 733.24; 781.27; 826.79; 955.41 955.41  
97 27.49 1699.58 955 
535.56; 579.35; 805.50; 893.53; 955.52; 
1127.35; 1323.58; 1491.55; 1538.81; 
1567.56; 1640.58   
98 27.65 1773.6 971 
595.55; 631.39; 777.31; 909.51; 971.51; 
1175.67; 1427.47; 1585.75; 1641.67; 
1755.62; 1826.65 
1826.65  
99 27.75 955.55  
319.96; 405.57; 485.53; 579.46; 761.49; 
775.49; 823.42; 893.50; 909.83  
A ion 
fragmentation 
100 28.22 1757.75 955 
501.39; 579.31; 823.44; 955.51; 1186.09; 
1287.56; 1535.49; 1626.70; 1697.51; 
1740.54; 1898.53 
1898.53  
101 28.28 1553.56 955 
485.07; 689.46; 805.40; 893.44; 955.53; 
1165.50; 1391.60; 1421.63; 1449.72; 
1626.55; 1813.42 
1813.42  
102 28.62 1331.56 895 452.38; 545.17; 650.31; 665.43; 793.36; 895.53; 939.56; 1031.46; 1271.41   
103 28.85 711.36  665.34; 711.20  M 
104 28.9 1904.63 955 
553.57; 699.48; 823.50; 955.52; 971.43; 
1272.66; 1528.12; 1697.38; 1742.63; 
1772.66; 1799.75; 1885.70; 1974.06 
1974.06  
105 28.96 1903.56 955.55 
554.28; 699.07; 805.43; 955.55; 971.56; 
1289.59; 1433.57; 1641.60; 1741.82; 
1771.80; 1918.72; 1954.32   
106 29.12 1475.75 895 
516.30; 625.57; 791.64; 895.53; 937.50; 
1084.55; 1295.65; 1331.60; 1373.57; 
1433.63; 1518.44; 1973.42   
107 29.3 1948.72 955 
581.51; 715.97; 823,49; 955.56; 973.35; 
1150.58; 1330.91; 1574.50; 1699.62; 
1786.60; 1816.80; 1861.74; 1929.67   
108 29.4 793.42  
306.93; 405.58; 485.42; 513.38; 567.39; 
661.39; 731.47; 770.76  M 
109 29.7 1872.79 955 
568.55; 699.34; 717.23; 793.49; 909.63; 
955.50; 978.71; 1356.59; 1380.65; 1421.48; 
1553.85; 1647.62; 1742.60; 1853.62; 
1978.73 
1978.73  
110 29.88 1683.63 955 
495.58; 805.55; 939.62; 955.52; 986.32; 
1308.58; 1511.67; 1553.66; 1665.63; 
1696.88; 1871.56 
1871.56  
111 29.94 1785.66 955 
581.45; 761.32; 823.53; 955.61; 1024.70; 
1263.29; 1393.33; 1621.69; 1653.69; 
1699.63; 1768.61; 1860.75 
1860.75  
129 
 
112 30.16 1475.65 895 515.56; 671.53; 715.55; 895.58; 937.44; 1193.58; 1331.60; 1373.55; 1458.68; 1751.49 1751.49  
113 30.16 1757.71 955 
501.39; 579.31; 823.44; 955.51; 1186.09; 
1287.56; 1535.49; 1626.70; 1697.51; 
1740.54; 1898.53 
1898.53  
114 30.38 1871.71 955 
565.11; 644.68; 823.56; 955.57; 995.90; 
1248.60; 1289.64; 1383.84; 1511.68; 
1553.65; 1665.68; 1853.68; 1905.35 
1905.35  
115 30.5 1975.42 955 
794.75; 837.34; 955.69; 1022.52; 1212.58; 
1351.46; 1633.81; 1665.99; 1828.79; 
1856.00; 1888.61; 1966. 91   
116 30.61 1885.73 823 
533.72; 643.38; 823.49; 970.56; 1148.79; 
1305.54; 1409.56; 1545.63; 1623.60; 
1867.52; 1990.50 
1990.5  
117 30.92 1987.84 955 
625.43; 793.48; 955.55; 1100.65; 1407.72; 
1511.66; 1553.78; 1647.78; 1819.66; 
1970.65   
118 31.28 1053.48  
483.21; 511.17; 699.00; 741.01; 909.32; 
951.53   
119 31.6 1476.63 895 
516.69; 629.65; 791.58; 895.57; 1108.52; 
1252.76; 1295.49; 1373.59; 1433.58; 
1518.31; 1879.62 
1879.62  
120 31.71 1856.75 955 
553.10; 643.49; 823.49; 955.51; 972.52; 
1247.57; 1379.64; 1421.65; 1515.71; 
1688.63; 1837.67; 1988.92 
1988.92  
121 31.91 1987.87 955 
582.65; 714.56; 836.65; 955.59; 989.56; 
1227.29; 1335.39; 1511.69; 1553.59; 
1647.59; 1726.60; 1820.91; 1969.61   
122 32.46 1825.69 955 
567.61; 661.56; 793.51; 955.48; 1049.08; 
1349.64; 1391.67; 1485.69; 1563.56; 
1808.73; 1876.79; 1977.04   
123 32.51 1897.74 955 
535.58; 775.44; 909.12; 955.54; 997.67; 
1223.70; 1380.21; 1421.86; 1463.68; 
1575.67; 1730.70; 1880.61; 1957.78   
124 32.78 1517.87 895 
435.21; 667.43; 715.65; 895.47; 937.57; 
1253.61; 1373.53; 1415.52; 1500.53; 
1750.79; 1941.58   
125 33.43 1692.68 895 
515.56; 653.44; 791.40; 895.50; 1027.57; 
1089.22; 1287.57; 1420.59; 1559.62; 
1589.65; 1649.65; 1723.23; 1836.60   
126 33.55 1972.57 939 
583.74; 807.44; 939.53; 1007.63; 1208.45; 
1405.90; 1495.73; 1537.74; 1631.69; 
1709.59; 1803.65; 1954.66   
127 33.7 1559.68 895 
515.48; 630.49; 791.55; 895.50; 1031.54; 
1176.33; 1287.58; 1457.53; 1517.56; 
1542.40; 1787.11; 1977.52   
128 34.54 1580.64 939 
469.11; 547.52; 565.36; 807.46; 939.51; 
1075.51; 1203.37; 1315.32; 1417.71; 
1447.65; 1561.52; 1858.42   
129 34.78 1358.98  
1093.00; 1134.37; 1255.29; 1317.47; 
1399.19   
130 34.84 909.63  
275.02; 409.54; 421.41; 535.06; 715.43; 
759.45; 777.46; 862.44; 1294.34 1294.34  
131 34.9 977.32  450.20; 841.08; 909.48; 931.43; 974.61   
132 35.2 1559.73 895 
483.08; 625.51; 715.60; 895.49; 937.57; 
1236.46; 1415.46; 1457.62; 1517.60; 
1680.82; 1996.52 
1996.52  
133 36.3 1688.64 895 
515.95; 626.73; 791.58; 895.49; 1108.10; 
1287.60; 1317.59; 1559.49; 1602.62; 
1627.65; 1669.67; 1701.13; 1861.49   
134 36.66 1680.14  
483.28; 631.29; 716.98; 1099.59; 1203.46; 
1339.48; 1507.18; 1619.29; 1984.64   
130 
 
 
135 37.84 1648.57 983 
555.17; 683.00; 852.53; 903.50; 983.51; 
1171.55; 1307.41; 1375.62; 1516.52; 
1545.57; 1606.54; 1764.18; 1943.10 
1943.1  
136 38.03 1051.09  919.97; 1141.82; 1826.61 1826.61  
137 38.29 1515.57 851 
586.02; 671.63; 787.81; 851.55; 893.47; 
1063.63; 1234.56; 1371.59; 1413.59; 
1473.63; 1682.74; 1786.26 
1786.26  
138 39.28 1518.45 937 
485.58; 605.19; 730.88; 937.35; 1041.48; 
1177.37; 1345.46; 1498.89; 1624.92; 
1904.77 
1904.77  
139 39.53 1562.34  
831.01; 963.03; 1069.42; 1295.36; 1440.97; 
1518.61; 1543.28   
140 39.68 1385.12  1252.30; 1438.49; 1516.19 1516.17  
141 40.07 815.34  304.89; 621.43; 747.45; 769.40; 1460.62 1560.62  
142 40.19 747.47  
393.29; 422.08; 497.66; 617.32; 729.51; 
958.38; 958.38; 1294.17; 1475.07 1475.07  
143 40.29 883.03  646.25; 815.36; 837.33; 852.04; 1559.17 1559.19  
144 40.91 905.09  
561.06; 798.32; 829.72; 1056.87; 1156.60; 
1240.99 1240.99  
145 41.1 1560.19  
485.58; 748.71; 833.43; 937.59; 1041.59; 
1083.37; 1219.44; 1387.26; 1517.41; 
1626.08 
1626.08  
146 42.9 959.27  
772.93; 891.29; 913.39; 940.46; 1129.73; 
1598.11 1198.11  
147 43.09 553.25  485.41; 523.36; 552.59  M 
148 43.59 649.11  
405.31; 477.08; 581.08; 605.07; 649.23; 
695.92; 871.05 871.11 M 
149 44.75 952.89  
804.97; 883.46; 909.40; 933.56, 1617.39; 
1638.84   
150 45.53 893.61  
423.43; 472.97; 587.00; 731.46; 761.47; 
846.94; 1392.12; 1489.73; 1794.95 1794.95  
151 45.53 1029.28  
403.60; 1125.82; 1185.38; 1269.92; 
1592.99 1592.99  
152 45.59 961.45  598.61; 893.37; 915.37; 938.35; 1704.67 1704.67  
153 45.72 893.52  
308.77; 423.30; 519.24; 544.42; 712.94; 
743.43; 761.40; 849.31; 946.86; 1447.57 1447.57  
154 46.31 961.41  868.74; 915.43; 1039.47; 1167.53 1167.53  
155 47.53 625.11  424.10; 463.55; 556.09   
156 47.53 1661.97  
870.93; 1308.69; 1380.57; 1565.93; 
1529.49; 1636.21; 1819.11; 1911.78 1911.78  
157 47.77 1615.77  
536.77; 967.89; 1075.51; 1221.45; 1353.49; 
1483.76; 1546.62; 1970.14 1970.14  
158 47.92 539.41  471.36; 492.91; 574.62; 963.43 963.43 M 
159 49.24 650.94  
582.45; 622.72; 817.81; 932.77; 1073.19, 
1295.65 1295.65  
160 49.5 607.19  539.40; 589.28; 715.77  M 
161 50.86 1660.84  
822.92; 968.25; 1336.33; 1379.42; 1613.45; 
1857.68; 1925.99 1925.99  
162 52.03 1637.73  
782.11; 1302.00; 1358.72; 1380.21; 
1515.25; 1564.46; 1700.69; 1822.35; 
1914.35 
1914.35  
163 52.64 939.27  
502.36; 532.98; 656.01; 802.36; 839.40; 
973.98; 989.00; 1460.88; 1768.17; 1813.08 1813.08  
164 52.85 1662.89  
743.42; 923.28; 1143.36; 1207.17; 1358.32; 
1551.21; 1593.54; 1615.57; 1804.80; 
1960.72 
1960.72  
131 
 
165 52.91 1663.9  
764.72; 1214.88; 1398.64; 1570.30; 
1594.49, 1616.27; 1807.05 1807.05  
166 53.04 1591.97  
597.22; 615.31; 648.30, 945.64; 1125.02; 
1207.45; 1335.49; 1445.41; 1546.57; 
1618.04; 1880.60   
167 53.7 1528.95  
633.25; 1265.54; 1482.26; 1510.71; 
1638.42 1638.42  
168 54.42 1504.98  
781.25; 1243.22; 1386.99; 1488.32; 
1511.63; 1700.32 1700.32  
169 54.74 1459.61  
483.07; 665.39, 751.44; 936.27, 1089.50; 
1113.56; 1221.45; 1313.45; 1457.08; 
1678.47; 1860.02 
1860.02  
170 55.4 1486.42  
482.82; 737.28; 889.13; 972.49, 1075.49; 
1221.56; 1256.86; 1396.54; 1505.84; 
1891.60 
1891.6  
171 55.53 1531.26  
818.30, 1432.81; 1484.46; 1535.67; 
1677.28; 1730.81; 1940.45 1940.45  
172 55.9 1591.38  
483.11; 555.12; 615.36; 805.58; 1011.70; 
1113.67; 1221.44; 1353.44; 1459.55; 
1501.64; 1525.86; 1708.22, 1906.69 
1906.69  
173 56.88 1617.49  
527.04; 555.15; 793.55; 929.69; 1113.58; 
1221.56, 1335.53; 1485.63; 1510.72, 
1694.46; 1990.43 
1990.43  
174 59.62 828.36  
253.31; 571.16; 768.43; 783.47; 951.88; 
1194.47; 1478.95 1478.95  
175 59.92 593.43  
187.17; 201.25; 337.06; 423.12; 549.47; 
595.11; 756.99  M 
176 60.1 833.61  
297.06; 391.15; 526.58; 553.19; 577.09; 
672.18; 833.61; 1264.97; 1646.55 1646.55  
177 60.22 1227.33  
714.40; 1228.49; 1624.82; 1760.13; 
1874.85 1874.85  
178 60.64 833.5  
241.24; 391.24; 413.31; 553.27; 577.31; 
772.54; 833.54; 886.94; 1323.40, 1613.88 1613.88  
179 60.7 1619.67  
469.41; 615.12; 811.29; 931.61; 1131.55; 
1221.55; 1353.51; 1487.48; 1667.13; 
1777.29; 1959.34 
1959.34  
180 60.89 1253.48  
763.10; 1163.02; 1259.21; 1505.70; 
1657.20; 1978.69 1978.69  
181 60.95 1665.06  
811.30; 978.32; 1001.47; 1265.28; 1375.11; 
1571.90; 1702.32; 1762.30; 1916.22 1916.22  
182 61.38 1620.55  
469.04; 615.27; 737.34; 973.59; 1113.02; 
1221.53; 1335.46; 1487.52; 1557.28; 
1741.31; 1871.34 
1871.34  
183 61.75 1227.47  
943.59; 1154.90; 1177.22; 1215.11; 
1354.38; 1455.88; 1577.60; 1623.45; 
1658.44; 1850.26 
1850.26  
184 61.99 1253.47  
1197.25; 1261.60; 1328.38; 1577.88; 
1636.21; 1696.72; 1848.81; 1916.32 1916.32  
185 62.36 745.38  
320.74; 414.93; 509.18; 555.50; 684.28; 
727.20; 744.44; 956.33; 1114.57 1114.57  
186 62.77 757.45  
349.94; 462.16; 699.19; 711.12; 739.29; 
756.40; 774.52  M 
187 62.84 731.43  
269.21; 307.30; 390.88; 494.19; 575.53; 
713.30; 730.41  M 
188 62.95 593.4  
187.15; 200.92; 337.02; 423.14; 524.98; 
593.41  M 
189 63.31 1487.29 985 
641.48; 749.23; 985.62; 1131.46; 1221.42; 
1266.87; 1397.29; 1496.68; 1697.75; 
1840.15 
1840.15  
190 63.49 1532.88  
642.41; 767.04; 795.27; 1017.04; 1094.34; 
1462.83; 1551.27; 1672.60; 1695.56; 
1789.21; 1882.07; 1968.16 
1968.16  
132 
 
 
191 63.55 1488.74  
466.12; 483.26; 665.71; 749.47; 968.20, 
1131.46; 1221.51; 1398.63; 1533.61; 
1817.90; 1976.00 
1976  
192 63.8 761.42  
305.01; 337.48; 390.81; 466.20; 649.22; 
661.02; 761.30  M 
193 64.63 691.42  
285.15; 413.20; 533.39; 601.16; 672.23; 
691.52; 828.29 828.29 M 
194 64.93 726.56  
243.81; 311.21; 446.96; 465.25; 584.31; 
690.51; 796.57 796.57 M 
195 65.05 733.57  
224.04; 327.34; 422.91; 477.06; 578.15; 
733.02; 795.76; 973.93 973.93  
196 65.11 727.21  264.22; 463.47; 584.26; 699.65  M 
197 65.47 728.42 956 
223.16; 321.24; 414.55; 471.10; 552.32; 
683.48; 728.29; 746.49; 956.13; 1133.08; 
1232.33 
1232.33  
198 66.36 593.38  
187.08; 201.18; 337.09; 423.21; 593.37; 
611.06; 812.09; 970.90   
199 66.57 693.39  
277.37; 413.18; 519.28; 665.47; 692.61; 
892.81  M 
200 66.63 745.57  
236.17; 260.13; 335.61; 422.92; 489.31; 
505.01; 727.33, 745.81  M 
201 67.47 726.22  
242.81; 445.27, 616.25; 681.41; 707.39; 
1157.49 1157.49  
202 68.31 669.58  
242.92; 261.00; 412.78; 431.31; 499.22; 
651.45   
203 69.63 687.19  447.07; 496.20; 642.69; 686.88; 837.38 837.38  
204 71.47 687.27  
255.31; 452.44; 545.56; 641.71; 686.73; 
1338.94 1338.94  
205 75.88 687.32  
280.91; 294.77; 544.77; 641.59; 686.70; 
1337.39 1337.39  
 
 
